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A B S T R A C T 
At least three populations of cells are thought to be required for 
the induction of cytotoxic T cell responses to alloantigens in vitro. 
These include: 
+ . 
a population of Ly 2,3 cytotoxic T cell precursors, a 
lymphoid stimulator population and an adherent accessory cell population. 
There is some suggestion that a fourth population of Ly-1+ helper T cells 
may also be a necessary inclusion. Although the T cells responding to 
alloantigens have been well characterised there is still considerable 
debate concerning the identity of the cells which stimulate responses. 
Thus, while it is generally agreed that lymphoid cells are a better source 
of stimulator cells than non-lymphoid cells the relative capacity of 
B cells, T cells and macrophages to stimulate cytotoxic T cell responses 
remains contentious. Similarly, the identity and the function of the 
adherent accessory cell population is unresolved. 
In this thesis an attempt is made to determine the relative stimu-
lator activity of various subpopulations of lymphoid cells and to 
characterise the adherent accessory cell population. These comparative 
studies were facilitated by the use of a standardised MLC procedure and 
the expression of cytotoxic activity in terms of a derived unit - the 
cytotoxic unit. 
Ontogenic studies and studies with adult lymphoid populations pro-
vided evidence that stimulator activity was a function of both mature 
and irmnature lymph oid cells and was not dependent on the presence of 
surface Ig, Ia or theta antigen, or Fe or complement receptors. In 
contrast to lymphocytes mature macrophages were poor stimulators. 
P815-X2 mastocytoma cells, L-929 cells and IgA plasmacytoma cells all 
induced responses of magnitude similar to those observed with lymphocytes. 
Significant cytotoxic T cell responses were obtained in the absence of 
an!_ region difference between the stimulator and the responder population, 
s .uggesti.ng that helper T cells which recognise Ia antigens are not an 
absolute requirement for the induction of cytotoxic T cell responses in 
vitro. 
When mature, non-adherent, resting lymphocytes were used as a source 
of stimulator cells in primary MLC there was an additional and absolute 
requirement for an adherent accessory cell population. This cell popu-
lation was present predominantly in spleen, bone marrow and foetal liver, 
and to a lesser extent in lymph nodes and the peritoneal cavity, but was 
absent from the thymus. The accessory cells were required for the 
induction rather than the maintenance of the response, functioned whether 
syngeneic or allogeneic with the responder population and were completely 
removed by treatment with carbonyl iron. Moreover, the observation that 
accessory cells could be replaced with L cells and factors produced by 
lymphoid cells cultured in the absence of antigen, suggested that this 
population featured in neither the presentation nor the processing of 
antigen and thus differed from the accessory cell population required for 
the induction of antibody responses in vitro. 
+ -
The splenic accessory cell was further characterised as an Ig 8 
+ + 
and tentatively FcR-, CR-, Ia cell which was not a mature macrophage. 
This data together with indirect evidence from ontogenic studies implied 
that the functional population was comprised predominantly of immature 
B cells, although the possibility that some accessory cells were immature 
+ FcR macrophages was not completely eliminated. 
Although accessory cells were required for the induction of primary 
responses when resting lymphocytes were the source of stimulators this 
requirement was less critical when neoplastic stimulator cells or memory 
responder populations were used. 
A model suggesting possible mechanisms by which cytotoxic T cell 
precursors, lymphoid stimulator cells and adherent accessory cells may 
interact in the induction of cytotoxic T cell responses in vitro was 
proposed. Briefly, this involved the recognition, by responder T cells, 
of alloantigens presented on the surface of "stimulator cells". It was 
s _uggested that only cells which were activated, and as a result of such 
activation, were able to produce inductive stimuli were able to function 
as "stimulator cells". The conversion of resting lymphocytes to 
"stimulator cells" was thought to be a function of the adherent accessory 
cell population. 
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Preamble 
In the past, the biology of the T lymphocytes has lagged well behind 
that of the B lymphocytes. The last five years, however, have seen the 
recognition of the functional heterogeneity of the T cell population, the 
complex interaction of T cells with each other and with B cells and macro-
phages, and perhaps most importantly, the central role of the products of 
the major histocompatibility complex (MHC) in T cell function. Today, 
this field is still highly speculative and there is little information 
regarding the nature of the antigens which stimulate the various sub-
populations of T cells, the cellular requirements for stimulation and the 
types of receptors T cells use for rec_ogni tion of an ti gen. 
One subclass of T cells - the cytotoxic T cells - which for some 
years has been thought to play a prominent role in allograft rejection 
and inununity to some virus infections and possibly tumours, has proven a 
useful model for the study of the cellular and ant_igenic requirements for 
T cell induction. The following review of cytotoxic T cells is not 
intended to be all-inclusive. Rather, the aim is to present an overview 
with emphasis placed on some of the currently important issues and 
problems in the field. By way of introduction, and, more importantly, to 
emphasise the complexity of T cells as a class, it was considered worth-
while to briefly review the literature which suggests that T cells can be 
divided into functionally unique subsets, one of these being cytotoxic T 
cells. 
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1.1 Functional heterogeneity of the T cell pool 
Historically, it was recognised that the immune response to foreign 
substances consisted of two basic components: (1) humoral immunity in 
which antibodies, characterised as immunoglobulin molecules, were 
synthesised and released into the circulation and (2) cell-mediated 
inununity which occurred independently of hurnoral immunity and was 
responsible for the delayed type hypersensitivity reactions, transplant-
ation immunity and cellular resistance to certain viruses and bacteria. 
Subsequently, the effector population in hurnoral immunity was found to 
be the bone marrow-derived B lymphocyte (for review, see Miller and 
Mitchell, 1969) and in cell-mediated immunity the thymus-derived T 
lymphocyte (for review, see Miller and Osoba, 1967). 
More recently, research has extended to the cellular requirements 
for the induction and control of these responses and it has become 
increasingly evident that T cells play a prominent role in this respect. 
Thus, T cells represent a very heterogeneous class of lymphoid cells 
whose diverse activities can be divided into the following categories: 
(1) Helper/initiator 
(2) Suppressor/regulator 
{3) Inflammatory ( GVH, DTH) 
(4) Cytolytic. 
Realisation of this functional heterogeneity has led researchers in 
the field to pose two fundamental questions: firstly, whether individual 
T cell functions are mediated by unique and separable subsets of T cells 
and secondly, if such differentiation does exist, whether it occurs 
before or after antigenic stimulation? 
In the past, attempts to answer these questions have been hampered 
' 
by the absence of both single cell techniques analogous to those used in 
the study of B cells and unique markers for individual T cells and their 
products. As a result of these limitations T cell subpopulations were 
characterised indirectly and defined by criteria such as quantity of 
cell surface theta (8) antigen (Shortman et al., 1972a, Shortman et al., 
1975); size, density and electrophoretic mobility (for review, see 
Shortman et al., 1975); horning characteristics and tissue distribution 
(Cantor and Asofsky, 1970; Cantor and Asofsky, 1972; Wagner, 1973; 
Tigelaar and Gorczynski, 1974); and sensitivity to adult thymectorny and 
anti-thymocyte serum(Kappler et al., 1974; Cantor et al., 1975). Taken 
collectively, data from these studies only suggested that following 
antigenic stimulation, individual functions may be performed by T cells 
that have different biological and physical properties. 
More recently, however, with the use of T cell specific anti-Ly 
alloantisera (Boyse et al., 1968; Itakura et al., 1972; Shen et al., 
1975) and antisera to the Ir region associated (Ia) antigens (Murphy 
et al., 1976) more direct evidence for the existence of functionally 
unique subsets of T cells has become available. Table 1.1 summarises 
data on the separation of T cells into various subclasses on the basis 
of these markers. 
Thus, at least three of the four categories of T cell functions 
appear to be mediated by individual and separable subpopulations of T 
+ + + 
cells, namely Ly-1 helper cells (TH), Ly2,3 Ia suppressor cells (TS) 
+ 
and Ly2,3 Ia cytotoxic cells (TC). T cells involved in delayed type 
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hypersensitivity (DTH), although separable from cytotoxic and suppressor 
T cells cannot currently be separated from helper cells. The differences 
between the two subpopulations of cytotoxic T cells will be discussed in 
subsequent sections. 
Further studies with Ly alloantisera have also indicated that 
helper (Cantor and Boyse, 1975a; Jandinski et al., 1976), suppressor 
(Jandinski et al., 1976) and cytotoxic (Cantor and Boyse, 1975a) T cells 
are functionally committed prior to stimulation with antigen. 
TABLE 1.1 
DIFFERENTIATION OFT CELLS ON THE BASIS OF CELL SURFACE MARKERS 
Ly expression 
T cell subset 
Ly-1 Ly-2 Ly-3 
Helper/initiator (TH} + 
Suppressor/regulator (TS) + + 
Cytotoxic (TC) allogeneic + + 
Cytotoxic (TC) TNP modified self + + + 
DTH (TD) + 
Surface Ia 
+ 
References 
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In surranary, it now appears that helper, suppressor and cytotoxic T 
cell functions are mediated by separate subpopulations of T lymphocytes 
which are committed to these functions pri or to contact with antigen. 
1.2 The history of cytotoxic T cells and their importance in vivo 
1.2.1 Historical review 
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Much of the early work on tissue transplantation was carried out 
using malignant tumours. From such studi es it was e stablished that 
lymphocyte infiltration was associated with the p athology of graft 
rejection (De Fano, 1910). However, Murphy (19 13, 1914) and Murphy and 
Taylor (1918) were the first to suggest that r e jection o f t ransplanted 
neoplastic tissue may be the result of an acti ve immune r e s p onse by the 
recipi"ent. 
Nearly twenty years elapsed before Gorer (1937 , 1938), i n a c lassic 
series of papers, defined histocompatibility antigens and thu s established 
the_ genetic and immunological basis of rejecti o n . At the s ame t ime, 
Medawar (1944, 1945) described the rejection of skin homografts in man 
and rabbits and formulated the general rule t hat tra nsplantation immunity 
was the outcome of a systemic and not a local reaction. Medawar (1944, 
1945) further proposed that the immunological me chanisms involved in 
graft rejection were specific and differed from thos e of c onventional 
antigen-antibody reactions. 
Support for this suggestion came later f rom histological studies 
performed by Kidd and Toolan (1950) which s h owed that infiltrating lympho-
cytes had a cytotoxi c effect on tumours under going rejection. Similar 
findings were later reported by Waksman (1960) for allograft rejection. 
If the small lymphocyte does in fact initiate the response to allo-
grafts, the inj e ction of such cells wo u ld be expected to transfer this 
capacity to non-immune ani mals and l ead either to sensitisation of the 
new recipient or to the breakdown of well established grafts in tolerant 
hosts. These expecta tions have been borne out, firstly , by experiments 
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involving adoptive transfer of tumour irrununity with sensitised lymph node 
cells by Mitchison {1954; 1955) and secondly, by abrogation of neonatal 
tolerance to transplantation antigens by transfer of lymph node cells of 
histoidentical donors (Billingham et al., 1956). The active population 
in such transfer studies was later identified as the small lymphocyte 
(Gowans, Gesner and McGregor, 1961; Gowans and Knight, 1964; Gowans and 
McGr_egor, 1965) . 
By 1961 there was therefore considerable evidence to suggest that 
specifically sensitised cytotoxic lymphocytes play a p=ominent role in 
both tumour and allograft rejection. 
1.2.2 In vitro demonstration of cytotoxic T cells 
The next major pr_ogress1.on in the study of irrununity to allografts 
and tumours was the development of in vitro methods for the assessment 
of the direct cytotoxic activity of immune lymphoid cells for donor target 
cells. Prior to 1960, evidence for cytopathic effects of lymphoid cells 
in graft rejection had been gathered, almost exclusively, from in vivo 
experiments where it was difficult to analyse the immune reaction at the 
cellular level. 
The pioneers 1.n the development of in vitro methods in this field 
were Govaerts (1960) and Rosenau and Moon (1961, 1962). The former 
author demonstrated that donor kidney target cells were specifically 
recognised and destroyed by TDL's from dogs bearing kidney allografts. 
Rosenau and Moon obtained similar results with BALB/c spleen cells from 
mice sensitised with L cells, as effectors, and L cells as targets. In 
contrast to Govaerts, these authors also demonstrated that target cell 
destruction by the effector population was independent of antibody or 
complement. 
Similar studies soon followed in many laboratories (for review, see 
Perlmann and Holm, 1969). The methods employed for the detection of 
effector cells ranged from estimations of cell death (Govaerts, 1960; 
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Rosenau and Moon, 1962; Wilson, 1963) and cloning assays (Brunner et al., 
1966) to an isotope ( 51 Cr) release assay initially described by Holm and 
Perlmann (1967), and later adapted by Brunner and colleagues (1968), 
which has subsequently been universally adopted as the method of choice. 
The lymphoid cells responsible for direct cytotoxic effects in vitro 
in the 51 cr release assay have been shown to be T cells. Initially this 
was demonstrated indirectly using in vivo sensitised thymus cells 
(Cerottini et al., 1970a) and then subsequently directly, using anti-8 
serum and complement treatment of sensitised cells (Cerottini et al., 
1970b) • The activity of cytotoxic T cells, as well as bei_ng specific was 
also shown to be independent of antibody and complement, normal Tor B 
cells, antibody producing cells and macrophages (Cerottini et al., 1970b; 
Cerottini et al., 1971 i Cerottini et al., 1972). 
These results, which were confirmed in several other studies 
(Blomgren et al., 1970; Miller et al., 1971; Sprent and Miller, 1972), 
clearly indicated that sensitised T cells capable of specifically and 
independently lysi_ng cells syngeneic with those used for sensitisation, 
could be obtained from animals undergoi_ng allograft rejection or GVH 
reactions. 
Much less information is available in syngeneic tumour systems. 
The two systems most extensively studied are those involving murine 
leukaemia and sarcoma virus induced tumours in rodents (for reviews, see 
Shellarn et al., 1976; Tevethia et al., 1976). Using these models several 
workers have demonstrated the presence of specific cytotoxic T cells 
in animals undergoing tumour rejection (Leclerc et al., 1973; Djeu et al., 
1974; Shellam, 1974). 
It should be emphasised at this point that cells other than cyto-
toxic T cells have since been found to mediate in vitro cytotoxicity in 
both allograft and tumour systems. Two main cell types are involved, 
namely, K cells and macrophages. K cells are lymphoid-like cells which 
lyse antibody-coated target cells in the absence of complement (for 
reviews, see Perlmann and Holm, 1969, Cerottini and Brunner, 1974). 
Macrophages also have the capacity to lyse some antibody-coated target 
cells directly (Zighelboim et al., 1973). Additionally they can be 
specifically armed by T cells (for reviews, see Lohmann-Matthes, 1976, 
Evans and Alexander, 1976) or activated (for review, see Nelson, 1969; 
Keller, 1976) to lyse target cells. 
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Thus, it is clear that cell-mediated cytotoxicity in vitro is by no 
means the expression of a single mechanism. It is pertinent, therefore
, 
to establish the in vivo roles, if any, of the various cell populations 
which exhibit in vitro cytotoxicity. 
1.2.3 The in vivo role of cytotoxic T cells 
(a) Allograft and tumour immunity - The first evidence for 
the in vivo activity of inunune T cells was provided by Sprent and Miller 
(1971, 1972), who showed accelerated and specific graft rejection in 
neonatally thymectornised (NTX) CBA mice following intravenous injection 
of a highly enriched population of CBA T cells immunised against the gra
ft 
alloantigens. The T cells which were obtained from thoracic duct lymph 
were shown to contain cytotoxic T cells in vitro. The same population 
when mixed with P815 tumour cells bearing the relevant alloantigens 
prior to intraperitoneal injection into NTX mice was able to inhibit 
tumour growth. Essentially similar findings to those reported by Sprent
 
and Miller have also been reported by Cerottini et al. (1972), and 
Freedman et al. (1972). These workers used heavily irradiated recipients 
rather than NTX recipients to demonstrate that alloinunune T cells alone 
protected CBA mice from P815 tumours and induced GVH reactions. It was 
also noted about this time that labelled immune T cells, when injected 
into animals bearing allografts, accumulated preferentially at specific 
graft sites (Lance and Cooper, 1972; Cerottini and Brunner, 1974). 
Experiments of this kind strongly suggested that the cytotoxic T 
cells were the active component in rejection. It should be emphasised, 
however, that the populations used for transfer of immunity, although 
enriched for cytotoxic T cells almost certainly contained other T cell 
subpopulations as well, for example, DTH cells which could cause acti-
vation of macrophages in the recipient host. The data certainly does 
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not rule out a possible role for macrophages and K cells in the rejection 
process, although the existence of the latter at least in the Brunner 
and the Freedman systems is unlikely. Assuming that the predominant 
effector population is the transferred cytotoxic T cell, the question 
still remains whether these cells perform autonomously or in conjunction 
with host macroph_ages. 
Adoptive transfer studies have also been performed in syngeneic 
tumour systems and several groups have shown that populations containing 
cytotoxic T cells can transfer specific immunity (Gorczynski, 1974i 
Shellam, 1974; Gorczynski and Kn_ight, 1975a,b). As in studies with allo-
grafts and all_ogeneic tumours, a good correlation exists between the 
in vitro T killer activity of the transferred immune T cell population 
and its ability to cause tumour rejection in vivo. However, similar 
criticisms to those levelled at the all_ogeneic systems also apply to 
this one. 
The data concerning the requirement for macrophages for the activity 
of cytotoxic T lymphocytes in vivo is conflicting. Studies by Giraud and 
others (1970) and Rouse and Wagner (1972) with allografts and Zarling and 
Tevethia (1973a,b), in a syngeneic tumour system, suggested that cytotoxic 
T cells were unable to cause all_ograft or tumour rejection in irradiated 
recipients in the absence of bone marrow (BM) cells. Their interpretation 
of these observations was that BM cells provided a source of macrophage 
precursors required for rejection. In contrast to these findings, reports 
from others (Nomoto et al., 1970; Lubaroff, 1973; Freedman et al., 1972) 
using essentially similar experimental systems have not shown the same 
requirement for BM cells for graft rejection by T cells. 
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One possible explanation for the discrepancy may be that sensitised 
T cells under optimal experimental conditions are autonomous as killers, 
whereas under less artificial conditions they may require co-operation 
with other effector cells for graft or tumour rejection to occur. There 
is, in fact, considerable evidence from in vitro studies that immune T 
cells can produce factors which specifically arm macrophages which in 
turn acquire cytostatic (Seeger and Owen, 1974) or cytotoxic activity for 
tmoour cells (Alexander et al., 1972; Lohmann-Matthes and Fischer, 1973). 
It is not known, however, whether the cells which produce arnu.ng 
factors are cytotoxic T cells or, more importantly, whether such a system 
operates in vivo, al tho_ugh there is some evidence that macrophages may 
be important in tumour rejection and control of metastases (Gorer, 1961; 
Evans, 1973; Eccles and Alexander, 1974) and possibly allograft rejection 
(Dyminski and Argyris, 1969). 
To date, there is little direct evidence for an in vivo role of K 
cells in tumour or allograft rejection. A number of reports (Spong 
et al., 1968; Clark et al., 1968) have shown that transfer of inunune 
serum causes first-set rejection in a kidney graft and that this is 
usually associated with an infiltration of mononuclear cells. Maclennan 
(1972) has since shown that antibody dependent killer cells can be found 
in the mononuclear infiltrate of a transplanted kidney that is undergoing 
chronic rejection. Such findings s _uggest, but do not confirm a possible 
role of K cells in vivo. A more recent report (Ramshaw, 1975) has 
demonstrated that the injection of a highly purified population of K 
cells together with antibody coated P815 tumour cells into the footpads 
of BALB/c mice resulted in the failure to produce measurable tumour 
growth, as compared to controls receiving untreated or antibody-coated 
P815 alone or K cells+ untreated P815. However, comparable tumour 
growth was observed when either untreated or antibody coated P815 cells 
alone were injected into footpads. This less artificial approach indicates 
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that the presence of antibody coated cells does not result in a more 
rapid recruitment of effector cells. It should also be noted that the 
time course for P815 tumour regression in the footpad parallels that of 
the generation of cytotoxic T cells in the draining lymph node. 
( . l . . t h 51 . b) Vira 1mmun1 y - Te Cr isotope release assay as well 
as being used for the detection of cytotoxic cells in tumour and allograft 
systems, has also been exploited in the study of T cell responses to virus 
infections. The presence of cytotoxic cells in animals with active viral 
infections has been reported by many groups in the past (Speel et al., 
1968i Lundstedt, 1969i Oldstone and Dixon, 1970; Marker and Volkert, 
1973). Recently, more detailed characterisation of the specific effector 
cells in a variety of systems employing lymphocytic choriomeningitis (LCM) 
virus (Cole et al., 1973; Doherty et al., 1974) and ectromelia virus 
(Gardner et al., 1974a,b) have indicated that T cells acting alone kill 
virus infected targets in vitro. 
Evidence from in vivo protection studies with transferred immune 
cells strongly suggests that cytotoxic T cells play a significant role in 
the inununity to both ectromelia (Kees and Blanden, 1976) and LCM viruses 
(Zinkernagel and Welsh, 1976) . However, as with the tumour and graft 
systems, it is not known whether in vivo,cytotoxic T cells act alone or 
in concert with macrophages. There is no evidence that K cells play a 
part in inununity to either of these viruses. 
K cells do, however, appear to have activity in some in vitro virus 
models. These include herpes simplex virus (Ramshaw, 1975; Rager-Zisman 
and Bloom, 1975), measles virus (Labowskie et al., 1974), and rubella 
virus (Steele et al., 1973). It still remains to be determined how 
important this form of immunity is in the recovery from viral infections. 
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1.2.4 General conclusions 
(a) Cell mediated immune responses in vivo to allografts and some tumours 
and viruses can be shown to be mediated in vitro by three cell types, 
notably, cytotoxic T cells, macrophages and K cells. Each of these effec-
tor populations performs, in vitro at least, independently of the others. 
(b) The functional role of these effector populations in vivo is highly 
controversial. Although the immunity conferred in allograft, tumour and 
virus systems following transfer of immune T cells containing cytotoxic T 
cells correlates well with the in vitro killer activity of the trans-
ferred population the extent to which cytotoxic T cells alone are 
responsible for immunity in vivo is still unclear. 
It should be emphasised that many of the transfer studies performed -
particularly those in allograft and tumour models - have employed either 
cytotoxic T cells from animals undergoing GVH reactions or premixtures of 
such cells with tumour or grafted cells. Injection of such purified and 
highly potent populations may result in an exaggeration of the actual 
activity of the cytotoxic T cells. In the normal situation of HVG 
reactions, such a potent population of cytotoxic T cells may not in fact 
exist or may never concentrate in such extreme numbers at the reaction 
site. Under less artificial conditions - in vivo - cytotoxic T cells may 
in fact require co-operation with other effectors, particularly macro-
phages, for graft and tumour rejection or viral immunity to occur. Pre-
treatment of the immune T cell population with relevant anti-Ly allo-
antisera prior to transfer to recipients may allow a more precise deter-
mination of the in vivo role of the T subset in the future. C 
Transfer studies with macrophages and K cells have generally been 
unsuccessful. This failure is probably a reflection of the inability of 
these effector populations to recirculate in such a differentiated form 
rather than an indication of their lack of involvement in situ. 
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To conclude: cytotoxic T cells, macrophages and K cell s probably 
all function in vivo. The extent to which any one p opulation is active 
may depend on parameters such as the type of antigen, the site of antigen 
iocalisation, the presence or absence of circulating an t ibody and the 
period during the immune response that is studied. 
1.3 The in vitro generation of cytotoxic T c ells 
The preceding sections have considered the in vi vo gene rat ion o f 
cytotoxic T cells following challenge with allo-, t umour a n d v i ral antigens . 
Further evaluation of the cellular and genetic requ i r ement s for the 
induction of cytotoxic T cell responses has been facilit ated b y the use of 
in vitro culture techniques. Until very recently i n vitro models o f allo-
graft rejection have received the_ greatest considerati o n and the f o llowing 
discussion will therefore concentrate almost entirely o n these. 
1.3.1 The mixed leukocyte reaction 
By the end of 1963 it had become increasingly clear that a l arge 
number of antigens were capable of activating lymphocytes. Sin ce it was 
also known that lymphocytes contain on their surfaces a number of import-
ant transplantation antigens, it seemed likely that mixt ure s of lympho-
cytes from unrelated individuals or unrelated species migh t stimulate 
each other. That blast cells do appear in mixtures of lymphocytes from 
two unrelated individuals was first clearly shown in humans by Bain et al. 
(1964) and Bach and Hirschhorn (1964) and then la t er in mice (Dutton 1965, 
1966). The complex phenomena occurring wh en l ympho cy t es are cultured 
together later became known as the mixed l e ukocyte r eaction (MLR) and the 
culture as the mixed leukocyte culture (MLC). 
The major disadvantage of the original method was the difficulty it 
posed in assessing the individual contributi ons o f the two cell popu-
lations to the reaction. For this reas on, t he two- way MLC has been 
l~rgely repl a ced by its one-way modificat i o n where normal lymphocytes 
(responder population) are cultured with unre lated lymphocytes 
(stimulator population) which have previously been irradiated or mito-
mycin C treated to abolish mitotic activity (Cepellini et al., 1965; 
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Bach and Voynow, 1966). The response in MLC is quantitated by measuring 
the incorporation of radioactive thymidine by the dividing responder 
population. The MLC has been used extensively for clinical matching of 
donor and recipient for transplantation and is generally considered to 
represent the initial or sensi tisi.ng phase of the immune response to allo-
grafts in vivo (for references, see Bach, 1974; Bach et al., 1975). 
Further evidence for the immunological nature of the MLC was pro-
vided by the observation of Hayry and Defendi (1970) that immunologically 
specific cytotoxic cells were also generated in MLC. These cytotoxic 
cells were subsequently identified as T cells by the use of purified 
responder populations (Wagner, 1971; Hayry et al., 1972; Feldman et al., 
1972) and abrogation of the response following treatment of the responder 
population with anti-8 serum and complement (Wagner et al., 1972). 
In. general, the cytotoxic T cells generated in vitro, particularly in 
all.ograft systems, appear to be physically and functionally very similar 
to those. generated in vivo (for review, see Cerottini and Brunner, 1974) . 
The development of cytotoxic T cells in vitro would therefore appear to 
represent an in vitro analogue of the late, destructive phase of the 
immune reaction to allografts in vivo. 
1.3.2 The H-2 complex 
Following the foundation studies of Gorer and Snell, it was clear 
by the middle of the twentieth century that, in mice, a class of genes 
coded for alloantigens and that these alloantigens were responsible for 
rejection of incompatible neoplastic and normal tissue grafts (for 
references see Klein, 1975a). The antigens responsible for tissue 
compatibility were summarily designated by Snell (1948) as histo-
compatibility antigens and the genes coding for these structures as 
THE H~2 COMPLEX 
Regions t K t I S I I G I I D I 
Sub-regions I 
I-A I t t 1-c • • 1-C I 
Figure 1.1 - Diagrarranatic repres~ntation of the major histocompatibility complex in the mouse. 
The complex is divided into five regions with the!_ region further divided into five sub-
regions (Klein, 1975a,b; Shreffler et al., 1976; Murphy et al., 1976). 
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histocompatibility (li) genes. Differential susceptibility of mice to 
grafts led Counce and co-workers (1956} to conclude that there were two 
types of H-genes: major (strong) and minor (weak). Originally, H-2 
(coding for the first H-Ag discovered) was the sole representative of the 
strong categoryi all other H-loci being of the weak category. Today this
 
still holds true, but the H-2 class has been found to be multigenic and 
is now known as the major histocompatibility complex (MHC) (or H-2 complex) 
of the mouse. 
The MHC in the rrouse has been divided into five regions: K, .!_, §_, 
G, D, on the basis of marker loci for each region (Klein et al., 1975a; 
Shreffler and David, 1975). (See Figure 1.1.) Products of each of these 
~egions with the exception of the§_ region are expressed on the cell 
surface and are detectable by serological methods. The S region codes f
or 
two loci Ss and Slp whose products are secreted into the serum (Shreffler 
and Owen, 1963; Passmore and Shreffler, 1970). So far little is known 
about the products of either the §_ 6r the G regions, al tho_ugh recent 
studies by Meo et al. (1975) and Shreffler et al. (1976) have strongly 
implied that the mouse Ss protein is structurally and immulogically 
homologous to the fourth component of human complement (C4). Further 
properties of the§_ and G region products will not be discussed here but 
have been extensively reviewed elsewhere (Klein, 1975a,b; Shreffler, 1976). 
(a) H-2K and H-2D antigens - each H-2K or H-2D region codes for a 
series of antigens of which one is specific for the given haplotype 
(private antigen), and the others are shared by two or more haplotypes 
(public antigens) (for review, see Klein, 1975b). Both private and 
public H-2 antigens appear to be controlled by the same genes and may be
 
physically associated in the cell membrane, possibly on the same molecul
es 
(Hauptfeld and Klein, 1975). 
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(b) Ia antigens - Ia antigens are genetically controlled by the 
region between Kand S, namely, the.!_ region. Ia antigens are controlled 
by at least four or five loci in the.!_ region, notably IA, IB, IJ, IC 
and perhaps IE (Shreffler and David, 1975; Sachs et al., 1975; Murphy 
et al., 1976). Individual Ia antigen subregions redistribute in the 
membrane independently of both Kand D antigens and each other (Hauptfeld 
et al., 1975; Klein, 1975b). Ia antigens, which can also be divided into 
private and public classes, have been demonstrated on a high proportion 
of B cells, some macrophages, epidermal cells and teratocarcinoma cells 
and a small proportion of T cells (for review see Harnmerling, 1976). 
Further physical and biochemical properties of the K, D and Ia 
antigens will not be discussed here, but have been reviewed extensively 
elsewhere (Klein, 1975a,b; Klein and Hauptfeld, 1976; Hess, 1976; Cullen, 
1976) . 
1.4 Genetic control of MLR 
Lymphocyte activation, reflected by blast transformation, can be 
effected by a number of cell surface antigens. These antigens which 
include major and minor H determinants and MLR determinants have been 
termed lymphocyte activating determinants (Lad's) by Festenstein and 
Demant (1973) and lymphocyte defined (LD) antigens by Bach et al. (1972a,b). 
(a) Minor H antigens - The data from MLC combinations differing at 
single ITQnor H loci are contradictory. Using combinations involving 
differences at H-1, H-7, H-8, H-Y and H-9 in two-way MLC, Dutton (1966) 
and Rychlikova and Ivanyi (1969) failed to observe stimulation, whereas 
Adler et aZ..(1970) and Mangi and Mardiney (1970), using one-way MLC 
observed low but significant stimulation in combinations differing at 
H-1, H-3 and H-4. Stimulation has also been observed for antigens con-
trolled by the Thy-1 locus (Peck and Click, 1973). The discrepancies 
observed may be a result of the insensitivity of the MLC technique. 
Thus all minor H antigens may cause weak, but as yet undetectable 
stimulation. To date, no systematic study on the role of these 
antigens 
in lymphocyte activation has been attempted. 
(b) Mls locus determinants - Marked stimulation in MLC is observed 
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with lymphocytes from mice differing at the Mls locus (mouse minor MLC 
stimulating locus). This locus was first described by Festenstein (1966) 
who observed that H-2d identical BALB/c and DBA/2 mice reacted in
 MLC. 
The Mls locus thus segregates independently of H-2 and has at le
ast four 
alleles: Mlsa, Mlsb, Mlsc, Mlsd (Festenstein, 1974). The Mls deter-
minants have not been detected serologically but it is known tha
t they 
are on B cells and probably macrophages, but not T cells (van Boehmer and 
Sprent, 1974i Schirrmacher et aZ. 1975). 
(c) Major H antigens - In contrast to the weak stimulation observed 
with minor H antigens, MLC antigens cause stro.ng proliferative res
ponses 
in MLR. 
The tacit assumption of early workers (Dutton, 1965, 1966i Huemer et 
aZ., 1968) was that classical H-2 antigens defined by serological methods 
were responsible for the reaction. Followi.ng the discovery in m
an, by 
Yunis and Amos (1971), that MLC responsiveness could be separated from the 
two HLA loci coding for serologically detectable antigens, Rychl
ikova et 
al. (1970, 1971) reported that MLC stimulation in the mouse was associated 
almost exclusively with the K end of the H-2 complex. Bach et a
l. 
(1972a,b) using recombinant mice with crossovers occurring between the 
K and the !_ regions (AQR and BlO .A ( 4R) ) found that the !_ region rather 
than the K region was responsible for the 
11 K end" stimulation. These 
findings were later confirmed by Meo et aZ. (1973b) using A.TL, A.TH and 
. 
Bl0.A(4R) strains of mice. 
So far, three lymphocyte activating determinants (Lad's) have been 
reported in the region between Kand D. The strongest of these i
s 
associated with the IA region (Meo et al., 1973a). The strong stimulation 
observed by many investigators with strain combinations differing
 at the 
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entire central segment of the H-2 complex can probably be attributed to 
antigens coded in this region (Bach et al., 1972a; Widmer et al., ~973c; 
Meo et al., 1973b; Fathman et al., 1974; Lanai and McDevitt, 1974). 
A second, weaker Lad locus has also been mapped to the.!_ region (Bach et 
al., 1973b). The relationships of the Lad loci to the Ir-A, Ia and H-2I 
loci mapping in the same region is unclear. There is some evidence, 
however, that Ia antibody (no complement) can block the mixed lymphocyte 
reaction at the stimulator level, suggesting that Lad's and Ia determin-
ants may be either identical or closely associated on the cell membrane 
(Meo et al., 1976). The third Lad locus which also codes for a weakly 
stimulating antigen has been fonnally mapped between Ss and D (Widmer et 
al., 1973b). 
The involvement of the H-2K and H-2D regions in MLR is a contro-
versial one. Although both Kand D region differences can result in 
significant stimulation in some strain combinations (Bach et al., 1972a,b; 
Meo et al., 1973b; Plate, 1974; Nabholz et al., 1974), it has been 
argued that this stimulation is a result of antigens coded by Lad loci 
residing in the Kand D regions but distinct from H-2D or H-2K. Recent 
data from studies with H-2 mutants suggest that such an explanation is 
unlikely. 
Investigations with four H-2 mutants - CBA H-2ka (Blandova et al., 
1975), B6.C-H-2ba (Bailey et al., 1971), B6-H-2bd (Egorov and Blandova, 
1968) and Bl0.D2-H-2da (see Klein, 1975b) suggest that a single point 
mutation can be responsible for simultaneous changes in MLR, CML and 
histocompatibility (Widmer et al., 1973a; Klein et al., 1975b; Nabholz 
et al.11975a; Melief et al., 1975). 
The H-2ba mutant which does not differ serologically from its con-
genie partner, B6-H-2b, is one of nine mutants occurring at the hyper-
mutable Zl locus which has been mapped to the K end of H-2 (Melief et 
al., 1975). That these mutants involve a single genetic element in H-2K 
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has been established by the demonstration of classical codominant trans-
mission and by the results of complementation tests (for references, see 
Melief et al., 1975). Thus, a mutation at a single locus results in 
reciprocal stimulation in MLR, generation of cytotoxic T cells, graft 
versus host reaction and skin graft rejection between B6 -H-2b and its 
co_ngenic partner B6 .C-H-2ba. There are several possible explanations for 
these findings: 
(1) The ant_igens coded for by the Zl locus may stimulate 
both MLR and CML responses. 
(2) The cytotoxicity and skin graft rejection observed 
may be the result of recognition of!_ region determinants 
rather than K region determinants by cytotoxic T cells. 
This explanation is unlikely as Nabholz et al. (1975a) 
used FHA-stimulated target cells which are known not to 
display!_ region associated antigens. 
(3) A change in the H-2K locus may affect the expression of 
MLR determinants coded for in the I region, although 
there is no evidence to support an interaction of this 
type. 
(4) Two mutations may have occurred in the B6.C-H-2ba mouse -
one in the H-2K region (Zl locus) and a second in the I 
region. 
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Although the last alternative may be a possibility in the H-2K 
mutants, it certainly does not explain the reactivity of the CBA H-2ka 
mutant where the mutation has been convinci_ngly mapped to the K 
rather than the I region of the H-2 complex (Klein et al., 1975b). 
Alternatives (1) and (3) therefore seem to be the most likely 
explanations of the mutant studies. Further genetic, and more 
importantly, biochemical, characterisation of the MHC products involved 
will hopefully help to distinguish between these alternatives. 
In sununary, loci coding for the strongest Lad's map to the IA 
subregion of the H-2 complex. Currently, there is no convincing 
evidence to refute the existence of loci in the H-2K and H-2D regions 
coding for further, weaker Lad's as well. One interpretation of the 
mutant data would suggest that the Lad's coded in the K end, at least, 
cause both MLR and CML activity. 
1.5 Genetic control of CML 
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(a) The effector phase - A number of reports from different 
laboratories show that in the mouse the determinants detected by killer 
cells in CML are controlled by loci very closely linked or identical to 
the H-2K and H-2D regions controlling the classical, serologically 
defined MHC antigens (SD antigens) (Alter et al., 1973; Abbasi et al., 
1973; Nabholz et al., 1974). 
Further evidence suggesting the identity between the H-2K and H-2D 
antigens and the target antigens came from studies employing hyperinunune 
anti-H-2 sera with defined specificity (Brunner et al., 1968; Bonavida, 
1974; Nabholz et al., 1974). Such sera were found to block CML only 
when they were directed against the H-2K or H-2D incompatibility against 
which the cytotoxic cell was active. 
In apparent contradiction to the blocking data Berke et al. (1972a) 
observed cytotoxicity in the absence of serologically defined differe nces. 
Using a different experimental approach, early studies by Brondz and 
Goldberg (1970) showed that while target cells from the graft donor s train 
were destroyed in vitro by recipient spleen cells, target cells from an 
unrelated haplotype sharing several public H-2 specificities with the 
sensitising strain were not affected. In contrast, antiserum raised 
against either target was cross-reactive. Similar observations have 
subsequently been made by other groups (Forman and Moller, 1974; Lake et 
al., 1974). In more recent studies Brondz's group has further demonstrated, 
using both in vivo and in vitro models, that cytotoxic T cells do not 
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recognise public H-2 specificities but react selectively either to 
private H-2 specificities or to serologically silent products of H-2K or 
H-2D closely linked to private specificities (Brondz et al., 1975). 
Similar observations have also been made in other systems, for 
example, cytotoxic T cells sensitised against virus infected syngeneic 
cells will only lyse virally infected targets sharing the same private 
H-2 antigen as the donor (Gardner et al. 1975). The same holds true for 
other syngeneic systems, namely TNP (Shearer, 1974), minor histocompati-
bility antigens (Began, 1974) and the H-Y system (Gordon et al., 1975). 
There is also evidence which suggests that the antigenic determinant 
rec_ognised by cytotoxic T cells is serologically silent. This derives 
mainly from studies with the H-2Kb mutants, where some mutations have 
been found to change CML determinants qualitatively while they leave the 
serol_ogically detectable determinants, both private and public, · intact 
(Bailey et al., 1971; Berke and Amos, 1973a; McKenzie et al., 1976). 
However, this feature seems to be unique to the H-2b haplotype since SD 
differences have been observed between original strains possessing other 
haplotypes (H-2d and H-2f) a~d their respective mutants (Dishkant et al., 
1973; Egorov, 1974). 
The failure to recognise SD differences in the H-2b mutants was 
probably not the result of lack of generation of helper T cells through 
possible Ir (immune response) gene effects, as some immunisation procedures 
were performed on F1 hybrid mice where another genetic 
background was 
introduced (McKenzie et al, 1976). It is notable, however, that the anti-
body response to the private H-2D antigen, H-2.2, appears to be under 
multiple gene control (Lilly et al., 1973) so that assuming the private 
antigens are equivalent to the CML antigens, the lesion need not map to 
the Ir region. If the inability to make antibody to the H-2~ mutants is 
a genetic one it is not confined to B6 mice as (C3H x DBA/2)Fl mice were 
also unable to detect differences between the mutants and their congenic 
partner (McKenzie et al., 1976). Attempts with rats have also proven 
unsuccessful (for references see Nabholz et al., 1974). 
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Studies with humans also indicate that cytotoxic T cells do not 
recognise serologically determined antigens. Thus, Bach et al. (1976) 
have found that human cytotoxic T cells sensitised to lyse cells from the 
stimulating cell donor can also specifically lyse target cells from a 
third party not sharing any serologically detectable cross reactivities 
with the stimulating cell donor. 
In summary, the relationship between the antigens recognised by 
cytotoxic T cells and the antigens defined serologically is not clear. 
It seems to be generally accepted that public H-2 antigens are not 
recognised or are recognised only weakly by cytotoxic T cells. Whether 
the target antigen is, in fact, a serologically defined private H-2K or 
H-2D moiety or a serologically silent H-2K or H-2D moiety is as yet 
unresolved. 
da 
Further studies with the H-2 mutant may help to clarify 
this point. 
As mentioned in the previous section, I region differences alone 
induce strong proliferative responses in MLR. In early studies several 
groups reported that despite such strong proliferative responses only 
weak CML activity could be detected (Alter et al., 1973; Meo et al., 
1973a,b; Schendel and Bach, 1974; Nabholz et al., 1974). This observation 
was the more difficult to understand because an I region difference 
between donor and recipient had been shCMn to be sufficient for the rapid 
rejection of skin grafts (Klein et al., 1974a; Hauptfeld et al., 1974). 
The question therefore arose whether the failure to detect cytotoxic T 
cells directed against!_ region determinants was due to the fact that 
killers directed against these determinants were genuinely absent 
or whether the targets used in the previous studies - mainly PHA induced 
blasts and macrophages - did not express the relevant antig8ns. 
Klein et al. (1974b) were the first to show that CML across the I 
region could be obtained if killer cells were produced in vivo by skin 
grafting and LPS blasts were used as targets. More recently, 
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Wagner et al. (1975a) and Nabholz et al. (1975b) have confirmed these 
results with MLC activated cytotoxic T cells. Using A.TL/A.TH strain 
combinations both groups observed significant, but weak, cytotoxicity 
against LPS but not PHA induced blasts as compared with TC raised against 
a complete H-2 difference. It is not known whether these quantitative 
differences in cytotoxicity to K, D and I region determinants reflect a 
weak response to.!_ region determinants or an inadequate target which only 
expresses some of the.!_ region controlled CML determinants. 
Wagner's group mapped the loci controlling the stimulating deter-
minants to the IA subregion, whereas the data from Nabholz' s group 
suggested at least two genes between the Kand the D regions and possibly 
an extra - H-2 locus control the determinants detectable by the cytotoxic 
T cell population. Although Nabholz et al. showed that 60-80% of LPS 
blasts were lysed with anti-Ia serum and complement whereas this treatment 
had little effect on PHA blasts, the relationship between the .!_ region CML 
determinants, the MLR stimulating determinants and the serologically 
defined Ia antigens is still unknown. The solution will probably only be 
found when characterisation of the relevant molecules complements 
functional assays. 
To summarise: the target antigens recognised by cytotoxic T cells 
appear to be predominantly controlled by the H-2K and H-2D regions of the 
H-2 complex. Weak, but significant responses to I ~egion coded 
determinants have also been reported. 
It is notable that cytotoxic T cells are also able to recognise viral, 
tumour, xenogeneic, and minor histocornpatibility antigens. These 
responses will be discussed in detail in subsequent sections. So far no 
cytotoxic activity has been detected against Mls controll2d antigens 
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(Rollinghoff et al., 1975; Lilliehook et al., 1976). 
(b) The induction phase - Data reviewed in the two previous sections 
considered collectively indicates non-identity between the antigens which 
cause maximal proliferation(.!_ region coded) in MLR and those which are 
optimally recognised as target antigens (H-2K or H-2D coded) by cytotoxic 
T cells. This dichotomy has raised two fundamental questions: (1) Is 
the recognition of both antigens a requirement for the induction of 
cytotoxic T cells and, (2) if so, do separate subsets of T cells recognise 
these antigens? The past three years have seen many attempts to answer 
these questions. 
Pioneer mapping studies with recombinant mice by Alter et al. (1973) 
suggested that in some MLC combinations, notably those involving the 
recombinant mouse strains AQR and BlO.A which share the.!_ region of the 
H-2 complex, but differ at the K region, no significant proliferation or 
generation of cytotoxicity was observed. Further experiments by the same 
group demonstrated that both proliferative and cytotoxic responses could 
be induced by the addition of a second stimulator population, Bl0. T(6R) 
which differs from the . responder population only in the.!_ region 
(Schendel et al., 1973). Complementary results were obtained in similar 
studies with human lymphocyte combinations (Bach et al., 1973b; Eijsvoogel 
et al., 1973). The conclusions drawn from these studies were firstly, 
that recognition of both LD (I region coded) and SD (Kand D region coded) 
differences was a prerequisite for the generation of cytotoxic T cells 
and secondly, that these antigens were probably recognised by different 
T cell subpopulations. 
It should be emphasised, however, that the lack of MLR and CML 
responses to H-2K or H-2D coded antigens in the absence of.!_ region 
differences is not a univeral one. For example, BlO.G mice respond well 
to Bl0.T(6R) mice which differ only at H-2D (Schendel et al., 1973). 
Similarly, A and A.TL strain combinations differing at Kand Ss and A.TH 
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and A.SW combinations differing only at the D region also cause signifi-
cant and bi-directional generation of cytotoxic a c t ivity (Nabholz et al., 
1974). Also, as mentioned in previous sections, a l l o f the Kand D 
region mutants led to strong CML when co-culture d wi th their ~espective 
congenic partners (Klein et al., 1975b; Forman and Kle i n, 1975; Melief 
et al., 1975). Moreover, following improvements in their cult ure tech-
niques, more recent reports from Bach's group have s h own that significant 
CML is generated with the original BlO.A/AQR combination (Schendel and 
Bach, 1974). The further addition of Bl0.T(6R) cells, however, does 
s_ignificantly enhance the response. Similar results have also been 
obtained in in vivo studies (Solli_nger and Bach, 1976) wh ere AQR nuce 
were shown to be fully capable of rejecting BlO.A thyroid graf t s , although 
rejection was found to occur more rapidly when Bl0.T(6R) lymp h node 
cells were injected at the time of grafting. 
In order to save the original SD-LD concept, it was the n a rgued 
that the present delineation of Kand.!_ regions is arbi t r a ry s o that 
weak LD type loci may exist in the K region as presen tly defin e d by the 
existing recombinants. In an attempt to prove this po i n t Schendel and 
Bach (1974, 1975) heat-treated or UV-treated the BlO. A s t i mulator popu-
lation. These techniques have been reported to inactivat e LD antigens 
(Eijsvoogel et al., 1973) whilst leaving SD antige ns i ntact (Lindahl-
Keissling and Safwenberg, 1971; Lafferty et al ., 1974a ). The outcome 
of these experiments was that either heat- or UV- t r eatment of the BlO.A 
population completely abrogated the CML response while the combination 
of treated BlO.A populations and mitomyci n C t reated Bl0.T(6R) cells 
restored responses to their original l e vels. It is also notable that 
one of these rep orts (Schende l and Bach , 1 9 75) also contained evidence 
that Mls diffe r ences are as effe ctive as I region differences in 
enhancing responses. 
25 
Collectively, these results were taken by the authors as proof 
that LD differences, which can be coded in either the H-2K or the H-2I 
regions of the H-2 complex or alternatively the Mls locus are an 
absolute requirement for the induction of cytotoxic T cells. Alternate 
interpretations of the foregoi_ng reports will be discussed in a later 
chapter. 
In sununary, the plethora of data which has accrued from studies 
with reconminant, congenic and mutant mouse strains, whilst conclusively 
demonstrating that recognition of strong MLR determinants (coding in the 
.!_ region) is not a corequisite for induction of CML has nonetheless not 
eliminated the possibility of a requirement for recognition of cell 
surface antigens in addition to target antigens. Whether combined 
rec_ogni tion of target and non-target antigens actually occurs and is an 
absolute requirement for induction of CML or alternately only serves to 
implement a helper mechanism is as yet unknown. Moreover, the final 
answer will probably not come from studies with genetic recornbinants, as 
it may never be possible to absolutely separate genes coding for target 
antigens from those coding for other menmrane antigens. However, the 
problem can be considered from a different aspect. 
On the basis of a report by Cantor and Asofsky (1970, 1972) that 
functionally different subpopulations of T cells collaborate in GVH 
reactions, it was suggested initially by Bach et al. (1972a,b) and later 
by Wagner (1973) that MLR response and killer precursor cells belong to 
different subpopulations and that the collaboration between these, 
possibly triggered by different genetic incompatibilities, may be 
required for killer cell production. 
Results from absorption studies (Bach et al., 1973a) with allo-
irnmune human lymphocytes are consistent with the existence of ~HO 
separate populations of T cells, one responding to LD differences by 
proliferation and not adhering to a monolayer of the sensitising cells 
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and the other, the cytotoxic T lymphocyte s which do adhere to the mono-
layer. Similar results were also obtaine d with unsensitised cells but 
neither experiment provided evidence for collaboration b etween the two 
subpopulations. 
Further evidence that the cells proliferating in resp onse to strong 
LD-type differences may be separable from cytotoxic cells comes from 
studies with T cell populations activated against K region de t erminants. 
It has previously been shown that the activity of killer cel l s with 
l.mknown specificity can be assayed by incubating them with an agglutinating 
lectin such as PHA or con A and a sensitive target (Stavy et al., 1972; 
h 
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As erson and Fergula, 1973; Forman and Moller, 1973). Using this tee~-
nique R8llinghoff et al. (1975), and Dennert (1976), were able to show 
that T cells activated by Mls locus determinants are n ot cytotoxic . 
Similarly, in humans strong support for the i ndep endence o f the 
proliferating cells generated in the MLC reaction against LD d ifferences 
and cytotoxic T cells corres from a recent report by Mawas et al . , 1975. 
In this study, patients suffering from primary immun o-defi c iencies 
either lacked MLC responsiveness or had defects in k il l er cell induction 
or both, indicating that these two functions may be i n dependent of one 
another. 
Early evidence for collaboration between T cell subsets in the 
induction of cytotoxic T cells came from studies s imilar to those of 
Cantor and Asofsky. Thus the combination of thymus an d l imiting numbers 
of peripheral,T responder cells was found to produce MLR and CML 
responses far exceeding those of either p op ulation alone or the values 
expected from a simple additive effect. (Coh e n and Hews, 1973; Wagner, 
1973; Hayry and Anderson, 1974). The syn optic interpretation of these 
experiments was that peripheral T c e ll s p r ovide the major source of 
precursor cells of cytotoxic lymph ocy t e s, while thymocytes perform mainly 
a helper or amplifier function. 
More recently, the T cell populations responding in MLC have been 
+ 
separated on the basis of Ly markers into two subsets, namely, Ly-2,3 
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+ 
and Ly-1 cells (Cantor and Boyse, 1975a,b). As discussed in an earlier 
+ 
section, the precursor cytotoxic cells belong to the Ly-2,3 subset. The 
+ 
maturation of these cells was shown to be amplified by Ly-1 cells which 
did not themselves contribute to the killer cell pool. This amplificati on 
. + 
was abolished by excluding the Ia cells from the stimulator population 
during MLC, suggesting that amplification was due to the selective recog-
+ 
nition of I region determinants by Ly-1 cells (Cantor and Boyse, 1975b). 
It should be stressed, however, that significant amplification was only 
+ 
evident when Ly-2,3 cells were used in limiting numbers (cf. thymus/ 
peripheral T cell experiments). 
+ 
Thus, optimal numbers of Ly-2,3 cells 
alone coul~ generate substantial killer activity. 
It is also noteworthy that in MLC's involving a complete H-2 
+ 
difference removal of Ly-1 responder cells only caused a 40 per cent 
reduction in thymidine uptake, implyi_ng that Ly-2, 3 + cells do divide in 
+ 
MLC. On the other hand, Ly-1 cells account for almost all of the pro-
liferati ve response in MLC 's invol vi_ng I region incompatibility only 
(Cantor and Boyse, 1975a). 
To conclude, there is still considerable debate regarding the genetic 
requirements for induction of cytotoxic T cells. It would appear, though, 
that under optimal culture conditions, the recognition of H-2K or H-2D 
coded determinants by Ly-2,3+ cells is sufficient for the generation of 
substantial cytotoxic activity. The response may be further amplified by 
+ Ly-1 helper cells responding principally to antigens coded in the I 
region. So far there is no evidence for the absolute requirement for T 
help that has been shown for the production of antibody to most antigens 
(for review, see Miller and Osoba, 1967). 
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1.6 Generation of cytotoxic T cells against othe r ce ll surface an t igens 
In addition to allogeneic cells, precursors of cytotoxic T cells are 
known to respond to two other categories of stimulator cell: 
(a) Xenogeneic cells 
(b) Syngeneic (or allogeneic) cells bearing membrane 
associated antigens in addition to .MHC coded antigens. 
(a) Despite early reports that MLR in xenogeneic combinations was 
either weak or non-existent (Wilson and Nowell, 1970; Lafferty and Jone s, 
1969), several groups, using various culture conditions have established 
that in some species combinations MLR reactivity to xenogeneic cells is o f 
the same magnitude as that to allogeneic cells (Widmer and Bach, 1972; 
Shons et al., 1973; Asantila et al., 1974). 
Data from Asantila I s group s _uggested that the degree of responsive-
ness in xenogeneic combinations was a function of the phylogenetic distance 
between the two reacting species. Thus, while the response of human 
lymphocytes to rat lymphocytes was strong, the response to frog lympho-
cytes was considerably weaker (Asantila et al., 1974). 
Recently, Lindahl and Bach (1976), in a human/mouse system, demon-
strated a significant connection between the antigens stimulating in 
allogeneic MLR and those stimulating in xenogeneic MLR. Accordingly, I 
region coded antigens caused a stronger proliferative response than 
either H-2K or H-2D region coded antigens. 
Early studies by Berke et al. (1971) in a rat/mouse system indicated 
that cytotoxic cells were also produced in xenogeneic MLR. AlL~ough 
these cells were shown to be specific for the sensitising strain they 
were not identified as T cells and their reactivity was not compare d t o 
similarly activated allogeneic cells. 
More recent data from in vivo studies in a rat/mouse system (Hines 
et al., 1976) and in vitro studies in a human/mouse system (Lindahl and 
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Bach, 1976) have established that xenoantigens do stimulate a CML 
response, but in contrast to the MLR data, this r e s ponse is considerably 
weaker than that generated in an allogeneic interaction . Ut ilising a 
restimulation technique to analyse the mouse specifici t ies that stimulate 
human cytotoxic T cell precursors, Lindahl and Bach (1975, 1976) con-
cluded that in xenogeneic, as well as in allogeneic combinat i ons , cyto-
toxicity is directed predominantly against antigens code d by the H- 2K and 
H-2D regions of the MHC. 
Although these results are preliminary, they suggest t hat the 
antigens recognised by human lymphocytes may well be identical t o those 
recognised by mouse lymphocytes in the mouse allogeneic reacti on. The 
generally depressed xeno CML responses indicate that in any animal there 
are more cytotoxic T cell precursors with specificity for alloanti gens 
than for xenoantigens. Possible explanations for these differe nces will 
be considered in a later chapter. 
(b) It has been well documented that when cytotoxic T cell precur sors 
are sensitised with syngeneic, virus-infected lymphoid cells (Zinkernag el 
and DohertyJ 1974a; Blanden et al., 1976; Koszinowski and Ertl , 1975), 
TNP-treated lymphoid cells (Shearer, 1974; FormanJ 1975; Kore n et aZ., 
1975) or lymphoid cells bearing markers absent on the responding popu-
lation such as minor histocompatibility antigens (Bevan , 1975; Gordon and 
Simpson, 1975), the resultant cytotoxic effector population can only 
recognise and lyse targets which share its H-2K or H- 2D haplotype. This 
phenomenon has been termed "H-2 restriction 11 and was con cur rently 
described by Zinkernagel and Doherty (1974a) in t h e LCM vi r us system and 
Shearer (1974) in the TNP system. 
Despite the overwhelming evidenc e for "H-2 r e s t r iction" at the 
effector level, such restriction is not obser ved at the induction level. 
This point has been well illustrated in expe r iments using radiation 
chimaeras (Zinke rnage lJ 1976; von Boehme r and Haas J 1976) where it has 
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been shown that the cytotoxic T cell precursor can "see" antigen associated 
with any H-2K o~ H-2D haplotype but once sensitised to this combination it 
will only lyse targets presenting the same configuration. In effect then, 
"H-2 restriction" occurs at the level of the stimulator and the target 
rather than the effector and the target. 
The involvement of the .MHC in the induction and effector phases of 
the immW1e response is not limited to cytotoxic T cells. There is also 
some evidence that T helper cells rec_ognise antigen in association with Ia 
antigens (Erb and Feldman, 1975a) while T cells responsible for DTH see 
some antigens (e.g., fowl gamma globulin) in association with Ia antigens 
and others (e.g., DNFB) in association with H-2K or H-2I gene products 
{Miller et al., 1975, 1976). Thus, H-2K (or D) cell surface moieties 
themselves (or other products of closely linked genes coding in the .MHC 
locus) and the .!_ r _egion coded Ia antigens are intimately involved in 
antigen recognition by various subsets of T cells, i.e., H-2 appears to 
be a priori for T cell recognition. 
With respect to cytotoxic T cells this involvement may be explained 
by one of at least three mechanisms: 
1. physiological interaction 
2. altered self 
3. Ag-H-2 complexing. 
The feasibility and universality of each of these mechanisms has been 
discussed at length in numerous reviews (Doherty et al., 1976; Blanden 
et al., 1976; Forman et al., 1976; Shearer et al., 1976) and will only 
be briefly considered here. 
The physiological interaction model as originally described by 
Zinkernagel and Doherty (1974b) has been generally discredited experi-
mentally and will therefore not be further discussed (Zinkernagel, 1976; 
van Boehmer and Haas, 1976; Davidson et al., 1976). 
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Two mechanisms for altered self have been proposed. The first, which 
was originally suggested by Zinkernagel and Doherty (1974b) as an alter-
native to physiological interaction requires that viruses act as modifying 
.agents which immunologically alter cell surface structures coded by the 
MHC. Although chemical alteration may be feasible in the case of viruses, 
as a more general explanation this mechanism is deficient, particularly 
if the data from studies with minor histocompatibility antigens is 
considered. 
The second mechanism for altered self requires that non-H-2 antigens 
become closely associated with H-2K or H-2D region controlled products 
on the cell membrane with the resultant creation of new antigenic deter-
minants (NAD's) or interaction antigens (Bevan, 1975) which may have 
components provided by both H-2 and antigen. 
The last mechanism, antigen H-2 complexi.ng, involves the physical 
association of antigen and cell surface MHC products to form an antigen 
complex in which both components retain their antigenic integrity. 
The last two mechanisms are currently the most favoured as explan-
ations for the apparent requirement for H-2 recognition for T cell 
induction. It should be emphasised, however, that both of these models 
should be regarded only as working hypotheses as our present understanding 
of events occurring at the molecular level is, to say the least, 
rudimentary. 
From the foregoing it is clear that cytotoxic T cells recognise 
something special about H-2K (or D) region coded determinants. Whatever 
the nature of the receptors involved, their dictionary appears to extend 
from self to xeno histocompatibility antigens. In the syngeneic systems 
described, H-2K or H-2D coded structures are possibly recognised in 
either physical or chemical association with other membrane expressed 
antigens. The fundamental question therefore arises whether a universal 
recognition system exists such that allogeneic and xenogeneic systems 
also involve recognition of structures other than, or in addition to, 
H-2K or H-2 coded antigens or whether T cells with completely different 
receptor dictionaries are involved. 
1.7 The nature of the cytotoxic T cell receptor for antige n 
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While it is clear that membrane bound inununoglobulin molecules serve 
as receptors for antigen on B cells, the nature of the antigen specific 
receptor on T cells has remained elusive. There are three potential 
classes of receptors: 
1. Immunoglobulin (Ig) 
2. Structures consisti_ng of Ig and non-Ig subunits 
3. Non-Ig receptors. 
There has been considerable controversy in the past over the presence 
of conventional Ig classes on T cell surfaces (Crone et al., 1972; 
Marchalonis and Cone, 1973). However, in the past few years evidence has 
been accumulati_ng which s _uggests that normal irnmunocompetent B and T 
lymphocytes with the capacity to react against the same antigenic deter-
minants share idiotypic determinants (Ramseier and Lindenmann, 1972; 
McKearn, 1974; Eichmann and Rajewsky, 1975; Binz and Wigzell, 1975a). The 
general conclusion drawn from these studies is that Band T lymphocytes 
reacting to the same antigenic determinants use the same set of V genes 
to code for the relevant antigen binding receptors. The findings of 
other workers (Eichmann and Rajewsky, 1975; Black et al., 1976 and 
HM.mrnerling et al., 1976), using anti-idiotypic antibody to stimulate 
idiotype positive T cells are also consistent with this view. Genetic 
linkage experiments in the latter system indicate that the T cell idiotypic 
determinants are coded by genes linked to the heavy chain allotypes of Ig 
molecules. Recently, Binz and Wigzell (1976) have shown that T cells re-
lease, in soluble form, molecules carrying antigen binding specificity as 
well as idiotypic markers. These molecules exist as monomers of molecular 
33 
weight approximately 70,000 daltons or as dimers of molecular weight 
150,000 daltons. There is no evidence that either of these T cell 
iooieties is linked to conventional light chain molecules. Similarly, 
conventional serological markers of the constant region of heavy or light 
chains were not in evidence either. 
Thus, at the moment, there is considerable evidence to suggest that 
at least part of the T cell receptor system consists of a single or 
dimeric Ig H chain having a previously undescribed constant region. 
Studies examining the specificity of T cell recognition in binding 
and functional assays indicate that the ability to discriminate between 
related but different synthetic antigens is at least as great as that 
found with the B cell (Schlossman et al., 1969; Hfumnerling and McDevitt, 
1974; Janeway, 1976). The question then arises whether T cells with a 
receptor system composed solely of Ig chains could allow such fine 
discrimination to occur. Although it is known thatig H chains bind antigen 
specifically, albeit with lower affinity than wholeigH(Utsumi and Kanush, 
1964) , little is known about the fine specificity of Ig H chains or their 
bindi_ng properties with complex antigens. 
If, in fact, T cells do recognise MHC coded determinants and membrane 
bound antigens as independent moieties on the cell surface, it is highly 
probable that they use a different gene product for each receptor unit. 
Thus 1 just as B cells make two genetically unlinked Hand L chains1 T 
cells may also make genetically independent receptor structures which may 
or may not be linked on the cell surface. 
Given that two independent receptors do exist on T cells, the second, 
and as yet undefined, receptor must be largely confined to recognising 
self and foreign MHC antigens. Similarly, at least some of the VH gene 
coded receptors must also be involved in MHC coded determinant recognition 
as well in order to account for the large number of T cells reported to 
respond to alloantigens (Wilson et al., 1968; Ford et al.1 1975; Binz and 
Wigzell, 1975b; Martz, 1975). 
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From the foregoing brief outline of the dictionary range and possible 
nature of the receptors on cytotoxic T cells it is obvious that, despite 
intensive investigations, the exact nature of the T cell receptor system 
and the type of antigens it recognises is still a matter of speculation. 
1.8 Nature of the stimulator population 
Although it is established that both the recognitive and effector 
phases of MLR are mediated by T cells the tissue distribution of potential 
stimulator populations remains unclear. 
Until recently, most attempts to ascertain the cell types with 
stimulating capacity have been concerned primarily with measurement of 
proliferative rather than cytotoxic responses. The data surmnarised in 
Table 1.2 gives an indication of some of the cell types which have been 
tested. 
Although many of the reports are conflicting it appears that allo-
geneic normal or transformed lymphoid populations generally stimulate 
better than non-lymphoid populations. This holds true for both prolifer-
ative and CML responses in all of the animal species tested so far. Some 
exceptions do exist, however, in that epithelium, endothelium and 
spermatazoa have also been reported to cause significant proliferation, 
and in one instance, epithelial cells generated cytotoxic activity as 
well. Whether the stimulation observed with non-lymphoid populations is 
'' z the result of Ia antigens present on their surfaces (Hammerling et a., 
1975), or alternately reflects contamination of the cell preparations with 
small but significant numbers of lymphoid cells is, as yet, unresolved. 
The discrepancies observed in the levels of the proliferative and 
cytotoxic T cell responses generated following stimulation with E cells, 
T cells or macrophages may relate to differences in MLC methodology, 
mouse strains or cell purification techniques. 
Cells 
A. Lymphoid 
T 
B 
Macrophages 
TABLE 1.2 
THE STIMULATOR POTENTIAL OF VARIOUS LYMPHOID 
AND NON-LYMPHOID POPULATIONS 
Donor MLR CML Authors 
Mouse +++ NT Cheers and Sprent, 1973 
Mouse NT +++ Wagner and Wyss, 1973 
Mouse + NT Plate and McKenzie, 1973 
Mouse +++ NT von Boehmer, 1974 
Mouse +++ NT Lanai and McDevitt, 1974 
Mouse Simpson, 1975 
Human NT Lohrmann et al., 1974 
Human +++ +++ Sandel et al., 1975 
Mouse +++ NT Cheers and Sprent, 1973 
Mouse NT +++ Wagner and Wyss, 1973 
Mouse +++ NT Plate and McKenzie, 1973 
Mouse +++ NT von Boehmer, 1974 
Mouse +++ NT Lanai and McDevitt, 1974 
Mouse +++ +++ Simpson, 1975 
Human +++ NT Lohrmann et al., 1974 
Human +++ +++ Sandel et al., 1975 
Human ++ NT Levis and Robbins, 1970 
Human +++ NT Bain and Lowenstein, 1969 
Human ++ NT Alter and Bach, 1970 
Human +++ NT Rode and Gordon, 1973 
Human +++ NT Twomey et al., 1970 
Mouse +++ NT Talmage and Hermningsen, 1975 
Mouse +++ NT Schirrmacher et al., 1975 
Table 1.2 (contd.) -
Cells 
Macrophages (contd.) 
B. Neoplastic cell 
lines 
Myelorna 
Thymoma 
T lymphoblast 
B lymphoblast 
HeLa 
Lymphoma 
L2C leukaemia 
cells 
C. Non-lymphoid 
Polymorpho 
nuclear cells 
Platelets 
Epithelium 
Donor 
Mouse 
Mouse 
Guinea 
pig 
Mouse 
Mouse 
Human 
Human 
Human 
Human 
Guinea 
pig 
Human 
Human 
Guinea 
pig 
Human 
Mouse 
Mouse 
Rat 
Rat 
MLR 
+++ 
NT 
+++ 
NT 
NT 
+++ 
+++ 
+++ 
+++ 
+++ 
NT 
+++ 
+++ 
CML 
+++ 
+ 
NT 
+++ 
+++ 
+++ 
+++ 
+++ 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
+++ 
NT 
NT 
Authors 
Simpson, 1975 
Wagner, 1973 
Greineder and Rosenthal, 1975 
Wagner and Wyss, 1973 
Wagner and Wyss, 1973 
Royston et al• I 1974 
Callewaert et al., 1975 
Royston et al• I 1974 
Callewaert et al., 1975 
Hardy and Ling, 1969 
Hardy and Ling, 1969 
Greineder and Rosenthal, 
Rode and Gordon, 1973 
Mardiney et al., 1972 
1975 
Greineder and Rosenthal, 1975 
Rode and Gordon, 1974 
Gillette et al., 1972 
Steinmuller and Wunderlich 
Main et al., 1971 
Lane and Ling, 1973 
Table 1.2 (contd.) -
Cells Donor 
Epithelium (contd.) Human 
Endothelium 
Sperm 
Brain, kidney 
thyroid 
Melanoma, 
Osteosarcoma 
Fibroblasts 
RBC 
NT not tested 
+++ good response 
Dog 
Human 
Human 
Rat 
Human 
Mouse 
Rat 
Human 
Guinea 
pig 
Human 
++ moderate response 
+ poor response 
no response 
MLR 
+++ 
++ 
++ 
+++ 
+++ 
+++ 
+ 
NT 
CML 
NT 
NT 
++ 
NT 
NT 
NT 
NT 
NT 
+ 
+++ 
NT 
NT 
NT 
Authors 
Lane et al.r 1975 
Levis and Miller, 1972 
Hirschberg et al., 1975 
Vetto and Burger, 1972 
Hirschberg et al., 1975 
Levis et al., 1976 
Lane and Li.ng, 19 7 3 
Han, 1972 
Wagner and Wyss, 1973 
Berke • I 1969 
Lonai • I 1972 
Schellekens and Eijsvoogel, 
1970 
Greineder and Rosenthal, 1975 
Hardy and Ling, 1969 
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In addition to being lymphoid stimulator cells must also be physically 
intact and metabolically active. Thus, sub-cellular alloantigen prepar-
ations stimulate weak or negligible primary proliferative or cytotoxic 
responses (Gutterman et al., 1972; Wagner and Boyle, 1972; Engerset al., 
1975b; Hayry and Andersson, 1976; Wagner et al., 1976a). Similarly, 
actinornycin A or D treatment (Wagner, 1973) heat treatment (Eijsvoogel et 
al., 1973; Schendel and Bach, 1974; Wagner, 1973), UV irradiation 
(Lafferty et al., 1974; Wagner et al., 1974# Schendel and Bach, 1975; 
Hayry and Andersson,1976; RBllinghoff and Wagner, 1975) or fixation 
(Dennert and Lennox, 1974) of the stimulator population abrogates stimu-
lator capacity. In contrast to the requirements for primary stimulation, 
those for secondary stimulation are much less stringent. Accordingly, 
sub-cellular fractions of tumour or lymphoid cells (Engers et al.# 1975b; 
Hayry and Andersson, 1976; Wagner et al., 1976a) and UV treated (Hayry and 
Andersson, 1976; Rollinghoff and Wagner, 1976), or fixed (Dennert and 
Lennox, 1974) # lymphoid or tumour cells are all capable of restimulating 
previously primed populations to the same extent as untreated cells. 
To summarise, the stimulator cell, at least ~n primary induction, 
appears to be more than an inert vehicle of transplantation antigens and 
may in fact, as suggested by Lafferty and Cunningham (1975), actively 
participate in the stimulation process. Although subcellular fractions 
stimulate poorly in primary cultures and do not inhibit the activity of 
cytotoxic T cells against allogeneic target cells (Engers et al., 1975b) it 
remains to be determined whether cytotoxic T cell precursors respond to 
secreted transplantation antigens or only to membrane bound antigens. 
The requirement for macrophages for the generation of cytotoxic T cells 
demonstrated by Wagner and colleagues (1972) has been taken by these 
workers as an indication that soluble antigens may be the stimulating 
moieties (Wagner, 1973; Wagner et al.# 1972). 
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Several rrodels, based on the Bretscher and Cohn 2-signal model for 
B cell induction (Bretscher and Cohn, 1970) have been proposed to explain 
the induction of cytotoxic T cell responses. These will be discussed in 
detail in subsequent chapters. 
1.9 Mechanisms of cytotoxicity 
The process by which a T cell is able to lyse a target cell has been 
shown, by the use of various pharmacologic agents and incubation at 
different temperatures, to be a multi-staged event (Berke and Amos, 1973b; 
Henney, 1973; Wagner and Rollinghoff, 1974). 
It is_ generally agreed that the first stage involves the physical 
adhesion between the effector cell and target cell (Brondz, 1968; Golstein 
et al., 1971; Berke and Levey, 1972). This is rapidly followed by the 
second, post-recognition stage where a "lethal hit" of an unknown nature 
is delivered to the target cell (W_agner and Rollinghoff, 1974; Martz, 1975). 
The final, target cell disintegration stage results in the release of 
radioisotope from the pre-labelled target cells. In contrast to the first 
two stages, the final stage does not require the continual presence of an 
active effector cell population (Martz and Benacerraf, 1973; Miller and 
Dunkley, 1974; Wagner and Rollinghoff, 1974). 
The chelating agents EDTA and EGTA have proven useful in distinguish-
ing the various stages of cytolysis. Early studies by Mauel et al. (1970) 
showed that if EDTA was added at the initiation of an in vitro cytotoxicity 
assay, no specific 51 cr release was seen. However, if the addition was 
delayed by 45 minutes, the rate of 51 cr release proceeded norrnally. Henney 
and Bubbers (1973) confirmed and extended these observations and con-
cluded that the EDTA effect was reversible and blocked some lytic process 
requiring ca++ and/or Mg++. 
Stulting and Berke (1973) established that the initial recognitive 
phase, as investigated by specific absorption on monolayers, can occur in 
the presence of either ca++ or Mg++. Th.is work has subsequently been 
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confirmed by Golstein and Smith (1976) in a similar system. In contrast, 
~ th f ' ++ ++ Plaut et a~. (1976) have shown e irst stage to be more Mg than Ca 
dependent. 
The temperature dependency of the first stage is controversial. 
Thus Goldsein et al. (1971) found that adherence of effector populations 
to monolayers occurred at 37°C, but not at 4°C, whereas Stulting and Berke 
(1973), using a similar technique, found that significant adherence 
occurred at 25°C. Martz (1975) has shown that adhesions between centri-
fuged killers and targets occur at 15°C, but are optimal at 37°C. In 
If 
contrast, Wagner and Rollinghoff (1974), using a similar centrifugation 
technique, concluded that the recognition phase could occur at 4°C. 
However, since adhesion between centrifuged cells may occur in one minute 
at 37°C (Martz, 1975), the warnung period between 4°c and 45°C which the 
cells must pass through in Wagner's system in order to be inactivated may 
be of sufficient duration for both adhesion and lethal hit to occur. The 
first phase therefore appears to be relatively temperature independent 
with optimal binding occurring at 37°C. 
The binding of killer to target has been shown to be reversible 
If 
in the very early stages of phase I (Wagner and Rollinghoff, 1974; Martz, 
1975). Binding is also energy dependent (Werkele et al., 1972) and 
completely, but reversibly, inhibited by cytochalasin B (Cerottini and 
Brunner, 1972; Henney, 1973). It is not known whether the action of 
cytochalasin Bis at the level of disruption of microfilaments or membrane 
transport (for review, see Cerottini and Brunner, 1974). 
The second, or post-recognition-hit stage of cytolysis required 
Ca++ rather than Mg++ (Golstein and Smith, 1976; Plaut et al., 1976) and 
in contrast to the first stage is highly remperature dependent (Berke 
11 
et al., 1972b; Wagner and Rollinghoff, 1974) and irreversible (Wagner and 
If 
Rollinghoff, 1974). The second stage is inhibited by colchicine and 
adenyl cyclase activators such as the S catecholamines and cholera 
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enterotoxin, but is unaffected by cytochalasin B (for review, see Henney, 
1973). Although the first two phases of the lytic cycle ~ppear to be 
separable by several criteria it is notable that target cells become com-
mitted to lysis within minutes of contact with killer cells, so the 
" duration of both phases is extremely short (Wagner and Rollinghoff, 1974; 
MacDonald, 1975; Martz, 1975) • 
. 
The final stage in the lytic cycle is ca++ and Mg++ independent 
(Henney and Bubbers, 1973; Martz, 1975; MacDonald, 1975); is highly 
II • 
temperature dependent (Wagner and Rollinghoff, 1974); occurs independently 
of the presence of killer cells (Martz and Benacerraf, 1973; Wagner and 
R8llinghoff, 1974; Miller and Dunkley, 1974) and in contrast to the first 
two stages requires three-four hours in order to be completed (Wagner and 
R8llinghoff, 1974; Martz and Benacerraf1 1973). 
Recent kinetic studies with limiting numbers of effectors or labelled 
effectors have indicated that the sensitized cytotoxic T cell is unharmed 
duri_ng its interaction with a specific allogeneic target. Further, after 
administering lethal damage to one target cell, the killer cell retains 
its capacity to destroy other target cells (Brunner et al., 1970; Berke 
et al., 1972b; Andersson and Hayry, 1973; Martz, 1976). Data from Martz' 
laboratory suggest that a single killer cell may be able to sequentially 
kill more than six individual target cells (Martz, 1976). Hence, even a 
small number of specifically sensitised cytotoxic T cells could play an 
important role in the dest1.'"Uction of "foreign" cells in vivo. 
The mechanism by which cytotoxic T cells inflict their "lethal hit" 
remains a mystery. Berke and Amos (1973b) and Martz (1976) have suggested 
that killer cells cause permeability lesions in target cell membranes, 
possibly by alteration of transmernbrane potential, which ultimately kill 
the cell, probably by a combination of loss of intracellular metabolite 
pools and colloid osmotic swelling. Alternately, Henney (1973) has 
postulated that killing results from the action of a secreted antigen-
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induced mediator or toxin. The latter alternative seems unlikely for 
several reasons. Firstly, if such a toxin did exist, it would have to 
be highly specific and have a short ra_nge of action, as no toxic sub-
stances have been detected in supernatants from cytotoxicity assays 
(Hayry et al., 1972; Martz and Benacerraf, 1973), and third partly 
labelled bystander targets and the effector population itself are not 
destroyed (Cerottini and Brunner, 1974). Secondly, in the event of a 
non-specific toxin, one would have to postulate that the effector cell 
had evolved resistance to its own toxic product, since cytotoxic T cells 
have been shown to be susceptible to killing by other specifically 
induced cytotoxic T cells (Golstein, 1976; Martz, 1976). Finally, the 
toxin would have to be non-protein in nature since protein synthesis 
inhibitors such as pactamycin and emetine reportedly do not affect lytic 
activity (Thorn and Henney, 1976). 
CHAPTER 2 
QUANTITATION OF THE CYTOTOXIC RESPONSE 
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2.1 Introduction 
With the possible exception of a plaguing assay recently described by 
Bonavida and colleagues (1976) there are no methods yet available for the 
precise estimation of the frequency of cytotoxic T cells or their pre-
cursors. However, kinetic studies using the 51 cr release assay described 
by Brunner et al. (1968), have led to the formulation of mathematical 
models which estimate the relative cytotoxic activity of effector popu-
lations. 
Alth h 1 f s 1 C . . . oug re ease o r is a sensitive measure of target cell 
d~age, it is not per sea quantitative assay of effector cell activity. 
For comparison of the relative nurrber of cytotoxic effector cells in 
different populations, it is necessary to _establish a quantitative 
relationship between the cytotoxic activity (i.e., percentage of chromium 
released) and the number of effector cells present. 
Canty et al. (1971), and later MacDonald et al. (1973a), observed 
that percentage of target lysis plotted as a function of the logarithm of 
the sensitized cell concentration generated a sigmoid dose response curve. 
The midportion of this curve was approximately linear and its slope 
independent of the number of cells present. By determining the number of 
lymphoid cells required to obtain a fixed lysis value on the linear 
portion of the curve, MacDonald et al. (1973a) were able to obtain a 
quantitative estimate of the relative frequency of effector of progenitor 
cells in the population. Cerottini and Brunner (1971) used a similar 
analysis to define a lytic unit which is the number of effector cells 
required to produce 33 per cent lysis of 25,000 target cells. Both of 
these methods make possible quantitative comparisons of the cytolytic 
activities of different lymphoid populations. Henney (1971) observed that 
the specific lysis curves obtained in the 51 cr release assay could be 
reasonably well fitted by an expression of the form: 
where, K = 
N = 
y = 
y = 1 -
constant 
-KN 
e 
total number of sensitised cells 
fractional specific lysis. 
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This expression is identical to that predicted by the Poisson probability 
distribution for the fraction of cells inactivated by a discrete process 
in which "one hit" is sufficient for inactivation (Zimmer, 1961). In the 
same report, Henney was able to show that when specific lysis was plotted 
on a log/log scale against the number of effector cells the slope obtained 
approximated one, thus implying that cell-mediated lysis is a "one hit" 
phenomenon. Similar findings have also been reported by Lafferty et al. 
(1974a). Together, these studies confirmed earlier work with cytotoxic 
rat lymphocytes by Wilson (1965) and Berke et al. (1969) which also 
suggested that a "single hit" was sufficient for target cell inactivation. 
Miller and Dunkley (1974) have given a theoretical basis for Henney's 
observations and have shown that the interaction between cytotoxic cells 
and targets can be described by: 
a. = 
-ln(l - p) 
Nt 
where, a is proportional to the frequency of cytotoxic T cells 
N = the number of lymphoid cells used in the assay 
t = incubation time 
p = fractional specific lysis. 
Alpha (a) can be evaluated from any single value of lysis where fairly 
dilute suspensions of target cells and lymphocytes are assayed. 
The cytotoxic activity of the lymphoid populations described in the 
following chapters will also be expressed in terms of a derived unit, 
namely the cytotoxic unit. This chapter will primarily be concerned with 
the mathematical derivation of the cytotoxic unit and a description of the 
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experiments designed to determine the optimum conditions for the generation 
of cytotoxic T cells in vitro. 
2.2 Materials and methods 
2.2.1 Animals 
8 - 10 week old CBA/H and BALB/c inbred mice maintained in the Animal 
Breeding Establishment of this school were used. 
2.2.2 Tissue culture cell lines 
The DBA/2 mastocytoma cell line, P815-X2 was used as the targe~ in 
cytotoxicity assays. The cell line was maintained in vitro in 75 cm2 Falcon 
tissue culture flasks (Falcon Plastics, Oxnard, California, USA) containing 
30 ml of Dulbecco's Modified Eagle's Medium (Cat. No. H-16, GIBCO, Grand 
Island, NY, USA) supplemented with 10% heat inactivated (56°C for 30') 
foetal calf serum (FCS, CSL, Melbourne, Victoria) and antibiotics (100 µg/ml 
streptomycin and 100 units/ml penicillin G). The flasks were gassed with 
10% CO2, 7% 02, and 83% N2 and maintained at 37°C. 
Cells were cultured at an initial concentration of 10 5 viable cells/ml. 
Subcultures were made at 2-3 day intervals when the cell concentration was 
1-2 x 10 6 viable cells/ml. Cells for use as targets were generally obtained 
by subculturing cells from 2-3 day cultures overnight in fresh medium. 
2.2.3 Preparation of lymphoid cell suspensions 
Spleens and lymph nodes (mesenteric, popli teal, lumba.r, and inguinal) 
were collected aseptically, cut into small pieces and pressed through a fine 
stainless steel sieve into Eagle's Minimal Essential Medium (Cat. No. F-15, 
GIBCO, Grand Island, NY, USA) containing antibiotics (100 µg/ml streptomycin 
and 100 units/ml penicillin G), l0- 4 M 2-mercaptoethanol and 10% heat 
inactivated foetal calf serum (CSL, Melbourne). This medium will henceforth 
be referred to as "culture medium". Cell suspensions were washed and 
declumped three times. Cell viability was determined by Trypan blue 
exclusion and was usually better than 90%. 
43 
Stimulator cell populations were adjusted to 4 x 10 6 /ml, gassed with 
a mixture of 10% CO2, 7% 02, and 83% N2 and incubated for 90 minutes at 
37°C. These cells were then irradiated with 1000 R of gamma irradiation 
from a cobalt-60 source. 
2.2.4 Mixed lymphocyte cultures 
Mixed lymphocyte cultures were set up according to the methcrl of 
Lafferty et al. (1974a,b) with some modifications. Briefly, 1.0 ml of the 
stimulator cell suspension and 1.0 ml of the responder cell suspension were 
mixed in 16 mm diameter wells in 24-well trays (Linbro Model FB-16-24-TC 
Multidish Disposo-trays, Linbro Chemical Co., New Haven, Conn., USA). All 
assays were set up in triplicate. Trays were placed in air-tight boxes, 
gassed with humidified 10% CO2, 7% 02, 83% N2 and maintained at 37°C for 
4-7 days. Except where otherwise stated stimulator populations were BALB/c 
spleen cells and responder cell populations were CBA/H lymph node cells. 
2.2.5 Cytotoxicity assay 
P815 cells were harvested from culture flasks and washed three times 
with H-16. For labelling, the cell concentration was adjusted to 5 x 10 6 
viable cells/ml and 100 µCi/ml of 51 cr (Na2 51 Cr 0 4 ) was added~ Tubes were 
gassed with 10% CO2, 7% 02, 83% N2 and incubated for 60' at 37°C. Cells 
were then washed three times in F-15 + 10% HIFCS and made up to a final 
concentration of 1 x 10 6 viable cells/ml. 
Cytotoxic cell populations consisted of cells pooled from triplicate 
culture wells which were centrifuged once and resuspended in 2.0 ml of 
culture medium. Twofold serial dilutions were made over a 0-Sfold range . 
0.1 ml of each dilution was added to 0.1 ml of labelled target cells in 
96 well 6 mm diameter culture trays (Linbro model IS-FB-96-TC Multidish 
Disposo trays). All assays were set up in quadruplicate. Spontaneous 
51 cr release was determined by adding 0.1 ml of culture medium to 6 wells 
containing 0.1 ml of target cells, while total releasable 51 cr was 
determined by adding o.l ml of target cells to tubes containin g 0.9 ml of 
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Figure 2.1 - Log/log plot of specific lysis vs. effector cell concen-
tration indicates linear relationship with slope ~1.0, implying lysis 
is a 'one-hit' phenomenon. 4 x 10 6 BALB/c stimulator cells were 
cultured with 2 x 10 6 CBA/H lymph node responder cells and assayed on 
day 5 on 5 1 Cr labelled P815 targets. A , D , • , represent three 
separate experiments. 
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distilled water. All rr~xtures were incubated for 4 hours at 37°C. Aliquots, 
0.5 ml of the supernatants of water lysis controls and 0.1 ml of the super-
natants of all other samples, were taken and counted in a Packard Gamma 
Scintillation Counter for one minute each. 
2.3 Results 
2.3.1 The derivation of the cytotoxic unit 
The cytotoxic activity of killer populations was expressed in terms of 
the number of cytotoxic units (C.U.) per culture well. One cytotoxic unit 
was defined as that entity capable of lysing one target cell. All cytotoxic 
activities were related to the number of responder cells used in the 
original MLC rather than to the numbers of surviving cells actually used 
in the killer assay. This eliminated any bias of the results due to prefer-
ential survival in MLC of cytotoxic cells over non-cytotoxic cells. 
The following derivation of the cytotoxic unit rests on two basic 
assumptions. Firstly, it is assumed that the amount of releasable 51 cr 
from a target cell is the same by all methods of lysis: water, spontaneous 
or cytotoxic cell activity. Secondly, it is assumed that the lysis process 
is a "one hit" phenomenon, requiring no interaction between cells in the 
killer population. That such kinetics do in fact prevail is shown in 
Figure 2.1 where a plot of log (specific 51 cr release) versus log (No. of 
effector cells) resulted in a straight line with a slope approximating one. 
Since the killer-target interaction is "one hit", the amount of chromium 
released in unit time will be proportional to: 
(a) the number of targets one killer can contact 
in unit time, 
(b) the proportion of live contacts which cause lysis, 
(c) the number of killer cells present, 
(d) the proportion of live targets rerr.aining in the 
culture. 
I 
Now if we define -
N 
µ 
t 
= No. of t~gets one killer can contact in unit time 
proportion of live contacts which cause lysis 
duration of the assay 
y - total number of target cells 
0 
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Ye - number of targets lysed by a number, c, of the killer population 
a - 51cr release by one lysed target 
then 
and 
= 
aye 
Yo - Ye 
Yo 
total specifically releasable 51 cr 
51 cr specifically released by c cells of killer population 
= proportion of killer-target interactions involving 
live targets, 
then, -:.he number of targets killed in unit time is proportional to: 
C.N.µ 
i.e. 
= - M. c.N. µ 
where Mis a constant equal to the fraction of the killer population which 
are active killers. 
= 
when c=O, y =O, •. A = y 0 
also, M.c.N.µ.t = total number of targets lysed by c cells of 
killer population 
= number of cytotoxic units inc cells of 
killer population 
= Uc (say) 
. 
Yo -
• • 
. 1 -
. . 
Now, 
Ye = 
Ye 
= 
Yo 
= 
Yoe-Uc/Yo 
-u /y 
e C 0 
aye 
a.Yo 
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specific 51 cr release by c cells of killer populn. 
total specifically releasable 51 cr 
= 
• 1 - y = 
. . 
. ln(l y) - = -
. . 
. 
Uc = -
. . 
Number of c.u. 
= 
y (say) 
e-Uc/Yo 
Uc 
-
Yo 
Yo ln(l - y) 
C. U. /assay 
per MLC culture 
-Y ln (1 - y) 
0 
f 
where f is the fraction of the culture assayed. 
2.3.2 Expression of results 
All estimations of cytotoxic activity will be expressed as log C.U./ 
culture.The values reported are means of values obtained with three 
different effector to target cell ratios. 
Conventionally, cytotoxicity data is expressed as a value+ 2 S.E. 
where the standard error is calculated from replicates of a single 
population of effectors. Since this is not a true estimation of the 
variability a different approach has been adopted here. The variabil i ty 
was calculated by assaying twenty individual cultures at the peak of the 
response and calculating the S.D. from the values obtained. This 
estimation has been carried out on several occasions in this and other 
laboratories (K. Lafferty, personal communication) and a S.D. value of 
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Figure 2.2 - Time course for the generation of cytotoxic T cell activity 
in vitro. ~, 4 x 10 6 ; ~, 8 x 10 6 ; II, 2 x 10 6 BALB/c stimulator 
spleen cells were cultured with 2 x 10 6 CBA/H lymph node responder cells 
for the time intervals indicated. cultures were assayed on 51Cr l abelled 
P815 cells. 
---
, background. 
w 
~ 
:::> 
..... 
...J 
6.0 
:::> 
u ~ 5.0 
. 
:::> 
u 
C> 
0 
...J 
4.0 
--· ----------
~--
/ . 
• 
I 
• 
• 
• ..,._ ____________________ _ 
2.0 A.0 8.0 16.0 
STIMULATOR CELL CONCENTRATION xl0-6 
Figure 2.3 - Dose response curve obtained when 2 x 10 6 CBA/H lymph node 
cells were cultured with varying numbers of BALB/c spleen stimulator 
cells. All cultures were assayed on day 5 on 1 x 105 51 cr labelled P815 
target cells. -- - -- , background. 
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0.06 log C.U. has consistently been obtained. A value of+ 2 S.D., i.e. 
0.12 log C.U. has therefore been arbitrarily set as the variability range 
for all C.U. estimations, thus, no S.D. bars will be expressed with 
reported data. 
Background values were determined by using the medium lysis value 
+ 2 S.D. This method has been shown to give values very similar to those 
obtained with populations from syngeneic MLC's. Thus, a value of 
4.25 ± 0.16 log C.U. was obtained from multiple syngeneic MLC's assayed 
on day 5 of culture, while the estimation based on medium lysis gave a 
value of 4.37 log C.U •. 
2.3.3 Dose response and kinetic studies for the generation of 
cytotoxic T cells 
The MLC experiments reported here, and most of those reported in 
subsequent chapters, were carried out with BALB/c spleen stimulator cells 
and CBA/H lymph node responder cells. Spleen cells were chosen as a 
source of stimulating cells for reasons of convenience, i.e., the spleen 
provided large numbers of lymphoid cells. Lymph nodes were used as a 
source of responder cells because they were generally found to give better 
responses than spleen cells (unpublished observations Davidson, Cooley, 
Lafferty). The kinetics of the cytotoxic response obtained with mixtures 
of these cells are shown in Figure 2.2. Thus, when the number of responders 
are held constant at 2 x 10 6 /well the cytotoxic response peaked on days 5-6 
for all concentrations of stimulators tested. Stimulation occurred over a 
four-fold concentration range of stimulator cells with 8 x 10 6 and 4 x 10 6 
cells/well giving similar and slightly better responses than 2 x 10 6 cells/ 
well. A wider range of stimulator cell concentrations was tested on day 5. 
From Figure 2.3 it can be seen that optimal stimulation only occurred ove r 
a narrow range of cell concentration values. The response dropped signifi-
cantly when the stimulator concentration exceeded 8 x 10 6 cells/well or 
fell below 2 x 10 6 cells/well. 
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Figure 2.4 - Dose response curve obtained when 4 x 10 6 BALB/c sp l een 
stimulator cells were cultured with different numbers of CBA/H lymph 
node responder cells. All cultures were assayed on day 5 of culture 
on 51 Cr labelled P815 targets. - • - Background. 
The optimal concentration of responder cells was determined on day 5. 
Figure 2.4 shows that, as with the stimulator population, an optimal 
response was only obtained over a narrow concentration range. Peak 
responses were observed between 2 x 106 and 4 x 106 lymph node cells/well. 
Values outside this range resulted in markedly reduced stimulation. 
Except where otherwise stated all subsequent MLC's were carried out 
with 4 x 10 6 stirnulators and 2 x 106 responder cells/well and were 
routinely assayed on day 5 of culture. The levels of cytoxicity generated 
in day 5 cultures were very consistent, thus estimations from sixteen 
separate experiments gave a mean value of 6.11 ± 0.12 log C.U./culture. 
2.3.4 Medium supplements 
The culture medium used in these studies was routinely supplemented 
with 2-mercaptoethanol and foetal calf serum. Very little proliferative 
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or cytotoxic activity was observed in the absence of either of these agents. 
The foetal calf serum used in cultures was screened for toxicity and 
effectiveness before use as batches were found to vary considerably. 
Batches were selected on the basis of efficacy in allowing maximal gener-
ation of cytotoxic T cell activity. Only two batches of serum have been 
used in the studies reported in this thesis and both gave similar results. 
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D I S C U S S I O N 
The errpirical observation of Henney (1971) that fractional specific 
lysis can be very accurately fitted with an expression of the form, 1 - eKN 
has allowed the derivation of a unit which is proportional to the number 
of killer cells in an effector population. Additionally, and inbuilt into 
the function is the ability to correct for loss of linearity for lysis 
values between 35 and 65%. The function derived here also bears simi-
larity to that derived by Miller and Dunkley (1974). 
The main advantage in expressing data in terms of cytotoxic units is 
that it allows valid comparisons to be made between different populations. 
Such comparisons cannot be made with data expressed in terms of chromium 
release because the latter is not linearly related to the number of cyto-
toxic cells in the effector population. Thus, direct comparison of percent 
51 cr release values may not reflect the different cytotoxic activities of 
individual cell populations. Expression of the data in terms of cytotoxic 
units per culture avoids tedious enumeration of effector populations and 
thereby, the biased concentration of weakly reactive populations. It is 
also particularly useful in the study of stimulator populations where the 
number of responder cells is held constant. 
Since very high or very low values of specific lysis, which result in 
(1 - y) tending towards O or 1 respectively give very inaccurate esti-
mations of cytotoxic activity, titrations of effector populations were 
routinely performed. Except where high or low values occurred this 
practice also ensured that multiple estimates of the one point were made. 
The two main sources of variation in this adaptation of the MLC have 
been shown by Lafferty et al. (1974b) to be the foetal calf serum and the 
animals. The variation due to differences in batches of foetal calf 
serum was avoided by the use of a standard batch, while the animal 
variation was minimised by pooling the spleens of at least five animals 
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when preparing the stimulator population. Responder lymph node cells 
were also obtained by pooling the cells from five donors. It is also 
notable that only log phase P815 cells were used as targets in cytotoxicity 
assays as these were found to give much lower medium lysis values than 
cells taken later in the growth phase. 
Stimulator populations were routinely incubated for 90' at 37°C prior 
to irradiation. This procedure has been shCMn by Lafferty et aZ. (1974b) 
to lead to considerably enhanced stimulation. The mechanism underlying 
this phenomenon is unknown. 
In the past, in vitro assays of stimulation in mouse MLC have 
suffered from difficulties associated with the maintenance of cell 
viability (Hayry and Defendi, 1970). The report of Cheng and Hirsch (1972) 
that the addition of 2-mercaptoethanol (2-ME) to culture medium enhanced 
the survival of mouse lymphocytes s _uggested that this _agent may be of 
benefit in the mouse MLC assay. The enhancement of both thyrnidine uptake 
(Heber-Katz and Click, 1972i Lafferty et aZ. 1 1974b; Bevan et al., 1974) 
and generation of cytotoxic T cells (Bevan et al. 1 1974; Cerottini et al., 
1974; Lafferty et al., 1974a) in MLC's following the addition of 2-ME has 
subsequently been reported. The mechanism of action of 2-ME is not clear. 
Heber-Katz and Click (1972) reported that the sulph-hydryl group of 
2-ME was the active moiety since three unrelated reducing agents produced 
similar enhancing effects. Engers et al. ( 1975a) on the other hand have 
shown that both oxidised and reduced 2-ME caused enhanced cytotoxic T cell 
responses, suggesting that the enhancing activity of 2-ME is not related 
to its reducing capacity. Similarly, there is also controversy over the 
kinetics of activity of 2-ME. Thus Heber-Katz and Click (1972) suggested 
that 2-ME affected early events in MLC since addition of the agent after 
24 hours had little effect. In contrast, Engers et al. (1975a) have 
reported that addition of 2-ME can be delayed by up to 3 days after 
initiation of the culture without significant loss of cytotoxic activity. 
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These workers have suggested that one of the effects of 2-ME may be 
related to the differentiation of CTL precursor cells into active effector 
cells. 
Whether 2-ME acts directly on lymphocytes or requires the presence 
of adherent cells is unknown. Bevan et al. (1974) have suggested that 
2-ME may substitute for macrophages in the generation of cytotoxic T cells. 
Experiments described in later chapters indicate that in the culture 
system described here both accessory cells and 2-ME are required. 
The degree of cytotoxic activity_ generated in MLC assays carried out 
in the presence of 2-ME was very much dependent on the cell density. 
Thus when the number of responding cells was held constant at 2 x 10 6 /well 
and the density of the stimulator population was varied over a 16-fold 
range the cytotoxic activity passed through a maximum and then declined. 
The low levels of activity observed with less than 2 x 10 6 stimulator 
cells/well may be the result of II limi ti_ng antigen" or alternatively 
limiting numbers of accessory cells which are known to be required for 
the generation of cytotoxic T cells in vitro (Wagner et al. 1 1972). The 
loss of activity observed with high numbers of stimulators may be due to 
the more obvious causes of medium depletion, accumulation of toxic products 
or overabundance of macrophages which are known to be toxic in culture 
(Rode and Gordon 1 1974). Alternately 1 loss of activity may be attributed 
to tolerisation of the responding population or the selective generation 
of a suppressor population. The last two possibilities are probably remote, 
however, since all attempts to tolerise cytotoxic T cells in this 
laboratory have failed (data not shewn) and although suppressor cells are 
known to be generated during responses to alloantigens both in vivo (Rich 
and Rich, 1974) and in vitro (Fitch et al., 1976), there is no evidence 
that these cells are selectively induced in antigen excess. Similar dose 
response curves were observed when the number of stimulators was held 
constant and the number of responders varied. The first three explanations 
suggested for the observations with the stimulator population also apply 
to the responder population. There is no evidence that the decline in 
the response observed with la_rge numbers of responders is due to the 
presence of a suppressor population. 
The kinetic studies described here coincide with those reported in 
other laboratories using similar culture conditions (Cerottini et al., 
1974; Fitch et al., 1976) with peak cytotoxic activity occurring between 
day 5 and 6 of culture. The rapid fall in activity after day 6 has been 
attributed to the conversion of cytotoxic T cells to memory cells 
(MacDonald et al., 1974a,b) and possibly to the presence of a regulator 
or suppressor population (Fitch et al., 1976). 
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The dose response and kinetic studies described here indicate the 
importance of characterising each conponent of the MLC. Thus preliminary 
dose response and kinetic studies have been performed whenever investi-
gations with a new stimulator or responder population have been initiated. 
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SUMMARY 
A method for quantitati_ng cytotoxic T cell activity in vitro has been 
described. The standardisation of both the MLC procedure and the cyto-
toxicity assay has led to minimisation of sources of variation and thus 
made the procedures suitable for quantitative studies. Except where other-
wise stated a standard MLC procedure has been adopted using 4 x 10 6 spleen 
stimulators and 2 x 10 6 lymph node responders per well, and assaying 
cytotoxic activity on day 5 of culture. 
Cytotoxic activity was routinely expressed in terms of log cytotoxic 
units per culture. The standard deviation (S.D.) of replicate cultures 
was found to be 0.06 log cytotoxic units. Any values differing by more 
than two standard deviations, i.e. 0.12 log cytotoxic units, were con-
sidered to be significantly different. This policy was adopted for the 
data presented in all subsequent chapters. 
CHAPTER 3 
THE CAPACITY OF VARIOUS CELL POPULATIONS TO 
INDUCE CYTOTOXIC T CELL RESPONSES I N VITRO 
3.1 Introduction 
For the induction of optimal primary proliferative and cytotoxic T 
cell responses in vitro, alloantigens must be presented on the surface of 
stimulator cells (Wagner and Boyle, 1972; Engerset al., 1975b Lafferty et 
r 
al., 1974a; Hayry and Andersson, 1976; Wagner and R3llinghoff, 1976). 
Although some exceptions exist it is generally agreed that lymphoid popu-
lations and some neoplastic cell lines are a better source of stimulator 
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cells than non-lymphoid cells (Wagner and Wyss, 1973; Rode and Gordon, 1974; 
Lafferty et al., 1975; Wagner and Rollinghoff, 1975). However, whether all 
subpopulations of lymphoid cells, T cells, B cells and cells of the macro-
phage/monocyte series have an inherent capacity to stimulate remains con-
troversial. 
+ While there is general agreement that Ig cells are able to induce 
both proliferative (Cheers and Sprent, 1973; Plate and McKenzie, 1973; van 
Boehmer, 1974; Lanai and McDevitt, 1974; Lohrman et al., 1974; Simpson, 
1975; Sandel et al., 1975) and cytotoxic T cell (Wagner and Wyss, 1973; 
Simpson, 1975; Sandel et al., 1975) responses in mice and humans there is 
still debate over the stimulator potential of Ig cells. Accordingly, some 
investigators have observed significant proliferative (Cheers and Sprent, 
1973; von Boehmer, 1974; Lonai and McDevitt, 1974; Sandel et al., 1975) and 
cytotoxic T cell (Wagner and Wyss, 1973; Sandel et al., 1975) responses to 
Ig cells while others have been unable to demonstrate such activity (Plate 
and McKenzie, 1973; Simpson, 1975; Lohrman et al., 1974). The apparent 
contradictions found in these studies may in some way relate to differences 
in MLC methodology or cell purification techniques. 
Conflicting results have also been obtained with mouse macrophages as 
a source of stirnulators, since it has been shown that macrophages stimulate 
better than lymphocytes (Talmage and Henuningson, 1975; Schirrmacher et al., 
1975), that macrophages and lymphocytes stimulate equally (Simpson, 1975) 
and that lymphocytes stimulate better than macrophages (Wagner and Wyss, 
1973) • 
The following studies, using the standardised MLC procedures 
described in the previous chapter and a variety of cell separation tech-
niques were undertaken to determine the comparative ability of lymphoid 
populations from various sources, neoplastic cell lines, Ig 
cells and macrophages to induce cytotoxic T cell responses. 
+ 
cells, Ig 
Experiments 
were also carried out to determine whether the presence of Fe receptors, 
complement receptors or Ia antigens conferred superior stimulator 
potential on lymphocytes. 
3.2 Methods and materials 
3.2.1 Animals 
b ba 8-10 week old CBA/H, BALB/c, B6.H-2, B6.C-H-2 A.TH and A.TL nuce 
were obtained from the breeding colonies of this school. 
3.2.2 Tissue culture procedures 
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Mixed lymphocyte cultures and cytotoxicity assays were performed as 
described in Chapter 2. Macrophage targets were prepared by culturing 
peritoneal macrophages in Eagle's Minimal Essential Medium (Cat. No.F-15, 
GIBCO, Grand Island, NY, USA) containing antibiotics and 10% heat inacti-
vated foetal calf serum at a concentration of 1 x 106 /well in 6 mm diameter 
culture trays (Linbro model IS-FB-96-TC Multidish Disposo Trays) overnight 
at 37°C in 10% CO2 , 7% 02 and 83% N2. Monolayers were washed thoroughly 
and labelled in the wells by adding 7.5 µCi 51 cr/well in 50 µl of F-15 
medium. Plates were incubated for 1 hour at 37°C and then washed thoroughly 
with warm complete F-15 medium. Killer cell populations were added to 
target cells in a total volume of 0.2 ml. The cultures were incubated for 
4 hours or overnight at 37°C in 10% CO2, 7% 02 and 83% N2. All assays were 
set up in quadruplicate and 0.1 ml of the supernatant was counted. Water 
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lysis and medium lysis values were determined as described for the labell i ng 
of P815 cells (see section 2.2.5). 
L-929 cells were labelled in suspension at a concentration of 5 x 10 6 
cells in 0.4 ml of F-15 containing 300 µCi 51 cr. Cells were incubated for 
1 hour at 37°C with frequent mixing and then thoroughly washed. Labelled 
cells were dispensed into flat bottomed 6mm Linbro culture trays at a 
concentration of 2 x 104 cells/well. Immune cells were added to target cells 
in a total volume of 0.2 ml and following a 4 hour incubation period in an 
atmosphere of 10% CO2, 7% 02 and 83% N2, 0.1 ml of the supernatant was 
counted. Water and medium lysis values were estimated as described for P815 
cells (see section 2.2.5). 
3.2.3 Neoplastic cell lines 
Continuous line mouse fibroblasts (L-929) (Sanford et al., 1948) were 
grown in MEM with 5% FCS and 100 µg/ml of penicillin and streptomycin and 
incubated at 37°C in a humidified atmosphere. IgG and IgA plasmacytoma 
cells obtained from BALB/c mice were the gift of Dr Noel Warner. These 
cells were maintained in MEM with 5% FCS and 100 µg/ml of penicillin and 
streptomycin and were incubated in an atmosphere of 10% CO2, 7% 02 and 
83% N2. Cultures were fed every 48 hours. 
3.2.4 Carbonyl iron treatment 
Cell suspensions at 2 x 10 7/ml were mixed with enough carbonyl iron 
powder (Fe 3 (C0) 12 ), Atomergic Chemetals Co., New York, to render the 
solution dark grey. The mixtures were then rotated (30 revs/min) for 
1 hour at 37°C. The iron adherent cells were removed by an electro-magnet. 
The iron powder was washed twice to recover non-specifically trapped cel l s . 
Recoveries varied according to the tissue treated and viabilities were 
>95%. 
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3.2.5 Preparation of anti-8 reagent 
Anti-8 ascitic fluid was prepared in AKR/J nu.ce which were given up to 
10 intraperitoneal injections of 5 - 10 x 107 CBA thymocytes at weekly 
intervals. The first injection was given with 109 B. pertussis organisms. 
Three days before the final dose of thymocytes, the nu.ce were injected 
intraperitoneally with 0.2 ml of a 10% suspension of sarcoma 180 cells in 
saline (Tikasingh et al., 1966). The ascitic fluid was harvested 7 days 
after the final thymocyte injection. Unimmunised AKR/J mice were used as 
donors of control ascitic fluid. The anti-8 ascitic fluid was cytotoxic 
for >98% of thymus cells and for 20% to 30% of spleen cells. 
3.2.6 Treatment of cells with anti-8 and complement 
Cells were incubated (37°C, 30 min.) at a concentration of 5 x 10 7 -
1 x 10 8 cells/ml with a 1:4 dilution of anti-8 ascitic fluid, washed and 
resuspended in a 1:3 dilution of guinea pig serum, previously absorbed on 
agarose (80 mg/ml, 1 hour, 0°C). Cells were then incubated for a further 
15 minutes at 37°C, washed and recounted. Viability was judged by trypan 
blue (0.05%) dye exclusion. 
3.2.7 Treatment of cells with anti-Ia serum and complement 
Cells bearing Ia antigens were eliminated by treatment with A.TH anti-
A.TL serum and rabbit complement as described by McKenzie and Parish (1976). 
Briefly, 1.5 x 10 8 cells in 1 ml of medium (F-15 + 10% FCS) were incubated 
with 1.0 ml of anti-Ia 1, 2, 3, 7 at 1:2 dilution for 30' at 37°C. 10 ml of 
medium were added and the cells sedimented. 1.3 ml of rabbit complement 
(RC), (1:3 dilution)was added and a further 30' period of incubation at 37°C 
performed. Cells were then washed twice in medium and their viability 
assessed by trypan blue exclusion. After treatment with anti-Ia serum and 
complement 53% of CBA/H spleen cells were lysed while RC treatment alone 
lysed only 8%. 
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3.2.8 Preparation of cell suspensions 
Spleen and lymph node populations were prepared as described in 
Chapter 2. Mouse peritoneal cells (PC) were obtained by injecting 4 ml of 
cold PBS IP. The abdomen was then gently massaged and the inoculum 
aspirated. The cells were centrifuged in siliconised glass tubes at 4°C 
for 5' at 400 g then resuspended in cold culture medium. Viable cells 
were counted by trypan blue exclusion. Adherent cell monolayers were 
prepared by incubating PC at various concentrations in 24 well Linbro trays 
for 4 hours at 37°C. Non-adherent cells were removed by vigorous washing 
with warm (37°C) culture medium. Between 50% and 60% of PC were found to 
be adherent by this method. Adherent spleen cell monolayers were prepared 
in a similar way. In this case 20% to 30% of the population was adherent. 
Non-adherent cells were collected from centrifuged washings. 
Bone marrow cells were flushed from femurs and tibias with a syringe 
and dispersed by repeated aspiration. They were then washed, declumped 
and counted as for spleen and LN cells (Chapter 2). Peripheral blood 
leukocytes (PBL's) were prepared by collecting blood in Alsevers solution. 
The erythrocytes were removed by layeri_ng the cell suspension on to the 
separating medium (Isopaque/Ficoll) described in section 3.2.9.3. 
Following centrifugation the purified PBL's were washed three times and 
counted. 
3.2.9 Cell separation procedures 
+ . + 
Cells bearing surface immunoglobulin (Ig), theta antigen (8) or 
complement (CR+) or Fe (FcR+) receptors were removed from lymphoid cell 
suspensions by forming rosettes and separating the rosetting and non-
rosetting cells by centrifugation in Isopaque/Ficoll. The methods used 
have been described elsewhere (Parish and Hayward, 1974; Parish et al ., 
1974; Parish and Chilcott, 1975) and are also detailed below. 
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3.2.9.1 Antisera - Antisera to mouse IgG and rabbit IgG were prepared 
by Dr C.R. Parish. Briefly, mouse IgG and rabbit IgG were obtained from 
(NH 4 ) 2 S0 4 precipitation (40% saturation) of mouse or rabbit serum 
respectively. After extensive washing the precipitate was dissolved in a 
20 mM sodium phosphate buffer, pH 8.0 and passed through a DEAE coltLTTin 
eluted with the same buffer. The protein eluted was then concentrated by 
pressure dialysis, applied to a sephadex G-200 column and the IgG fraction 
from the column collected and concentrated. 
Antisera to rabbit Ig were raised in outbred merino sheep by injecting, 
into multiple sites, 1 mg of rabbit IgG emulsified in FCA (1.0 ml/sheep of 
a 1:1 mixture of FCA and antigen). Four to six weeks later the animals 
were boosted with 1 mg of rabbit IgG in FIA and the sheep were bled out 7 -
14 days after the secondary challenge. The globulin fraction of this anti-
serum was precipitated with (NH 4 ) 2 S0 4 at 40% saturation and after 
extensive washing the precipitate was redissolved in 0.15 M NaCl. 
Antisera to mouse Ig were raised in rabbits by an identical immunis-
ation schedule. 
3.2.9.2 Rosetting procedures -
A. Surface immunoglobulin - The procedure for rosetting mouse lympho-
cytes for surface immunoglobulin consisted of two stages: first, reaction 
of the lymphocytes with rabbit anti-mouse Ig and second, rosetting of the 
lymphocytes with SRBC coated with sheep IgG specific for rabbit Ig. 
To 2.5 ml of spleen cells at 4 x 10 7 cells/ml in complete medium was 
added 10 µl of hyperimmune rabbit anti-mouse Ig serum. This antiserum had 
been titrated against spleen cells and a dilution selected at which the 
number of Ig rosetting cells had reached a plateau. The cell antiserum 
mixture was incubated on ice for 30 minutes and then centrifuged at 300 g 
for 5' at 4°. The cell pellet was resuspended in 2.5 ml of medium and 
2.5 ml of a 20% suspension of SRBC (which had been previously coated using 
Cr Cl 3 , with sheep IgG specific for rabbit Ig) was added. The method of 
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coating consisted of adding 10 µl of the sheep anti-rabbit Ig to 0.25 ml of 
packed SRBC in 4 ml of saline; the red cell suspension was mixed and 
immediately 0.25 ml of Cr Cl3 was added with constant shaking. The mixture 
was left to react at room temperature for 10 minutes and then unreacted 
Cr Cl3 inactivated by adding two volumes of PBS. The coupled red cells 
were washed twice in PBS and resuspended to make a 20% suspension. 
The lymphocyte-erythrocyte mixture was then centrifuged at 300g for 
5 minutes at 4°C to enable rosette formation. Sodium azide (20 µlat 25%) 
was added just before resuspending the cell pellet. Samples were taken and 
diluted in PBS containing 1% (V/V) glutaraldehyde and 2% (W/V) crystal 
violet. 
rosette. 
Any lymphocyte which bound >5 erythrocytes was counted as a 
+ By the above method 45% - 52% of spleen cells were Ig. 
B. Fe rosetting - Equal volumes of a 5% suspension of washed SRBC in 
PBS and an optimal dilution of mouse anti-SRBC antibody in PBS were 
incubated at 37°C for 30 minutes. The sensitised cells were washed three 
times with PBS. A 20% suspension of sensitised red cells in medium was 
prepared and stored on ice. Rosettes were formed by mixing 2.5 ml of cells 
at a concentration of 4 x 10 7 /ml with 2.5 ml of a 20% suspension of sensi-
tised red cells. The mixture was incubated at 37°C for 10 minutes then 
spun at 20°C for 5 minutes at 300 g. Sodium azide (20 µl of 25%) was added 
just before resuspending the cell pellet. Samples were taken and counted 
as for Ig rosettes. 40% - 50% of spleen cells formed Fe rosettes. 
C. Complement rosetting - Equal volumes of a 5% SRBC suspension in 
PBS and an optimal dilution (previously determined) of rat anti-SRBC anti-
body in PBS were incubated at 37°C for 30 minutes. The sensitised cells 
were washed twice with PBS and resuspended to 5% concentration. Equal 
volumes of 5% antibody coated SRBC and a 1/10 dilution of fresh mouse serum, 
which acted as a source of complement, were then incubated at 37°C for 20 
minutes. The sensitised red cells were then washed twice with PBS and 
resuspended in culture medium to a final concentration of 20%. 
Rosetting was performed as for Fe rosettes (section 3.2.9.2.B). 
+ 20% - 30% of spleen cells were found to be CR. 
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D. Ig and theta (8) rosetting - 0.5 ml of anti-8 serum was added to 
2.5 ml of spleen cells at a concentration of 4 x 10 7 /ml. The cells were 
incubated on ice for 30 minutes, washed twice and resuspended in 2.5 ml 
medium. The cells were then mixed with 10 µl of rabbit anti-mouse Ig anti-
serum, incubated on ice for 30 minutes, washed once and resuspended in 
2.5 ml of complete medium. The cells were then rosetted as for surface 
imrnunoglobulin (3.2.9.2.A). 70% - 75% of spleen cells were found to be 
Ig+6+ by this method. The Ig-6-cells consist of K cells, null cells and 
macrophages. 
3.2.9.3 Separation of rosetting and non-rosetting cells_ 
The method of separation was based on a procedure described by Boyum 
(1968), for obtaining lymphocytes from peripheral blood. 
The rosetting of cells with different surface markers was carried out 
as described in the preceding sections. 5 ml of each preparation was 
brought to 20°C and layered gently on to 4 ml of separating medium pre-
warmed to 20°C which consisted of 12 parts of 14% (mass/vol) Ficoll 
(Pharmacia, Uppsala, Sweden) dissolved in distilled water and 5 parts of 
32.8% (mass/vol) sodium metrizoate (Isopaque; Nyegaard and Co., Oslo, 
Norway). This mixture had a density of 1.09 and is referred to as Isopaque/ 
Ficoll. The separations were carried out in U-bottomed siliconised poly-
carbonate centrifuge tubes, 15 mm in diameter. The tubes were centrifuged 
at 20°C for 20 minutes at 1200 g. After centrifugation the supernatant 
above the Isopaque/Ficoll interface was discarded and the lymphocyte layer 
together with all the separating medium above the red cell pellet was 
collected. The lymphocyte fraction was diluted to 10 ml with complete 
medium, mixed well, and the lymphocytes pelleted by centrifugation at 300 g 
for 10 minutes. The cells were resuspended in 5 ml of complete medium and 
counted. 
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3.2.10 Preparation of neoplastic stimulator cells 
P815-X2 mastocytoma cells and IgA and IgG plasmacytoma cells were 
irradiated (5000 R) prior to use as stimulator cells. L-929 cells were 
treated with mitomycin C as follows1 20 µg/ml of mitomycin c (Calbiochem, 
Los Angeles, California) was added to L cells at 10 7 /ml and the mixture 
incubated at 37°C for 30 minutes. After two washes the cells were suspended 
in culture medium to the desired concentration. 
3.2.11 Estimation of thymidine uptake by cultured cells 
Mixed lymphocyte cultures set up in 24 well Linbro trays were mixed 
well after 4 or 5 days incubation and 0.2 ml aliquots removed from each well 
and dispensed into flat bottomed 6 mm Linbro culture trays. 25 µl of [ 3 H] 
thymidine (Amersham, TRA 120, 5 ci/mM at a concentration of 150 µCi/ml in 
PBS was added to each culture. After a further incubation period of 5 hrs 
at 37°C in a humidified atmosphere of 10% CO2 , 7% 02, 83% N2 the cultures 
were harvested on a MASH II harvester (Microbiological Associates) onto 
glass fibre filter discs. These discs were then dried in an oven at 100°C 
for 20 minutes. Each disc was then placed in a vial containing 8.0 ml of 
scintillation fluid (0.5% PPO, 2,4 diphenyloxazole in toluene) and its 
content of tritium estimated in a Packard liquid scintillation counter. 
3.3 Results 
3.3.1 The tissue distribution of stimulator cells 
Except where otherwise stated all lymphoid stimulator cells were 
obtained from BALB/c (H-2d) mice and CBA/H (H-2k) lymphoid cells, at a 
concentration of 2 x 10 6 /culture, were used as responders. Dose response 
and kinetic studies were routinely performed. 
A. Lymphoid and neoplastic cells - The results of a comparative study 
of the stimulator capacity of various lymphoid populations and neoplastic 
cell lines are summarised in Table 3.1. 
Stimulator 
population 
a Spleen 
Lymph node 
Peripheral 
blood 
lymphocytes 
Bone marrow 
Thymus 
Peritoneal 
cells a 
P815 
mastocytoma 
cellsb 
L cellsc 
IgA 
plasmacytoma 
cellsb 
IgG 
plasmacytoma 
cellsb 
TABLE 3.1 
THE STIMULATOR CAPACITY OF VARIOUS LYMPHOID 
AND NEOPLASTIC CELL POPULATIONS 
Optimal stimulator 
cell concentration/ 
culture 
2 X 10 6 
4 X 10 6 
4 X 10 6 
2 X 106 
1 X 106 
5 X 105 
2 X 10 5 
5 X 10 5 
2 X 10 5 
1 X 10 5 
5 X 10 4 
1 X 10 5 
5 X 10 4 
1 X 10 4 
1 X 10 6 
5 X 10 5 
1 X 10 5 
1 X 10 6 -
Cytotoxic activity 
log C.U./culture 
6.08 
6.00 
5.85 
5.99 
5.33 
4.56 
4.33 
5.13 
4.72 
Bgd 
4.58 
5.62 
5.20 
5.61 
4.79 
4.46 
5.09 
5.51 
5.06 
Bg 
Background 
log C.U./ 
culture 
4.20 
II 
" 
" 
II 
4.11 
II 
II 
II 
4.18 
4.37 
4.18 
4.18 
a Irradiated BALB/c stimulator cells cultured with 2 x 10
6 CBA/H lymph 
node responder cells and assayed on day 5 on 51 cr labelled P815 targets. 
b 
C 
d 
. 
d 
Irradiated (5000 R) P815-X2 mastocytoma cells or IgA or IgG (H-2) 
plasmacytoma cells were cultured for 5 days with 2 x 10
6 CBA/H lymph 
node cells then assayed on 51 cr labelled P815 cells. 
Mitomycin C treated L-929 cells cultured with 2 x 10 6 BALB/c lymph 
node cells for 5 days then assayed on 51 cr labelled L cells in a 4 hr 
assay. 
Bg = Background. 
Since the dose response data with all lymphoid stimulator cell popu-
lations except peritoneal cells parallels that already described for 
spleen cells (Chapter 2, Figure 2.3), only values obtained with optimal 
concentrations of these stimulator cells have been tabulated. 
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With the exception of an IgG plasmacytoma cell line, all cells tested, 
both lymphoid and neoplastic, were capable of stimulating significant cyto-
toxic T cell responses. Spleen, bone marrow, peripheral blood and lymph 
node cells induced about twice as much cytotoxic activity (double the 
number of cytotoxic units/culture) as P815 mastocytoma cells, L cells and 
IgA plasmacytoma cells and 5-8 times more than thymus and peritoneal cells. 
Peak cytotoxic activity was observed on day 5 with all stimulator popu-
lations except thymus cells, where the peak occurred a day later. 
It is notable that maximal stimulation with neoplastic and peritoneal 
cells occurred with 10-40 times fewer cells than were required for maximal 
stimulation with lymphoid cells. The dose response curves also proved to 
be different. Whereas stimulation with lymphoid cells (excluding peritoneal 
cells) occurred over at least an 8-fold concentration range (see Figure 2.3, 
Chapter 2), stimulation with neoplastic and peritoneal cells was only 
observed after a narrow concentration range. Accordingly, cytotoxic 
activity often dropped dramatically when the stimulator cell concentration 
giving optimal responses was increased or decreased as little as 2-fold 
(Table 3.1). 
B. Adherent and non-adherent lymphoid cells - Adherent, non-adherent 
and untreated spleen and peritoneal cells were tested for their stimulator 
activity. In these studies adherent cells were those cells which remained 
attached to plastic tissue culture wells after a 4 hour incubation period 
followed by thorough washing. 
As the data in Table 3.2 indicates all of the spleen cell populations, 
plastic adherent and non-adherent, and untreated induced similarly high 
levels of cytotoxic activity. In comparison, untreated and plastic adherent 
TABLE 3. 2 
THE ABILITY OF PLASTIC ADHERENT AND NON-ADHERENT BALB/c 
SPLEEN AND PERITONEAL CELLS TO STIMULATE 
Stimulator 
Stimulatorc Cytotoxic activitya 
population concentration/ log C.U./culture 
well 
Peritoneal 2 X 10 5 5.13 
cells 
Plastic adherent 
peritoneal cells 2 X 10 5 5.23 
Non-plastic? 
adherent 
peritoneal 
cells 1 X 106 5.57 
Spleen 4 X 10 6 6.16 
Plastic adherent 
spleen cells 'vl X 10 6 6.17 
Non-plasticb 
adherent spleen 
cells 'v3 X 10 6 6.15 
Background 
log C.U./ 
culture 
4.66 
II 
II 
4.37 
II 
II 
a 2 x 10 6 CBA/H lymph node cells were used as responders throughout. 
2 S.D. for all estimations was 0.12 log C.U. 
b Non-adherent cells were those cells which did not adhere to plastic 
during 4 hours incuba.tion at 37°C. 
c Cell numbers giving maximal stimulation of cytotoxic activity. 
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Figure 3.1 - The stimulator activity of Ig+, 8+ and Ig-, 8 BALB/c spleen 
subpopulations. 
·-· 
X 106 + e+ -I 4 Ig ' + Ig , e (recorrbined population) cells 
·-· 
106 - e , 1 X Ig ' cells 
o-o 3 X 10 6 + e+ cells I Ig ' 
All stimulator cells were irradiated and cultured with 2 x 10 6 CBA/H lymph 
+ + % Ig, 8 cells= 75%. node cells. Background= 4.8 log C.U. 
peritoneal cells stimulated responses significantly above background but 
8-10 fold lower than those induced by spleen cell stimulators. When 
plastic adherent cells were removed from the peritoneal cell population 
5 times more cells were required for a maximal response but the response 
obtained was significantly higher than that observed with adherent and 
untreated peritoneal cell stimulators. 
Whether the cells which stimulate in spleen and peritoneal adherent 
cell populations are macrophages or adherent lymphocytes or both is 
debatable. In an effort to determine whether Ig-, 8-, cells, which 
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presumably include conventional macrophages, were able to stimulate, spleen 
cells were rosetted for both of these surface markers simultaneously. The 
rosetting and non-rosetting populations were separated by centrifugation 
through Isopaque/Ficoll. + + - -Ig, 8 and Ig, 8 populations cultured in the 
proportions in which they rosetted, and the recombined populations were all 
tested for their stimulator capacity. As shown in Figure 3.1 each popu-
lation was able to stimulate but the peak responses observed with the 
+ + 
recombined population and, more particularly, the Ig, 8 population 
occurred a day earlier and were significantly higher than the response 
-induced by Ig , 8 cells. This result suggested that the stro_ng stimu-
lation observed with plastic adherent spleen cells (Table 3.2) may not be 
completely attributable to conventional macrophages or other Ig-, 8- cells. 
The apparent enhancement of stimulator activity following the removal of 
-Ig, 8 cells from the stimulator population was not a consistent finding. 
Purification of macrophages often rests on two properties generally 
considered characteristic of this population, namely, radiation resistance 
and prolonged viability in culture. When plastic-adherent peritoneal cell 
populations were cultured under conventional conditions for as little as 
24 hours and then thoroughly washed their capacity to stimulate was 
observed to decrease dramatically (Table 3.3). A similar loss in stimu-
lator activity was observed with irradiated or untreated Ig , 8 peritoneal 
TABLE 3.3 
LOSS OF STIMULATOR ACTIVITY BY BALB/c PERITONEAL CELLS 
FOLLOWING CULTURE 
Culture intervala 
4 hrs 
24 hrs 
72 hrs 
Peritoneal cell 
concentration/well 
5 X 10 4 
2 X 10 5 
5 X 10 5 
5 X 104 
2 X 10 5 
5 X 10 5 
5 X 10 4 
2 X 10 5 
5 X 10 5 
a Culture interval prior to use as stimulator cells. 
Cytotoxic activit~ 
log C.U./ culture 
4.72 
5.23 
4.23 
_Bg 
II 
II 
Bg 
II 
II 
b Cytotoxic activity estimated by 51 cr release assay using 1 x 10 5 
labelled P815 cells. 2 S.D. = 0.12 log C.U. 
c Background value (Bg) = 4.66 log C.U. 
w 
Or! 
:::::) 
..... 
....I 
:::::) 
7.0 
u 
'---- 6.0 
. 
:::::) 
. 
u 
C) 
0 
....I 
5.0 
I 
I 
--------------·--------~ .-- ~• 
--- .. 
• 
• 
I 
• 
I 
4 5 6 7 
DAYS OF CULTURE 
+ Figure 3.2 - The stimulator activity of Ig and Ig BALB/c spleen sub-
populations. 
4 x 10 6 irradiated BALB/c stimulator cells were routinely cultured with 
2 x 10 6 CBA/H lymph node responder cells . 
.&--.& , Ig+ cells 
D-- 0 , Unfractionated cells 
·-· , Ig cells 
Background= 4.20 log C.U. + % Ig cells= 48%. 
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cells cultured for three days prior to the addition of responder cells. 
In both cases the cultured adherent cells were viable, able to phagocytose 
and morphologically resembled macrophages. 
In an effort to overcome any possible toxic effects of cultured 
adherent stimulator cells, responder cells were removed from stimulator 
monolayers at various intervals after initiation of culture. As evidenced 
in Table 3.4 this procedure did not result in a significant increase in 
stimulation. 
Further evidence that the loss of stimulator activity following 
prolonged culture of adherent cells was not due to non-specific macrophage 
toxocity was obtained from experiments where cultured adherent cells were 
incorporated into mixed lymphocyte cultures. As shown in Table 3.4 the 
addition of these cells at the concentrations tested did not result in 
significant inhibition of cytotoxic T cell responses. 
3.3.2 Surface markers on stimulator cells 
A. Imrnunoglobulin - When Ig + and Ig BALB/c spleen cells were 
separated by a rosetting procedure and then tested for stimulator potential 
both populations were observed to induce significant cytotoxic responses 
(Figure 3.2). However, an earlier and significantly greater (approximately 
4-fold) response was consistently observed with Ig+ stimulator cells. 
cells were also slightly better stimulators than unfractionated spleen 
cells. 
+ Ig 
+ Interestingly, when Ig and Ig cells were treated with carbonyl iron 
powder prior to culture to remove adherent cells, and the adherent popu-
lation was replaced with responder adherent cells, both populations 
induced similar levels of cytotoxic activity which in both instances peaked 
on day 5 of culture (Table 3.5). 
TABLE 3.4 
TOXICITY OF CULTURED PLASTIC-ADHERENT BALB/c PERITONEAL CELLS 
Peritoneal cell 
concentration/ 
wella 
A. 2 X 10 5 
1 X 10 5 
5 X 10 4 
1 X 10 4 
II 
II 
II 
B. 5 X 10 5 
1 X 10 5 
5 X 10 4 
1 X 10 4 
None 
Contact 
interval 
12 hrs 
24 hrs 
48 hrs 
5 daysc 
II 
II 
II 
n 
Log C.U./culture 
Bg 
Bg 
Bg 
6.30 
6.35 
6.42 
6.40 
6.38 
Background 
log C.U./ 
culture 
4.20 
II 
II 
II 
4.84 
II 
II 
II 
II 
a Approximately 60% of peritoneal cells adhere to plastic.BALB/c 
adherent cells cultured for 3 days prior to use. 
b 2 x 10 6 CBA/H lymph node cells were cultured with BALB/c macrophages 
for the intervals specified. All cultures were assayed on day 5. 
c 4 x 10 6 irradiated BALB/c spleen stimulators and 2 x 10 6 CBA/H lymph 
node responders were cultured on BALB/c macrophage monolayers for 
5 days. 
d Bg = Background. 
a 
TABLE 3.5 
+ ACCESSORY CELL REQUIREMENTS FOR THE RESPONSE TO Ig AND Ig 
Stimulator 
population a 
Ig +d 
Ig 
+ Ig 
Ig 
+ Ig 
_Ig 
SPLENIC STIMULATOR POPULATIONS 
Carbonyl iron Addition of 
treatment of CBA/H spleen 
stimulator accessory 
population cells 
b C 
- -
+ 
+ 
+ + 
+ + 
Cytotoxic 
activity 
log c.u*/ 
culture 
6.16e 
5.61 
4.69 
4.69 
5.82 
6.05 
2 x 106 irradiated BALB/c Ig+ or Ig stimulator cells and 2 x 10
6 
CBA/H lymph node responder cells were used throughout. 
b = not treated; +=treated. 
c = no accessory cells addedi + = 2 x 106 irradiated CBA/H spleen 
cells added. 
d Rosetting% = 45%; 
e Background= 4.20 log C.U. 
B. Fe and complement receptors - Separation of lymphocytes into 
subpopulations on the basis of Fe receptors, like separation on the basis 
of inununoglobulin, did not differentiate stimulator from non-stimulator 
populations. + Thus Fe and Fe subpopulations both induced similar levels 
of cytotoxici ty (Table 3. 6) • Similarly, Ig + cells with and without Fe 
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receptors and Ig cells without Fe receptors all stimulated responses which 
did not differ significantly from each other or from unfractionated controls 
(Table 3.5). Preliminary experiments with complement receptor bearing 
(CR+) cells have indicated that this surface marker like Fe receptors and 
surface immunoglobulin is not unique to stimulator cells. However, in 
contrast to studies with the latter markers neither CR+ nor CR cells 
stimulated as well as unfractionated cells (Table 3.6). 
C. Ia antigens - The effects of the pre-treatment of CBA/H stimulator 
spleen cells with A.TH anti A.TL serum (anti-Ia serum) and complement prior 
to culture with BALB/c lymph node responder cells are summarised in Table 
3.7. Although 47% of the cells were lysed by this treatment the residual 
population stimulated as well as the untreated population. 
Evidence that an.!_ region difference is not required for the gener-
ation of cytotoxic T cells is summarised in Table 3.8. In this study 
significant proliferative and cytotoxic responses by A.TL lymph node cells 
were observed following stimulation with CBA/H spleen cells. These popu-
lations are non-congenic but share the I region. The further a.ddition of 
irradiated A.TH spleen cells which differ from A.TL cells only at the I 
region enhanced both the proliferative and cytotoxic responses significantly 
(Table 3.8). This enhancement was not observed when irradiated A.TL spleen 
cells were added. 
Furthermore, significant specific cytotoxic T cell responses were also 
ba . b 
observed when mutant B6.C-H-2 spleen cells were used to stimulate B6-H-2 
lymph node responder cells which differ from the former by a point mutation 
at the K end of the H-2 complex (Table 3.8). 
Stimulator 
population a 
+ C FcR 
-FcR 
+ + lg FcR 
+ -lg FcR 
-lg FcR 
Unfractionated 
-CR 
Unfractionated 
TABLE 3.6 
SURFACE .MARKERS ON STIMULATOR CELLS 
Cytotoxic activityh 
log C.U./culture 
5.88 
6.20 
5. 86 
6.17 
5.82 
6.09 
5.14 
5.28 
5.60 
Background 
log C.U./culture 
3.84 
" 
" 
II 
II 
II 
4.26 
" 
II 
a 4 x 10 6 irradiated BALB/c stimulator cells used routinely with 2 x 10 6 
CBA/H lymph node responder cells. 
b All cultures assayed day 5 on 51 cr labelled P815 targets. 
c FcR rosetting%= 40%. 
d CR rosetting%= 23%. 
TABLE 3. 7 
ANTI-Ia SERUM AND COMPLEMENT TREATMENT 
OF CBA/H STIMULATOR POPULATION 
/ 
Treatment of 
stimulator 
population 
% viability 
following 
treatrnentc 
Cytotoxic activityd 
Anti Ia serum+ 
complementb 
Complement only 
Untreated 
53% 
92% 
98% 
log C.U./culture 
5.00 
5.11 
5.07 
a 4 x 106 CBA/H spleen cells used as stimulators and 2 x 10 6 BALB/c 
lymph node cells as responders. 
b A.TH anti-A.TL serum+ rabbit complement. 
c Viability estimated by trypan blue exclusion. 
d 2 x 10 4 51 cr labelled L cells used as targets. 
Background activity= 3.64 log C.U. 
TABLE 3.8 
GENERATION OF CYTOTOXIC T CELLS IN THE PRESENCE AND ABSENCE OF 
AN H-2I REGION DIFFERENCE 
Stimulator spleen cella Cytotoxic activity 3H-T uptakeb 
A. 
B. 
a 
b 
C 
d 
e 
f 
combinations log C.U./culturec c.p.m. 
4 X 10 6 CBA/H 5.93 30, 183 
4 X 10 6 CBA/H + 
4 X 10 6 A.TH 6.42 40, 728 
4 X 10 6 CBA/H + 
2 X 10 6 A.TH 6.48 72, 849 
4 X 10 6 CBA/H + 
1 X 10 6 A.TH 6.65 76, 873 
4 X 10 6 CBA/H + 
4 X 10 6 A.TL 6.08 40, 169 
4 X 10 6 CBA/H + 
2 X 10 6 A.TL 6.19 42, 059 
4 X 10 6 CBA/H + 
1 X 10 6 A.TL 6.11 33, 556 
4 X 10 6 A.TH 5.25 55, 783 
2 X 10 6 A.TH 5.00 39, 670 
1 X 10 6 A.TH 4.26 23, 785 
4 X 10 6 A.TL Bg 3, 920 
2 X 10 6 A.TL Bg 1, 576 
1 X 10 6 A.TL Bg 1, 542 
B6.C-H-2 ba f 5.7od N.T. 
B6.C-H-2 ba 4.8oe N.T. 
6 2 x 10 A.TL (s kkkk d) lymph node responder cells were used routinely 
CBA/H (k kkkk k) and A.TH (s ssss ~ stimulator cells were both 
irradiated (1000 R). 
Tritiated thymidine ( 3H-T) uptake measured day 5 of culture S.E. = ±5%. 
Cultures assayed on 2 x 10 4 51 cr labelled L cells, incubation period, 
4 hrs. Background= 4.20 log C.U. 
5 51 ba Cultures assayed on 1 x 10 Cr labelled B6.C-H-2 macrophages, 
incubation period, 16 hrs. Background= 4.80 log C.U. 
5 51 b Cultures assayed on 1 x 10 Cr labelled B6-H-2 macrophages, 
incubation period, 16 hrs. Background= 4.80 log C.U. 
4 x 10 6 irradiated ~6.C-H-2ba spleen stimulator cells were cultured 
with 2 x 10 6 B6-H-2 lymph node responder cells for 5 days. 
N.T. - not tested. 
67 
D I S C U S S I O N 
The use of a derived cytotoxicity unit has allowed comparative studies 
of the stimulator capacity of various lymphoid subpopulations and neo-
plastic cells of both lymphoid and non-lymphoid origin. 
Lymphoid and non-lymphoid stimulators 
All lymphoid tissues except the thymus and the peritoneum proved to 
be a rich source of stimulator cells. As will be sha..m in Chapter 5 the 
relatively poor stimulation observed with thymocytes reflects a deficiency 
of a necessary accessory cell population in the thymus rather than an 
innate inability of thymocytes to stimulate. A similar requirement for 
the addition of accessory cells when thymocytes are used as a source of 
stimulators has also been reported by others (Dyminski and Smith, 1975, 
1976) • 
An alternate explanation must be invoked for the poor stimulation 
observed with peritoneal cells as this population is known to contain 
significant numbers of accessory cells (see Chapter 5). Since non-plastic 
adherent peritoneal cells induced significantly greater responses than 
unfractionated peritoneal cells at any of the concentrations tested, one 
possibility is that plastic adherent cells inhibit the response in some 
way. Support for this suggestion comes from recent reports where adherent 
peritoneal cells were shown to produce factors in vitro, capable of 
inhibiting cell division (Calderon et al., 1974; Calderon and Unanue, 1975). 
The characteristic dose response kinetics observed with neoplastic 
cells probably reflects the accumulation of toxic or inhibitory factors 
when these cells are used above a certain critical concentration. There is 
considerable evidence that some lymphomas and non-lymphoid neoplasias, such 
as P815 mastocytoma cells, can suppress both antibody and cell-mediated 
immune responses in vitro (Wong et al., 1975; Tanapatchaiyapong and Zolla, 
1974; Kamo et al., 1975; Rodey et al., 1974; Bonnard and Herberman, 1975; 
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Pikovski et al., 1975). In some cases soluble factors have been shown to 
be responsible for the suppressive effects {Tanapatchaiyapong and Zolla, 
1974; Pikovski et al., 1975). The complete lack of stimulation at any 
concentration observed with IgG plasmacytoma cells suggests that this cell 
line may be a very efficient producer of suppressive agents. 
In contrast to lymphocytes only small numbers of neoplastic cells 
were required to stimulate optimal responses. There may be a simple geo-
metric explanation for this difference as neoplastic cells are considerably 
larger than lymphocytes. The possibility cannot be excluded, however, that 
the majority of neoplastic cells function as stimulators whereas only a 
subpopulation of lymphocytes may stimulate. 
Adherence properties of stimulators 
There is sorre controversy over the stimulator capacity of macrophage-
like cells. While there are numerous reports of macrophages inducing 
proliferative responses in humans (Levis and Robbins, 1970; Bain and 
Lowenstein, 1969; Alter and Bach, 1970; Twomey et al., 1970 and Rode and 
Gordon, 1974), mice (Talmage and Hemmingsen, 1975; Schirrmacher et al., 
1975), and guinea pigs (Greineder and Rosenthal, 1974) few studies exist 
on the capacity of these cells to induce cytotoxic T cell responses 
(Wagner and Wyss, 1973; Simpson, 1975). 
Two properties of macrophages, adherence to plastic surfaces and 
longevity in culture, were employed in the present study to separate 
macrophages from lymphocytes. The superior stimulation observed with 
splenic adherent cells as opposed to peritoneal adherent cells has also 
been reported by others. Thus Simpson (1975), showed that adherent spleen 
cells induced similar levels of cytotoxic activity to unfractionated spleen 
cells while Wagner and Wyss (1973) observed that adherent peritoneal cells 
induced considerably weaker responses than spleen cells. The reason for 
the differences in stimulator activity observed with splenic and peritoneal 
adherent cells is unknown but may reflect both functional and anatomical 
heterogeneity in adherent cell populations. 
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One disadvantage of using adherence properties to prepare macrophage-
enriched populations is that cells other than macrophages may be adherent. 
That the adherent cells which stimulated in spleen were not all macrophages 
was well illustrated by the finding that Ig, 8 cells (which include K 
cells, macrophages and null cells) induced 10-fold less cytotoxic activity 
+ + than Ig , fl cells. 
When adherent cells were cultured for prolonged periods their capacity 
to stimulate was observed to decrease dramatically. This loss in stimu-
lator activity did not appear to be a result of increased toxicity. A 
diminution in stimulator activity following prolonged culture of adherent 
cells has also been noted in proliferative studies in mice (Talmage and 
Henuningson, 1975) and in humans (Rode and Gordon, 1974). However in other 
studies of proliferative responses with mouse (Schirrmacher et al., 1975), 
htnnan (Bain and Lowenstein, 1969i Twomey et al., 1970) and guinea ~ig 
Greineder and Rosenthal, 1975) macrophages this phenomenon was not observed. 
At the moment, technical discrepancies and possibly variation between mouse 
strains can only be suggested as explanations for these differences. 
In conclusion, it appears that adherent cells which stimulate cytotoxic 
T cell responses in the mouse strains tested here are not conventional 
long-lived, phagocytic, radiation-resistant macrophages but may be sticky 
lymphocytes; precursors of macrophages or perhaps conventional macrophages 
with rapidly lost absorbed antigens. Whatever the identity of these cells 
the spleen seems to be a richer source than the unstimulated peritoneal 
cavity. Unfortunately, to date, there are no reports which examine human 
or guinea pig macrophages as stimulators of cytotoxic T cell responses. 
Surface markers on stimulator cells 
In a recent study of murine lymphocytes it was suggested that the major 
antigenic stimulus recognised by cytotoxic T cell precursors is present 
predominantly on B cells (Simpson, 1975). In another study (Sondel et al., 
1975) however, and in this one, effective stimulation was observed with a 
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population depleted of both B cells and adherent cells (Wagner et al., 1973; 
Sandel et al., 1975). 
The Ig population obtained by the rosetting procedure used in this 
study contains cell populations in addition to T cells (viz. macrophages, 
K cells and null cells). The relative contributions of each of these sub-
populations to the stimulator activity of the whole population is tech-
nically difficult to detennine. Although Ig , 8 cells induced significant 
levels of cytotoxic activity and anti-8 and complement treatment of the Ig 
population had little effect on its stimulator activity (data not shown) at 
this stage it cannot be concluded that T cells are devoid of stimulator 
activity. The observation that carbonyl iron treated Ig populations which 
are considerably enriched for T cells are able to stimulate strong cytctoxic 
T cell responses in cultures supplemented with responder accessory cells 
strongly implies that T cells do in fact have the capacity to stimulate. 
The recent development in this laboratory of a theta (8) rosetting pro-
cedure should help to resolve this issue. 
+ Since adherent cell depleted Ig and Ig populations both induced 
similar levels of cytotoxic activity when responder adherent cells were 
added in a three-cell system, the poorer stimulator observed with untreated 
Ig as opposed to untreated Ig+ populations, may reflect the loss of an 
adherent accessory cell population during the separation. The loss of 
adherent cells, particularly when T cell enriched populations are prepared 
by filtration through nylon wool columns, could account for the inability 
reported by others (Simpson, 1975) of these cells to stimulate. 
Separation of lymphocytes into subpopulations on the basis of the 
presence or absence of Fe and complement receptors, like separation on the 
basis of surface imrnunoglobulin, did not differentiate stimulator from non-
stimulator populations. 
As mentioned in Chapter 1, the central region of the H-2 complex, 
the.!_ (immune response) region, codes for a group of polymorphic cell 
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surface structures designated Ia antigens (David et al., 1973; Gotze et 
al., 1973; Hanunerling et al., 1974). These antigens have been classed as 
strong LD antigens but weak target antigens, that is, they induce strong 
proliferative responses (Schendel et al., 1973; Meo et al., 1973b; Fathman 
et al., 1974) but only weak cytotoxic T cell responses (Klein et al., 1974b; 
Nabholz et al., 1975b;Wagner et al., 1975a). Recently there has been some 
debate as to whether the simultaneous recognition of Ia antigens or other 
LD antigens by a subset of collaborating T cells is a co-requisite for the 
generation of cytotoxic T cells (Schendel et al., 1973, 1974; Wagner 
al., 1973; Bach et al., 1976). 
The three experimental approaches described here, namely: 
( a) 
(b) 
(c) 
+ 
the removal of Ia cells from the stimulator population; 
the use of stimulator and responder populations sharing the 
!_ region and, 
ba 
the use of the mutant strain B6.C-H-2 and its congenic 
b partner B6-H-2 as stimulator and responder populations, 
+ 
suggest that the presence of Ia cells on even an.!_ region difference is not 
an absolute requirement for the induction of cytotoxic T cell responses. 
However, evidence was obtained which suggested that the recognition 
of determinants coded in the!_ region could result in the amplification of 
the response. Thus, the cytotoxic response obtained with mixtures of I 
region compatible CBA/H stimulator and A.TL responder cells could be 
significantly enhanced by the further addition of A.TH stimulator cells 
which differ only in the.!_ region from the responder population. Wagner 
et al. (1976b) have recently obtained essentially similar results in the 
same system. Enhancement of proliferative and cytotoxic responses as a 
+ 
consequence of the presence of Ia stimulator cells has also been reported 
(Cantor and Boyse 1975b; Wagner et al., 1975b). 
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Since Mls locus coded antigens have been reported to replace Ia anti-
gens as the LD requirement (Schendel and Bach, 1975), in the induction of 
cytotoxic T cells it may be argued that the stimulation observed with Mls 
different CBA/H and A.TL combinations resulted from the activation of T 
helper cells by Mls coded antigens. Although this cannot be excluded as a 
possibility the data obtained with mutant mice suggests that significant 
levels of cytotoxic activity can be generated in the absence of both I 
region differences and Mls locus differences. The reciprocal stimulation 
observed with mutant mice and their congenic partners is well documented 
(Klein et al., 1975b;Forman and Klein, 1975; Melief et al., 1975; Hodes 
et al., 1976). 
An alternate approach to the problem has been to separate the various 
T cell subpopulations responding in MLC and to determine the antigenic 
requirements for their induction. Recently Cantor and Boyse (1975a,b) have 
+ 
shown that Ly-1 helper cells responding primarily to Ia antigens can 
+ 
enhance the response of Ly-2,3 precursor cytotoxic T cells. It should be 
stressed, however, that significant amplification was only evident when 
+ Ly-2,3 cells were used in limiting numbers. Thus, optimal numbers of 
+ Ly-2,3 cells alone could generate substantial killer activity. Preliminary 
studies in this laboratory (data not shCMn) have indicated that the removal 
+ 
of Ly-1.1 T cells from the responding population has no effect on the 
ability of cytotoxic T cell precursors to respond. 
To conclude, there is still considerable debate concerning the genetic 
requirements for induction of cytotoxic T cells. It would appear, though, 
that under optimal culture conditions the recognition of H-2K or H-2D region 
coded determinants by Ly-2,3+ cells is sufficient for the generation of 
+ 
substantial cytotoxic activity. The response may be amplified by Ly-1 
helper cells responding principally to antigens coded in the I region and 
possibly to other LD antigens. So far there is no evidence for the absolute 
requirement for T help that has been shCMn for the production of antibody to 
most antigens. 
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SUMMARY 
The comparative ability of various lymphoid subpopulations and neo-
plastic cell lines to induce cytotoxic T cell responses in vitro was studied. 
Lymphocytes were observed to be the best source of stimulator cells followed 
by P815 mastocytoma cells, L cells and Ig A plasmacytoma cells. Mature 
macrophages were poor stimulators. Both Ig + and Ig cells were able to 
stimulate but optimal stimulation by Ig cells was found to be dependent on 
the addition of accessory cells. The presence of Fe or complement 
receptors or Ia antigens on lymphocytes did not confer superior stimulator 
capacity. The role of I region in the induction of cytotoxic T cell 
responses was also discussed. 
CHAPTER 4 
ADHERENT CELL REQUIREMENTS 
FOR CYTOTOXIC T CELL INDUCTION 
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4.1 Introduction 
The requirement for a glass, nylon or cotton adherent accessory cell 
population for the induction of proliferative responses in MLC in human 
systems is well documented (Oppenheim et al., 1968; Rode and Gordon, 1970; 
Twomey et al., 1970; Alter and Bach, 1970; Berlinger et al., 1976). These 
adherent cells may be of stimulator or responder origin (Rode and Gordon, 
1970; Twomey et al., 1970; Alter and Bach, 1970) and are thought to play 
an essential but non-specific role. 
A similar requirement for glass or plastic adherent cells has also 
been reported for the_ generation of cytotoxic T cells in MLC in both murine 
systems (MacDonald et al., 1973b; Wagner et al., 1972), and in a xenogeneic 
rat/mouse system (Lonai and Feldman, 1971). To date there have been few 
attempts to characterise the functional adherent population or to determine 
its mode of action. 
In this study the role of adherent cells in the_ generation of cyto-
toxic T cells was investigated by preincubating stimulator and responder 
populations on plastic or by pretreating them with carbonyl iron powder, 
a procedure known to remove conventional macrophages, other adherent sub-
populations and non-viable cells (Lundgren et al., 1968; Erb and Feldmann, 
1975b) . 
4.2 Methods and materials 
4.2.1 Animals 
6-8 week old CBA/H, BALB/c, C57Bl/6, C57Bl/6 x BALB/c F1 and BALB/c x 
CBA/H F1 nuce were used routinely. 
4.2.2 Tissue culture procedures 
Cells were prepared and cultured as described in Chapters 2 and 3 
(sections 2.2.3 and 3.2.2). 
75 
4.2.3 Cytotoxicity assays 
Cultures were assayed for cytotoxic activity as described in Chapter 2 
(section 2.2.5). 
4.2.4 Removal of adherent populations 
Adherent cells were removed by incubation on plastic surfaces or by 
treatment with carbonyl iron powder as described in Chapter 3 (section 3.2.4). 
4.2.5 Trypsin treatment of carbonyl iron residues 
Cells were treated with carbonyl iron powder as described in Chapter 2. 
Following the removal of the non-adherent cells the carbonyl iron residue 
was washed twice in serum free medium. All supernatants were collected and 
added back to the original depleted population. The carbonyl iron residue 
was then resuspended in serum free medium containing trypsin at a concen-
tration of 1 mg/ml. The suspension was mixed for 30' at 37°C then cold 
medium containing foetal calf serum was added. The carbonyl iron was 
removed and the residue washed once. All supernatants were added back to 
the original depleted population. The cells were incubated for 2 hours at 
37°C prior to irradiation. 
4.3 Results 
4.3.l The effects of removal of adherent cells from stimulator 
and responder populations 
A. Lymph node responder cells - BALB/c spleen stimulator cells and 
CBA/H lymph node responder cells were either treated with carbonyl iron 
powder or incubated on plastic petri dishes to remove adherent cells. 
Following treatment with carbonyl iron powder 15-25% of spleen cells and 
10-15% of lymph node cells were routinely removed. Similar proportions of 
cells were also lost following incubation on plastic. 
6 4 x 10 spleen cells 
and 2 x 106 lymph node cells were used routinely. The concentration of 
treated populations was adjusted according to the proportion of cells lost 
(thus if 20% of spleen cells were lost following treatme nt the cell concen-
tration was adjusted to 3.2 x 10 6 /ml). 
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Figure 4.1 - The effects of carbonyl iron treatment of spleen stimulator 
cells and lymph node responder cells on the generation of cytotoxic 
activity. 
Stimulator= BALB/c spleen cellsi responder= CBA/H lymph node cells; 
treatment= carbonyl iron treatrrent prior to culture. 
&-A, treatment of responders only;~-~ , no treatment of stimulator 
or responder; •-• , treatment of stimulator only; 0-0 , treatment of 
both stimulator and responder. 
- - - = background value. 
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Figure 4.2 - The effects of the removal of plastic adherent cells from 
stimulator and responder populations on the generation of cytotoxic 
activity. 
Treatment= incubation on plastic for 4 hrs prior to culture. 
Stimulator= BALB/c spleen cells; responder= CBA/H lymph node cells. 
A A, treatment of responder only;~--~ , no treatment of responder or 
stimulator;·-·, treatment of stimulator only;0--0, treatment of 
both stimulator and responder. 
- • - = background value. 
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Figure 4.1 shows the effects of carbonyl iron treatment of the 
responder population alone, the stimulator population alone and both 
stimulator and responder populations. Untreated control populations were 
also included. Treatment of the responder population only, had no signifi-
cant effect on the response whereas treatment of the stimulator population 
resulted in a highly significant depression (20-50 fold) of the response 
on all days tested. Treatment of both populations completely abrogated the 
response. 
In contrast to the effects of the removal of carbonyl iron adherent 
cells, the removal of plastic adherent cells from the stimulator population 
alone, the responder population alone or both populations together had no 
significant effect on the response (Figure 4.2). 
B. Spleen responder cells - The same experiments described in 
section 4.3.1.A were carried out using CBA/H spleen responder cells instead 
of lymph node responder cells. As shown in Figure 4.3, and as observed with 
lymph node responder cells, carbonyl iron treatment of both the stimulator 
and responder populations completely abrogated the response while treatment 
of the responder populations alone had no significant effect. However, in 
contrast to the data obtained with lymph node cells, carbonyl iron treatment 
of the stimulator population alone resulted in only a slight reduction in 
the response. 
The removal of plastic adherent cells, prior to culture, from either the 
responder or the stimulator population or both, had no significant effect 
on the response (Figure 4.4). 
4.3.2 Some aspects of carbonyl iron treatment 
The data presented in Figures 4.1 - 4.4 suggest that a population of 
cells is required for the induction of cytotoxic T cells which is: 
(a) depleted by treatment with carbonyl iron but not by 
incubation on plastic surfaces, 
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Figure 4.3 - The effects of carbonyl iron treatment of spleen stimulator 
cells and spleen responder cells on the generation of cytotoxic activity. 
Treatment= treatment with carbonyl iron prior to culture; 
stimulator= BALB/c spleen cells; responder= CBA/H spleen cells. 
~~~, treatment of responder only;~~-~, no treatment of responder or 
stimulator; • , treatment of both responder and stimulator; 
0-0, treatment of stimulator only . 
..... - .... = background value 
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Figure 4.4 - The effects of the removal of plastic adherent cells from 
spleen stimulator and spleen responder populations on the generation of 
cytotoxic activity. 
Stimulator= BALB/c spleen cells; responder= CBA/H spleen cells; 
treatment= incubation on plastic for 4 hrs prior to culture. 
~~~, treatment of responder only; II II, treatment of stimulator 
orily; •-• , no treat~nt of stimulator or responder; 0-0 treatment 
of both stimulator and responder. -- - - , background value. 
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(b) present predominantly in spleen and 
(c) effective whether syngeneic with the responder or the 
stimulator population. 
The following studies were undertaken to devise a procedure for recovering 
these cells which would allow their subsequent characterisation. Stained 
cytocentrifuged deposits of suspensions of cells preincubated with carbonyl 
iron showed that in the majority of cases carbonyl iron particles were 
bound to the surface of cells rather than ingested. The temperature and 
cation dependence of adherence was therefore studied in the hope that the 
adherent cells could be recovered by varying these parameters. 
Suspensions of BALB/c spleen cells were prepared in phosphate buffered 
saline (PBS) without foetal calf serum or in complete medium and were mixed 
with carbonyl iron at 4°C or 37°C. Since the cell losses in serum free 
medium were quite considerable all cell populations recovered following 
removal of the carbonyl iron powder were adjusted to 4 x 10 6 /ml. l ml of 
these suspensions was then cultured with 1 ml of CBA/H lymph node cells in 
a final volume of 2 ml. As shown in Table 4.1 the binding of carbonyl iron 
to cell surfaces occurred at 4°C as well as 37°C and was independent of 
calcium ions. 
Trypsin treatment of the carbonyl iron residue was also attempted in 
an effort to strip the bound particles off the membranes of the accessory 
cells. Approximately 20% of the cells retained in the carbonyl iron were 
released by this treatment, but as shown in Table 4.1, addition of this 
population to the depleted population did not reconstitute the response. 
There are two lines of evidence which indicate that the carbonyl iron 
is not merely toxic for unbound cells. First, carbonyl iron treatment of 
the responder population alone had no effect on the response and second, 
responder spleen cells could reconstitute the response to treated stimulator 
cells. Further evidence that the capacity to stimulate or to respond is not 
affected following carbonyl iron treatment comes from studies with P815 
TABLE 4.1 
THE EFFECTS OF TEMPERATURE AND ca++ CONCENTRATION ON DEPLETION OF 
ADHERENT CELLS BY CARBO~'YL IRON TREATMENT 
Carbonyl iron 
treatment 
C 
+ 
+ 
+ 
+ 
+ 
Other treatments 
Calcium free medium, 4°C 
Calcium free medium, 37°c 
Corrg;,lete medium, 4°C 
Trysin treatment of carbonyl 
iron residue 
Cytotoxic activity 
log C.U./culture 
4.50 
Bg 
Bg 
Bg 
a 4 x 10 6 irradiated BALB/c spleen stimulator cells and 2 x 106 CBA/H 
lymph node responder cells were used throughout. Cultures were 
assayed on day 5 on 51 cr-labelled P815 targets. 
b Bg = <4.50 log C.U.s. 
c - = not treated;+= treated. 
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stimulator cells and CBA/H lymph node responder cells. As Table 4.2 shows 
carbonyl iron treatment of P815 stimulator cells has no significant effect 
on the response. 
4.3.3 Does removal of adherent cells from mixed lymphocyte cultures 
result in selective generation of suppressor cells or paralysis 
of the responder population? 
One explanation for the abrogation of the cytotoxic response following 
the removal of carbonyl iron adherent cells from both stimulator and 
responder populations is that such a treatment allows the selective gener-
ation of suppressor T cells. 
Alternately, the lack of response may reflect a tolerance phenomenon. 
Thus adherent cells may provide, either directly or indirectly, a signal 
necessary for the induction of cytotoxic T cell precursors. In the absence 
of this signal but in the presence of antigen cytotoxic T cell precursors 
may become tolerised. 
An experimental system was designed whereby both of these possi-
bilities could be tested simultaneously. C57Bl/6 x BALB/c F1 stimulator 
spleen cells and C57Bl/6 lymph node responder cells were both treated with 
carbonyl iron. The F 1 spleen cells were then irradiated and cultured with 
either 2 x 10 6 or 4 x 10 6 C57Bl/6 lymph node cells. Cultures were 
incubated for 48 hours then 4 x 10 6 irradiated CBA/H x BALB/c F1 spleen 
cells were added to each culture. Control cultures consisting of 4 x 10 6 
CBA/H x BALB/c F 1 and BALB/c x C57Bl/6 F 1 irradiated spleen cells and 4 x 10
6 
or 2 x 10 6 C57Bl/6 lymph node cells were also set up. Cultures were 
incubated for 5 days and then assayed on P815 or L cell targets. As the 
data in Table 4.3 shows, preincubation of C57Bl/6 responder cells in the 
presence of antigen and the absence of adherent cells, had no effect on 
k d 
their ability to subsequently generate a response to either H-2 or H-2 
coded antigens. Thus the removal of adherent cells resulted in neither the 
paralysis of the responder population nor the selective generation of 
suppressor cells. 
TABLE 4.2 
CARBONYL IRON TREATMENT OF P815-X2 MASTOCYTOMA 
STIMULATOR CELLS 
Stimulator population 
Untreated P815 cellsa 
Carbonyl iron treated P815 cells 
Cytotoxic activity 
l .og C.U./culture 
5.87 
a 1 x 10 5 irradiated (5000 R) P815 stimulators and 2 x 10 6 CBA/H lymph 
node cells used. Cultures assayed on 51 Cr labelled P815 targets on 
day 5. 
b Background; 4.65 log C.U. 
TABLE 4.3 
THE EFFECTS OF PREINCUBATION OF RESPONDER CELLS IN THE PRESENCE OF 
ANTIGEN AND THE ABSENCE OF ADHERENT CELLS 
Concentration 
of 
responders 
4 X 106 
2 X 106 
4 X 106 
4 X 106 
2 X 106 
Pretreatment of 
stimulator and 
responder 
populations 
· a 
+ 
C 
C 
a +=treated populations. 
Cytotoxic activity 
log C.U./culture 
P815 targets L cell targets 
6.20 5.21 
6.36 5.45 
6.20 5.18 
6.33 5.44 
4 x 10 6 irradiated carbonyl iron treated BALB/c x C57Bl/6 F1 spleen 
cells were cultured with 4 x 10 6 or 2 x 10 6 C57Bl/6 carbonyl iron 
treated lymph node cells. After 48 hrs, 4 x 10 6 irradiated BALB/c x 
CBA/H F1 spleen cells were added. Cultures were assayed 5 days later. 
b Same treatment as (a) but no BALB/c x CBA/H F1 cells were added after 
48 hrs. 
c - = untreated populations. 
Control cultures set up on day -5 consisting of 4 x 10 6 irradiated 
C 
BALB/c x CBA/H F1 spleen cells plus 4 x 10° irradiated BALB/c x 
C57Bl/6 F1 spleen cells and C57Bl/6 lymph node responder cells. 
d Background (Bg) = 4.73 log C.U. 
e Background (Bg) = 4.23 log C.U. 
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Figure 4.5 - The effects of the reIOC>val of accessory cells at various 
times during the culture period. 
Stimulator= BALB/c spleen cells; responder= CBA/H lymph note; 
treatment= treatment with carbonyl iron. 
+/+, cytotoxic activity generated with untreated stimulator and 
responder populations 
-/+, cytotoxic activity generated with treated stimulator and 
untreated responder populations. 
•-•. treatment of cultures at the time points specified. 
0-0 1 addition of fresh medium at the time points specified. 
~~~.agitation of the cultures at the time points specified. 
4.3.4 Time course for the removal of carbonyl iron adherent cells 
Carbonyl iron depletions were carried out at regular intervals 
following the initiation of culture to determine whether adherent cells 
were required during the early inductive stage of the response or only 
functioned in culture maintenance. As a control measure, additional 
cultures were harvested and centrifuged then resuspended in the same 
medium or fresh medium whenever carbonyl iron depletions were performed. 
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The results of this study, summarised in Figure 4.5, indicated a 
critical requirement for adherent cells in the first 0-24 hours of culture. 
Removal of adherent cells after this time had little effect on cytotoxic 
activity. Similarly, frequent renewal of the culture medium or physical 
disturbance of the culture during the 5-day incubation period had no 
s ignificant effect on subsequent cytotoxic activity. 
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D I S C U S S I O N 
The results reported in this chapter suggest that when lymphocytes are 
used as stimulator cells in mixed lymphocyte cultures there is an additional 
and absolute requirement for an adherent accessory cell population. This 
population is very efficiently depleted by treatment with carbonyl iron 
but, in contrast to reports by MacDonald et al. (1973b) does not bind avidly 
to plastic. 
Although the accessory cell populations required for the induction of 
cytotoxic T cell responses are removed by methods conventionally used for 
the depletion of macrophages the conclusion that these accessory cells, 
like those required for the induction of antibody responses in vitro are 
macrophages should not be hastily drawn. 
The observation that the removal of the accessory cells required for 
the induction of cytotoxic T cells is not temperature, serum or calcium ion 
dependent suggests that the active cells are not conventional macrophages. 
Shortman and others (1972) have shown that in addition to macrophages and 
polymorphs, dead cells and low density cells including immature and 
dividing cells of both T and B cell lineage adhere to glass bead columns. 
In addition, adherence of dead cells and low density cells, unlike that 
of macrophages and polymorphs, was temperature independent. A similar 
population of "sticky" lcw density lymphocytes may also bind carbonyl iron. 
The very efficient removal of dead cells and, in one report, B cells (Erb 
and Feldmann, 1975b) by carbonyl iron suggests that "sticky" cells can 
indeed be effectively removed by this method. Thus, the possibility can-
not be excluded that the accessory cells active in the induction of cyto-
toxic T cells are included in the temperature independent "sticky" lympho-
cyte subpopulation while those involved in antibody formation are members 
of the temperature dependent macrophage-like population. 
The accessory cells depleted by carbonyl iron treatment may be of 
either stimulator or responder origin and appear to be present in greater 
concentration in spleen than in lymph node cell preparations. The former 
observation has also been made by others in studies of both proliferative 
(Rode and Gordon, 1970; Twomey et al., 1970; Alter and Bach, 1970) and 
cytotoxic T cell (MacDonald et al., 1973b) responses. Two ways by which 
accessory cells may function in MLR include antigen processing or presen-
tation and culture maintenance. 
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It is well documented that a macrophage-like adherent cell population 
is required for the induction of antibody responses to most antigens (for 
review see Pierce and Kapp, 1976). Recent studies have suggested that for 
primary responses to T cell dependent antigens the adherent cells may be 
either syngeneic or all_ogeneic with the responding helper T cells (Pierce 
et al., 1976). For a secondary response, however, the antigen must be 
presented on macrophages syngeneic to those used for the primary immuni-
sation (Rosenthal and Shevach, 1973; Pierce et al., 1976). This restriction 
in response was found to be controlled by the MHC. One interpretation of 
these observations is that antigen is presented on the surface of adherent 
cells in unique association with antigens coded by the MHC (probably the I 
region). Once sensitised to any particular complex a cell will only be 
restimulated by the same complex. 
It seems unlikely that the accessory cells required for the gener-
ation of cytotoxic T cells function in the same way as those involved in 
antibody formation since the presentation of soluble stimulator MHC anti-
gens on the surface of responder adherent cells would require that 
responder MHC antigens, as well as stimulator MHC antigens, be recognised 
by the effector population. The fact that subcellular antigen fractions 
do not stimulate primary cytotoxic T cell responses (Wagner and Boyle, 
1972; Engers et al., 1975b; Hayry and Andersson, 1976; Wagner et al., 1976a). 
provides further evidence against the involvement of accessory cells in 
antigen processing or presentation. 
82 
If accessory cells are not involved in antigen presentation it is 
possible that they merely optimise tissue culture conditions. Although 
culture maintenance cannot be excluded as a secondary function of accessory 
cells their critical early requirement in cultures (the first 24 hours) 
suggests that they have a more important primary role in the induction or 
recognitive phase of the MLR. Possible mechanisms by which accessory 
cells may function in the induction of cytotoxic T cells will be discussed 
in more detail in subsequent chapters. 
In addition to demonstrating the requirement for accessory cells in 
MLR the studies reported in this chapter have also convincingly shown that 
purified lymphocytes are very efficient stimulators provided they are 
cultured in the presence of an adequate number of accessory cells. Thus 
mice and humans seem to differ from guinea pigs in this respect, since 
guinea pig lymphocytes, even in the presence of responder accessory cells, 
are poor stimulators in MLC (Greineder and Rosenthal, 1975). 
That the abrogation of the response following removal of accessory 
cells from both the stimulator and responder populations was not a result 
of the selective generation of suppressor cells or to tolerisation of the 
responder population was also shown. Attempts to paralyse responder cells 
by incubating them with stimulator lymphocytes in the absence of 2-ME and 
accessory cells (data not shown) were also unsuccessful. Before dis-
missing a 2-signal model of induction similar to that proposed by Bretscher 
and Cohn (1970) for the induction of B cells, where recagnition of antige n 
in the absence of an inductive signal results in paralysis of the responder 
population, the possibility that extraneous sources of signal-2 sufficient 
for the prevention of paralysis but insufficient for induction, would have 
to be eliminated. 
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SUMMARY 
The data presented in this chapter indicated that when resting lympho-
cytes were used a source of stimulator cells in .MLC there was an additional 
and absolute requirement for a population of accessory cells which was 
removed by treatment with carbonyl iron but not by incubation on plastic 
surfaces. This adherent population was present predominantly in spleen 
and was effective whether syngeneic with the responder or the stimulator 
population. 
The accessory cells were only required in the first 24 hours of 
culture, a result which implied that they were actively involved in the 
inductive process and did not merely function in culture maintenance. 
Furthermore, indirect evidence suggested that the active cells were not 
mature macrophages and were unlikely to function in antigen presentation. 
Carbonyl iron treatment did not result in the selective generation 
of suppressor cells or paralysis of the responder population. The failure 
to recover functional accessory cells from carbonyl iron residues suggested 
that the cells may have been destroyed during the depletion process. 
CHAPTER 5 -
CHARACTERISATION OF ACCESSORY CELLS 
5.1 Introduction 
In the previous chapter it was shown that when resting lymphocytes 
were used as a source of stimulator cells there was an additional and 
absolute requirement for an accessory cell population which did not bind 
avidly to plastic but which was very efficiently removed by treatment 
with carbonyl iron. Since the active cell population could not be 
recovered from the carbonyl iron residue an alternative method had to be 
contrived for its characterisation. 
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An assay system was devised which took advantage of the findi.ng that 
accessory cells could be of either stimulator or responder origin. It 
consisted of a "three-cell system" which was comprised of irradiated 
carbonyl iron treated stimulator cells, untreated lymph node responder 
cells and irradiated accessory cell- containing populations of responder 
genotype. Using such a system the accessory cell activity of various 
lymphoid populations was evaluated. 
In addition, the accessory cell requirements for primary responses 
to neoplastic cells and for secondary responses to lymphoid cells were 
also assessed. The accessory cell requirements for the restimulation of 
memory cells was of particular interest since it has been well documented 
that the requirements for restimulation are much less stringent than for 
primary induction. 
II 
Thus UV treated (R8llinghoff and Wagner, 1975; Hayry 
and Andersson, 1976), heat treated or glutaraldehyde fixed (Rollinghoff 
and Wagner, 1975), stimulator cells and subcellular fragments (Wagner et 
al., 1976a; Hayry and Andersson, 1976) have all been reported to stimulate 
secondary responses but not primary responses. 
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5.2 Methods and Materials 
5.2.l Animals 
8-10 week old CBA/H and BALB/c mice were used routinely. 
5.2.2 Tissue culture procedures 
Cells were prepared as described in Chapter 2 (2.2.3) and Chapter 3 
(3.2.8). Mixed lymphocyte cultures and cytotoxicity assays were performed 
as described in Chapter 2, sections 2.2.4 and 2.2.5 and Chapter 3 (3.2.2). 
5.2.3 Carbonyl iron treatment 
Cells were treated with carbonyl iron as described in Chapter 3 
(3.2.4). 
5.2.4 + + + Removal of Ig , Ia and 8 cells 
The procedures used for the removal of these cells are outlined in 
sections 3.2.9; 3.2.7 and 3.2.6, respectively, of Chapter 3. 
5.2.5 Preparation of adherent cell monolayers 
Spleen and peritoneal adherent cell monolayers were prepared as 
described in Chapter 3 (3.2.8). Macrophage monolayers were prepared in a 
similar way but were cultured for three days prior to use. 
5.2.6 Neoplastic cells 
P815-X2 DBA/2 mastocytoma cells and L-929 cells were pretreated as out-
lined in Chapter 3 (3.2.10) prior to use as stimulator cells. 
5.2.7 Inununisation of mice with P815 cells 
20 µ1 of washed, packed P815 cells (~2 x 10 7 ) were injected into the 
footpads of CBA/H mice. A sample of popli teal lymph nodes was taken 10-14 
days later and tested for cytotoxic activity. The remainder of the animals 
were left for 6-8 weeks before use. In all cases only popliteal lymph nodes 
were used as a source of primed lymph node responder cells. Uninununise d 
animals of the same age were used as controls. 
TABLE 5.1 
ADDITION OF CBA SPLEEN ACCESSORY CELLS RESTORES THE RESPONSE TO 
CARBONYL IRON TREATED POPULATIONS 
Carbonyl Accessory Carbonyl 
Stimulator population iron cell iron 
treatment 
a b population treatment 
4 x 10 6 BALB/c spleen cells - - -
II + - -
II + 6 4 x 10 CBA/H spleen 
-
II + 2 x 10 6 CBA/H spleen -
II + 1 x 10 6 CBA/H spleen 
-
II + 4 x 10 6 CBA/H spleen + 
It 4 x 10 6 CBA/H spleen 
-
a Carbonyl iron treatment removed 29% of cells. 
b CBA/H spleen accessory cells were irradiated (1000 R). 
c 2 x 10 6 CBA/H lymph node responder cells were used except where otherwise stated. 
Cytotoxic activity 
log C.U./culture 
5.76c 
4.02 
5.76 
5.90 
5.15 
4.02 
4.02d 
d 4 x 10 6 irradiated BALB/c spleen cells were cultured with 4 x 10 6 irradiated CBA/H spleen cells in the 
absence of responder cells. 
+=treatment; - = no treatment. Background= 4.02 log C.U. 
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Figure 5 .1 - Time course for the addition of accessory cells. •-. , 
4 x 10 6 irradiated CBA/H spleen cells were added to cultures of irradiated 
carbonyl iron treated BALB/c spleen cells and 2 x 10 6 CBA/H lymph node 
responder cells at the specified tines. Cultures were assayed after 5 days 
5 l 
on Cr labeled P815 targets. 
+/+, Cytotoxic activity generated in cultures of untreated BALB/c spleen 
stimulator cells and CBA/H lymph node responder cells. 
-/+, Cytotoxic activity generated in cultures of carbonyl iron treated 
BALB/c spleen cells and CBA/H lymph node responder cells. 
5.3 Results 
5.3.l Description of the three-cell system used for the 
characterisation of accessory cells 
Any attempts to characterise the accessory cells in the stimulator 
population are hampered by the fact that some adherent cells stimulate in 
their own right. This problem has been circumvented by characterising 
accessory cells of responder rather than stimulator origin. 
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In the previous chapter it was shown that cells present in responder 
spleen but deficient in responder lymph node at the cell concentrations 
used, could restore the response to carbonyl iron treated stimulator cells. 
Cultures were therefore set up containing irradiated carbonyl iron treated 
stimulator cells, untreated lymph node responder cells and irradiated 
responder spleen cells. Characterisation of the accessory cells could 
then be achieved by manipulation of the irradiated responder population. 
As shown in Table 5.1 the incorporation of irradiated responder spleen 
cells into accessory cell depleted cultures restored the cytotoxic 
response to the levels of untreated controls. Optimum reconstitution was 
attained with 2-4 x 10 6 cells. The significant drop in the response when 
only 1 x 10 6 cells were used suggests that a critical number of accessory 
cells must be present before a response is induced. 
That restoration of the response resulted from the addition of adherent 
cells was evidenced by the abrogation of restorative capacity following 
carbonyl iron treatment of the irradiated CBA/H spleen cells (Table 5.1). 
Furthermore, since corrbinations of irradiated BALB/c and irradiated CBA/H 
spleen cells do not generate effector cells it is unlikely that cells in 
the irradiated CBA/H spleen population contribute directly to the effector 
population. 
The results of experiments involving the addition of irradiated CBA/H 
spleen cells to accessory cell depleted cell mixtures at various time 
intervals after the initiation of culture are illustrated in Figure 5.1. 
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Figure 5.2 - Accessory cell content of various lymphoid tissues. 
+/+, Culture containing 4 x 106 irradiated BALB/c spleen cells and 
2 x 106 CBA/H lymph node cells. 
-/+, Culture containing 4 x 10 6 irradiated carbonyl iron treated 
BALB/c spleen cells and 2 x 106 CBA/H lymph node cells. 
Effects of addition irradiated CBA/H cells to(-/+) cultures . 
• , spleen; ~ , lymph node; .A , bone marrow; 
[] , peritoneal cells ; • I thymus. 
TABLE 5. 2 
RECONSTITUTION OF THE RESPONSE TO CARBONYL IRON TREATED 
STIMULATOR CELLS BY PLASTIC ADHERENT AND NON-ADHERENT CELLS 
Stimulator 
population 
Carbonyl 
iron 
treatment 
Accessory 
cell 
population 
Cytotoxic activity 
log C.U./culturea 
A. 4 X 106 
BALB/c 
spleen 
cells 
a 
5.90 
B. 
fl + 4.48 
If + 1 X 10 6 adherent 6.03 
CBA/H spleen cellsb 
II + 
6 3 x 10 non-adherent 6.03 
CBA/H spleen cells 
fl + 4 X 106 CBA/H 6.14 
spleen cells 
4 X 106 6.32 
BALB/c 
spleen 
cells 
fl + 5.24 
fl + 2 x 10 5 BALB/c 6.06c 
adherent P.C. 
II + 1 X 10 5 CBA/H 5.85 
adherent P.C. 
II + 2 x 10 5 BALB/c Bg 
e 
a + = treatment; = no treatment. 
b Adherent cells were those which adhered to plastic in 4 hrs at 37°C. 
Non-adhernet cells were those cells removed following vigorous 
washing of the adherent cell monolayers. All splenic accessory cells 
were irradiated (1000 R). 
c The cytotoxic activity generated by BALB/c adherent peritoneal 
cells was subtracted from this value. 
d Cytotoxic activity was assayed on 51 cr labeled P815 cells in a 4 hr 
assay. 
e Background= 4.00 log C.U. 
It can be seen that the accessory cell population is required during the 
first 24 hours of culture, a finding which confirms the results obtained 
from depletion experiments described in the previous chapter where 
accessory cells were removed from the cell mixtures at regular time 
intervals after the initiation of culture (compare Figures 4.5 and 5.1). 
These experiments thus provided further confirmation of both the early 
requirements for accessory cells in mixed lymphocyte reactions and the 
equivalence of accessory cells of respqnder or stimulator origin. 
5.3.2 The tissue distribution of accessory cells 
The distribution of accessory cells in various lymphoid populations 
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is sununarised in Figure 5.2. In addition to spleen cells, bone marrow cells 
peritoneal cells and, to a lesser extent, lymph node cells, all effected 
significant reconstitution of cytotoxic responses. Thymus cells, on the 
other hand, did not reconstitute the response. With the exception of 
peritoneal cells, optimal reconstitution was obtained with 2-4 x 10 6 cells. 
The drop in reconstituting capacity when more than 1 x 10 6 peritoneal cells 
were used probably reflects the toxic effects of the macrophages contained 
in this population. The reconstitution observed with lymp h node cells 
suggests that this population contains accessory cells but these must be 
present in critical numbers before a response is observed. 
The poor stimulator and reconstituting capacity of thymus cells indi-
cates a paucity of accessory cells in this population. The finding that 
the response of lymph node cells to thymus stimulator cells can be augmented 
by the addition of irradiated responder spleen cells supports this 
suggestion (data not shown). 
5.3.3 The cap acity of adhe rent cells to reconstitute responses 
As illustrated in Table 5.2, the addition of fresh, plastic adherent 
spleen cells of responder genotype to accessory cell deficient cultures 
resulted in comp lete reconstitution of the r esponse while the addition of 
fresh, plastic adherent peritoneal cells of responde r or stimulator 
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+ Figure 5.3 - Addition of lg or lg irradiated responder spleens to 
adherent cell depleted cultures . 
+/+,-/+as for Figure 5.2 . 
Irradiated CBA/H spleen cell subpopulations added to(-/+) cultures. 
• , spleen cells; 
~ , lg- cells. 
+ lg ce lls; D + , lg + lg cells; 
Stimulator population a 
Carbonyl iron treated 
BALB/c spleen cells 
II 
II 
II 
" 
II 
II 
Untreated BALB/c 
spleen cells 
TABLE 5.3 
CHARACTERISATION OF THE ACCESSORY CELL POPULATION 
Treatment of b 
accessory cell population 
Untreated 
Anti-8 ascitic fluid+ complementc 
Normal ascitic fluid+ complementd 
Untreated CBA/H spleen cells mixed 
with SRBC then spun through 
Isopaque/Fico11e 
Untreated CBA/H spleen cells mixed 
with antibody coated SRBC then spun 
through Isopaque/Ficollf 
Untreated CBA/H spleen cells spun 
through Isopaque/Ficoll 
No accessory cells 
II 
% cells removed 
by treatment 
30% 
17% 
<5% 
<5% 
<5% 
Cytotoxic activity 
log C.U./cultureg 
5.88 
5.72 
5.91 
5.97 
5.90 
6.02 
4.28 
5.74 
Legends to Figure 5.3 -
a BALB/c irradiated stimulator cells were cultured with 2 x 10 6 CBA/H lymph node responder cells 
for 5 days then assayed on 51 cr labeled P815 targets, 
b Irradiated CBA/H spleen cells were used as a source of accessory cells throughout. Except 
where otherwise stated 4 x 10 6 cells were used. 
c 2.8 x 10 6 cells added/culture. 
d 3.3 x 10 6 cells added/culture. 
e Untreated lymphocytes and SRBC were mixed in the proportions used for Ig rosetting, spun at 4°C, 
resuspended then spun through Isopaque/Ficoll. 
f Sarne procedure as for (e), but untreated SRBC were substituted with SRBC coated with sheep anti-
rabbit Ig. 
g Background = 4.20 log C.U. 
genotype partially reconstituted the response. In Chapter 4 it was shown 
that the incubation of the stimulator population on plastic surfaces did 
not remove all accessory cells. The corollary also applies in that non-
adherent as well as adherent spleen cells were able to reconstitute the 
response (Table 5.2). 
In contrast to freshly adherent cells, adherent peritoneal cells 
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maintained in culture for three days prior to use did not reconstitute the 
response (Table 5.2). The inability of cultured macrophages to reconstitute 
the response was not the result of an increase in toxicity following culture 
since the incorporation of these cells into cultures of untreated stimu-
lator and responder populations did not cause significant inhibition of the 
cytotoxic response at any of the cell concentrations tested (see Chapter 3, 
Table 3.4.B). 
+ The reconstituting capacity of Ig and Ig spleen cells 5.3.4 
+ The reconstituting capacity of Ig and Ig spleen cells is summarised 
in Figure 5.3. + . ~ + Over the dose range tested Ig cells, remixes o~ Ig and 
Ig cells and unfractionated spleen cells almost completely restored the 
response while Ig cells reconstituted poorly. The observation, in this 
experiment, that 1 x 10 6 cells from a remix of Ig+ and Ig cells had a 
greater reconstituting potential than the same number of unfractionated 
spleen cells was not a consistent finding. It is unlikely that the accessory 
+ cells in the Ig population are a subpopulation of contaminating T cells 
with passively acquired surface Ig since anti-8 serum and complement 
treated CBA/H spleen cells reconstitute d the response as effectively as 
untreated populations (Table 5.3). The inferiority of the reconstitution 
observed with Ig cells suggests the presence of a limiting number of 
accessory cells in this population, possibly due to the incomplete separ-
+ ation of the Ig and Ig subpopulations. Alternately a small subpopulation 
-
of accessory cells may be Ig. Carbonyl iron treatment of both populations 
completely removed their activity (data not shawn). The possibility that 
TABLE 5 .4 
RECONSTITUTION OF THE RESPONSE TO CARBONYL IRON TREATED 
STIMULATOR CELLS BY VARIOUS ACCESSORY CELL POPULATIONS 
Stimulator 
population 
4 X 10 6 BALB/c 
spleen cells 
II 
II 
II 
II 
II 
Carbonyl 
iron 
treatment 
a 
+ 
+ 
+ 
+ 
+ 
Accessory 
cell 
population 
4 x 10 6 Ia CBA/H 
spleen cellsb 
4 X 10 6 C' treated 
CBA/H spleen cells 
1 x 10 5 L cellsc 
1 x 10 4 L cells 
a +=treatment; - = no treatment. 
Cytotoxic activit~ 
log C.U./culture 
5.90 
4.48 
5.56 
5.87 
6.15 
5.83 
b CBA/H spleen cells treated with anti-Ia serum+ rabbit C'. 
(% cells lysed = 47%). Controls treated with rabbit C' alone 
(% cells lysed = 8%). 
c L cells were rnitomycin C treated. 
d Cytotoxic activity assayed on 51 cr labeled P815 cells. 
Background = 4.00 log C.U. 
the accessory cells were Ig cells which rosetted naturally with SRBC was 
eliminated by carrying out the rosetting and 9eparating procedures used 
for Ig separations with untreated CBA/H spleen cells and either untreated 
or sheep anti-rabbit Ig coated SRBC. The reconstituting activity of the 
cells remaining at the interface of the Isopaque/Ficoll was tested and 
found to be unimpaired in each case (Table 5.3). 
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5.3.5 The reconstituting capacity of Ia spleen cells 
+ Ia cells were removed from CBA/H spleen cell populations by treatment 
with anti-Ia serum and complement. The addition of Ia spleen cells to 
accessory cell depleted cultures resulted in a 10-fold increase in the 
response compared to a 20-fold increase with spleen cells treated with 
complement only (Table 5.4). Although the 2-fold difference is significant 
-the data indicates that the majority of accessory cells are Ia. 
It is also notable that rnitomycin C treated L-929 cells were able to 
function as accessory cells. As shown in Table 5.4 the addition of 1 x 10 5 
L cells to adherent cell depleted cultures completely restored the response. 
This data suggests that tumour cells, like L cells, supply both stimulating 
antigen and accessory cell requirements. The accessory cell requirement 
for stimulation with tumour cells was examined further with P815-X2 masto-
cytoma cells. 
5.3.6 Accessory cell requirements for stimulation with neoplastic 
cells 
As shown in this chapter and the previous one, lymph node cells used 
at 2 x 10 6 /culture contain insufficient numbers of accessory cells to allow 
a response to accessory cell depleted lymphoid stimulator cells. The 
observation that P815 cells, L cells and IgA plasmacytoma cells, passaged 
in vitro~ stimulate lymph node cells (Chapter 3, Table 3.1), suggests that 
the accessory cell requirements for induction of cytotoxic responses are 
less stringent with neoplastic cells than with lymphoid stimulator cells. 
Further investigations carried out with P815 cells showed that removal of 
TABLE 5.5 
ACCESSORY CELL REQUIREMENTS FOR STIMULATION WITH 
NEOPLASTIC CELLS 
Carbonyl iron 
treatment 
of the stimulatora 
Carbonyl iron 
treatment b 
of responder 
Cytotoxic activity 
log C.U./cultured 
C 
+ 
+ 
+ 
+ 
5.67 
5.30 
5.87 
5.28 
a Stimulator population 1 x 10 5 irradiated (5000 R) P815-X2 DBA/2 
mastocytoma cells. 
b Responder population, 2 x 10 6 CBA/H lymph node cells. 
C - = no treatment; +=treatment. 
d Cytotoxic activity estimated on labeled P815 target cells. 
Background = 4.03 log C.U. 
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Figure 5.4 - The kinetics of memory responses. 
Memory lymph node cells were obtained from CBA/H mice injected with 
2 x 10 7 P815 cells intra footpad 8 weeks previously. Unprimed lymph 
node cells were obtained from untreated mice of similar age. 
A-& 4 x 106 irradiated BALB/c stimulator cells + 2 x 106 primed , 
popliteal lymph node cells. 
·-· 4 x 10 6 irradiated BALB/c stimulator cells + 2 x 10
6 
unprimed 
I 
popliteal lymph node cells. 
• -ra = Background. 
Stimulator population 
4 x 10 6 BALB/c 
spleen cells 
II 
II 
II 
II 
II 
a , no treatment; 
TABLE 5.6 
THE ACCESSORY CELL REQUIREMENTS FOR THE INDUCTION OF MEMORY RESPONSES 
Carbonyl iron 
treatment 
a 
-
+ 
+ 
+ 
+ 
+, treatment. 
Responder population 
6 2 x 10 CBA/H memory b 
lymph node cells 
II 
II 
2 X 10 6 CBA/H unprimedc 
lymph node cells 
II 
II 
Carbonyl iron 
treatment 
-
-
+ 
-
-
+ 
b Popliteal lymph nodes from mice immunised 8 weeks previously with 2 x 10 7 P815 cells IFP. 
c Popliteal lymph nodes from unirnmunised animals of similar age to those used in b. 
d Cytotoxic activity assayed on 51 cr-labelled P815 cells. 
e Bg = 3.98 log c.u. 
f Bg = 4.77 log C.U. N.T. = not tested. 
Cytotoxic activitya 
log C.U./culture 
I II 
6.26 6.14 
5.93 5.80 
N.T. N.T. 
5.95 6.13 
Bgf Bge 
N.T. Bg 
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accessory cells from the cultures caused only a 2 -2.5- fold decrease in 
the response (Table 5.5). This contrasted with the complete abrogation of 
the response when accessory cells were removed from cultures of lymphoid 
cells. Carbonyl iron treatment of the P815 cells had no significant 
effect on the response (Table 5.5). 
In surrunary, stimulation with neoplastic cells, unlike stimulation 
with normal lymphocytes, appears to be relatively accessory cell independent. 
5.3.7 The accessory cell requirements for the restimulation of 
primed responder cells 
In a preliminary set of experiments the kinetics of the generation of 
cytotoxic T cells were established. Popliteal lymph nodes from mice 
injected intra-footpad 8 weeks previously with P815 cells were used as 
responder cells in mixed lymphocyte culture. Control cultures were set up 
with popliteal lymph node cells from unimmunised mice of similar age. 
As illustrated in Figure 5.4, the preimmunised cells showed the characteris-
tics of memory populations, namely a premature and augmented cytotoxic 
response. Thus, in contrast to non-immune responder cells where no cyto-
toxic activity was detected before day 4 of culture, when memory cells were 
used as responders, significant cytotoxic activity was already in evidence 
by day 3 of culture. The peak cytotoxic response of memory cells was also 
significantly greate r (2-fold) than that of unprimed mice. These results 
agree with those published by others (R8llinghoff and Wagner, 1975). 
The requirement for accessory cells in secondary MLC was determined by 
culturing carbonyl iron treated stimulator cells with either unprimed or 
memory responder cells. Cultures were assayed for cytotoxic activity on 
days 3, 4 and 5 of culture but for simplicity only day 5 data has been 
tabulate d. As shown in Table 5.6, when memory cells were used as responders, 
the remova l of accessory cells from the stimulator population resulted in 
a 2-fold drop in cytotoxic activity while their removal from both stimu-
lator and responder populations resulted in a 10-fold drop in activity. 
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In the latter case, however, the cytotoxic activity was still 10-fold 
greater than the background value. Conversely, when unprimed responder 
cells were used, removal of accessory cells from the stimulator population 
alone or from both the stimulator and responder populations, completely 
abrogated the response. Thus, the induction of secondary cytotoxic T cell 
responses appears to be less accessory cell dependent than the induction 
of primary responses. 
D I S C U S S I O N 
In the previous chapter it was shown that a population of cells 
present in stimulator spleen and depleted by treatment with carbonyl iron 
was required for the induction of cytotoxic T cells when lymph node cells 
were used as the responder population. Furthermore, carbonyl iron 
adherent cells removed from the stimulator population could be substituted 
with carbonyl iron adherent spleen cells of responder genotype. In this 
chapter a three-cell system was described which proved the equivalence of 
these two populations of accessory cells and facilitated their further 
characterisation. 
The equivalence of accessory cells from responder and stimulator 
populations 
Experiments using the three-cell system described, demonstrated that 
the accessory cells in the responder population resembled accessory cells 
of stimulator origin in the following ways: 
(a) they were removed by carbonyl iron treatment, 
(b) they functioned following irradiation, 
(c) they were required in the first 24 hours of culture. 
The effector cells generated were derived solely from the lymph node 
donor. A responder population comprised of irradiated spleen cells and 
syngeneic untreated lymph node cells therefore appeared to be equivalent 
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to a responder population of untreated spleen cells. On the basis of these 
findings the three-cell system was used for the further characterisation 
of the accessory cells. 
Cells behaving like accessory cells were found to be present in a 
number of lymphoid organs besides the spleen. They were also detected in 
significant numbers in lymph node, bone marrow and the peritoneal cavity 
but were not present in detectable amounts in thymus. The finding that 
lymph node cells reconstituted the response suggests that critical numbers 
of accessory cells must be present before a response is induced. The 
suppressive effects normally observed following the use of more than 2 x 10
6 
lymph node responder cells/culture (see Chapter 2, Figure 4.4) seemed to 
be overcome when the extra lymph node cells were irradiated. The 
deficiency of accessory cells in thymus populations has also been reported 
by others (Dyminski and Smith, 1975, 1976) and probably accounts for the 
poor stimulation observed with this population when lymph node responder 
cells are used. Preliminary experiments have shown that the response to 
alloantigens presented on thymus cells can be considerably enhanced when 
combinations of spleen and lymph node responder cells are used. 
The fact that accessory cells from any source function following 
irradiation suggests that the cells involved are either radio-resistant or 
active very early in the response. If the first alternative applies the 
radio-resistant population is not included in the radio-resistant, long-
lived, adherent macrophage subpopulation since these are unable to function 
as accessory cells. However, the demonstration that accessory cells are 
required early in the response lends considerable support to the second 
alternative. 
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Adherence properties of accessory cells 
Data described in Chapter 3, which showed that both plastic adherent 
and non-adherent cells were equally capable of stimulating strong cytotoxic 
T cell responses, inferred that both of these populations contained 
adequate numbers of accessory cells. In this chapter data was presented 
which confirmed that plastic adherent and non-adherent spleen cells (and 
peritoneal cells) are indeed a rich source of accessory cells. The fact 
that considerable numbers of accessory cells are not plastic adherent also 
explains why preincubation of both the responder and the stimulator popu-
lations on plastic prior to culture had no significant effect on the 
subsequent cytotoxic T cell response (see Chapter 4). Since mature macro-
phages were unable to function as accessory cells it seems unlikely that 
the plastic adherent accessory cells belong to this subpopulation. 
Accessory cells from the spleen and peritoneal cavity therefore appear to 
fall into at least two subsets - a plastic adherent, and a non-plastic 
adherent - both of which are removed by carbonyl iron but neither of which 
includes the mature macrophage. Whether the accessory cells are all 
members of the same cell class expressing varying degrees of "stickiness" 
remains to be determined. These conclusions deviate somewhat from those 
reached by others in studies of the adherent cell requirements in MLC. 
For instance, Wagner et al. (1972), concluded that the cell population 
removed by_ glass bead columns which was required for optimal proliferative 
and cytotoxic T cell responses was a macrophage since it was also removed 
by anti-macrophage serum and complement treatment and, further, could be 
replaced by T cell depleted peritoneal exudate cells, a population consider-
ably enriched for macrophages. However, since the whole T cell depleted 
peritoneal exudate cell population and not the adherent, long-lived, sub-
population was used as a source of accessory cells, the possitility was not 
excluded that the active reconstituting moieties were B cells or immature 
cells which were also targets for the anti-macrophage serum. Likewise, 
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MacDonald et al. (1973b) in studies involving the removal of accessory 
cells by incubation on plastic surfaces or their inactivation by treatment 
with actinomycin D, also concluded that macrophages were the active cells. 
This conclusion could be erroneous however, since cells other than macro-
phages are known to adhere to plastic and accessory cells other than 
macrophages may be affected by actinomycin D. The former criticism can also 
be levelled at the early studies on the adherent cell requirements for 
proliferation in human MLC where unfractionated or freshly adherent cells 
were used as a source of accessory cells (Rode and Gordon, 1970; Twomey 
et al. 1 1970). In a more recent study, however, Rode and Gordon (1974) 
showed that lo_ng-lived adherent cells were able to reconstitute the pro-
liferative response in cultures of adherent cell depleted human lymphocytes. 
The difference between these results and those obtained in this study 
suggest that human macrophages and mouse macroph_ages may differ in their 
accessory cell capacity. 
Surface markers on accessory cells 
Cells with accessory cell activity were found to separate predominantly 
with the Ig+ subpopulation of spleen cells. Control studies involving 
anti-8 and C' treatment of the CBA/H spleen cell population and rosetting 
with antibody treated or untreated SRBC indicated that the accessory cell 
was neither a T cell nor any other Ig cell passively separating with the 
+ Ig cells. The weak reconstituting and stimulator activity of Ig cells 
suggests that small numbers of accessory cells do remain in this fraction. 
Since anti-8 and C' treatment does not remove these (data not shown) they 
are possibly immature cells or cells with only a small amount of surface Ig. 
The stimulation observed with FcR and CR spleen populations in 
cultures containing limiting numbers of responder accessory cells (see 
Chapter 3) suggests that all accessory cells do not bear these two 
+ 
receptors. Accordingly, it is unlikely that the Ig accessory cells all 
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exhibit surface Ig as a result of binding exogenous Ig via Fe receptors. 
The active population may therefore represent a subpopulation of adherent 
B cells or alte~natively may be comprised of a combination of Fe receptor 
bearing immature macrophages and B cells. Treatment of lymphocytes, firstly 
with trypsin to remove any irnrnunoglobulin bound passively via Fe receptors 
and then, after a recovery period, with anti-mouse Ig µ chains or IgG Fab 
fragments which would not bind to regenerated Fe receptors, may help to 
clarify this point. 
+ . Since the removal of Ia cells from either the accessory cell or the 
stimulator cell populations had little effect on the response (Chapter 3 
and this chapter) it is unlikely that the majority of accessory cells bear 
this surface marker. Again this implies that if the accessory cells are 
B cells they must represent a relatively immature subpopulation since the 
majority of mature B cells exhibit surface Ia antigens (for review see 
Harnrnerli_ng, 1976) . 
To summarise, the accessory cell population required for the induction 
of cytotoxic T cells in vitro appears to be comprised predominantly of 
+ - + + Ig, 8, FcR-, CR-, Ia cells which are not mature macrophages. It should 
be stressed, however, that the inability to detect complement and Fe 
receptors or Ia antigens on the surface of accessory cells may be a 
reflection of the sensitivity of the methods employed. These cells may thus 
have small, but so far undetected amounts of any one, or all, of these 
surface markers. It is notable that mitomycin C treated L cells are also 
able to function as accessory cells. This result implies that accessory 
cell activity is not restricted to lymphoid cells alone. 
A splenic accessory cell population resembling the one described here 
has also recently been described by Dyminski and Smith (1975, 1976). They 
showed that the induction of both proliferative and cytotoxic T cell 
responses in cultures of allogeneic thymus cells was totally dependent on 
th f I + CR+ 8- cells which were not mature macrophages. e presence o g , , 
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Furthermore, this population could be syngeneic with either the responder 
or the stimulator population and was required at the initiation of the 
response. 
Two other studies exist where the inclusion of splenic accessory 
cells in mixed lymphocyte cultures induced enhanced cytotoxic responses. In 
one study by Hodes et al. (1974), the synergising accessory cell was 
characterised as a nylon wool adherent, 8 1 non-macrophage. In the other 
study two populations of synergising accessory cells were described in nude 
spleens. The first of these was radio sensitive, was not retained on glass 
bead columns and had to be allogeneic with the stimulator before it could 
syne_rgise (Schilling et al., 1976). The second was radio resistant, 
adherent and functioned whether syngeneic or allogeneic with the stimulator 
population (Miller et al., 1976). It was suggested that the first popu-
lation gave rise to the second following stimulation with alloantigen. 
Whether the second population was a macrophage or a cell resembling the 
one described here was not determined. 
So far, the latter study is the only one reported where accessory 
cells resembling those described here have had to recognise stimulator cell 
antigens in order to function. Recognition of stimulator (or responder) 
alloantigens by the accessory cells described in this study is an unlikely 
requirement since responder accessory cells function as well as stimulator 
accessory cells when combinations of F1 stimulator and parental responder 
cells are used (data not shown). Furthermore, as will be shown in the two 
following chapters, irrununoincompetent foetal lymphoid cells and supernatants 
from unstimulated spleen cell cultures are both capable of fulfilling 
accessory cell functions. 
Accessory cell requirements for response s to neoplastic stimulator cells 
and for memory responses 
The response of unprimed T cells to neoplastic cells was found to be 
significantly less dependent on the presence of accessory cells than the 
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response to resting lymphocytes. Any explanation of this phenomenon 
requires some prior indication of the role that accessory cells may play 
in mixed lymphocyte reactions. In the formulation of any theory on the 
requirements for the induction of primary responses the prime consideration 
must be that recognition of antigen alone is insufficient for the induction 
of cytotoxic T cells. Suggestions for the role that accessory 
cells fulfil in the induction of T cell responses will be considered in 
greater detail in Chapter 81 but briefly, two possibilities are that 
accessory cells: 
(a) produce s _ignals required1 in addition to antigen 1 
which activate cytotoxic T cell precursors directly1 
(b) activate lymphocytes so that they in turn transmit 
such inductive signals. 
Neoplastic cells may circumvent the critical requirement for accessory 
cells observed with resting lymphocytes because they are already "activated" 
or because they have the properties of both stimulator and accessory cells. 
The observation that L cells can function as accessory cells provides some 
evidence for the latter alternative. 
It is now well established that the requirements for the restimulation 
of pre-primed allo-reactive T cells are much less stringent than those 
required for primary responses. Thus, UV and heat treated cells and sub-
cellular fragments all induce secondary but not primary responses (Engers 
t 1 II t 1 II d e av., 1975; Rollinghoff and Wagner, 1975; Wagner e av., 1976; Hayry an 
Andersson, 1976). The question then arises as to whetheY this difference 
represents a change in the receptor specificity or density on the memory T 
cell or alternatively reflects an independence of inductive stimuli (or 
second signal) not supplied by antigen alone. At this stage there is no 
answer to this question but if accessory cells do, in fact, either directly 
or indirectly result in the production of inductive stimuli memory T cells 
may be less dependent on this signal than unprimed cells. 
SUMMARY 
In this chapter a three-cell system comprising irradiated BALB/c and 
CBA/H spleen cells and untreated CBA/H lymph node responder cells was 
described and subsequently used to characterise the accessory cell popu-
lation required for the generation of cytotoxic T cells in vitro. 
Accessory cells of stimulator and responder origin were shONn to be 
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equivalent populations since they were both depleted by treatment with 
carbonyl iron, functioned following irradiation and were required in the 
first 24 hours of the response. In addition to the spleen, accessory 
cells were also found in lymph node, bone marrow and the peritoneal cavity 
but were absent from the thymus. The active population in the spleen was 
+ + + 
shONn to be predominantly Ig, 8 , CR-, FcR-, and Ia and did not include 
mature macrophages. The lack of mature B cell markers on these cells 
suggested that they may be immature B cells although the possibility of 
their being immature macrophages was not eliminated. Accessory cells could 
be further divided into plastic adherent and plastic non-adherent sub-
populations suggesting that they exhibited varying degrees of "stickiness". 
In contrast to primary responses, secondary responses were shown to 
be considerably less dependent on the presence of accessory cells. 
Similarly, when neoplastic cells were used as a source of stimulators 
rather than resting lymphocytes, the response was markedly less accessory 
cell dependent. Possible explanations for these differences in accessory 
cell requirements were discussed. 
CHAPTER 6 
THE ONTOGENY OF STIMULATOR AND ACCESSORY CELL FUNCTION 
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6.1 Introduction 
In studies on the ontogeny of stimulator activity several investi-
gators have shown that the strength of the proliferative response gener-
ated in cultures of immature stimulator cells and adult allogeneic 
responder cells increased with the age of the donor animal until adult 
levels were reached, generally well after birth. This was shown to be 
true for embryonic chicken spleen (Lafferty et al., 1972), foetal mouse 
spleen and liver (Mosier,1974), foetal rat skin (Lane et al., 1975) and 
neonatal mouse spleen and thymus (Howe and Manziello, 1972; Adler et al., 
1970; Wagner and Wyss, 1973). In no instance was significant stimulator 
activity detected before day 18 of gestation. From their studies with 
embryonic chicken spleen cells Lafferty et al., (1972), concluded that 
lymphoid cells in addition to being metabolically active must also be 
inununocompetent before they can function as stimulator cells. 
In contrast to the proliferative response only one study exists on 
the ontogeny of cells capable of inducing cytotoxic T cell responses and 
this involved the use of neonatal rather than foetal tissue (Wagner and 
Wyss, 1973). Nonetheless the findings were of considerable interest 
since they suggested that the stimulation of optimal cytotoxic T cell 
responses, unlike optimal proliferative responses, was not related to 
the age of the stimulator cell donor. Allogeneic 14 day foetal mouse 
liver cells have also been shown to immunise mice against a subsequent 
challenge with skin grafts syngeneic with the irnrnunising population 
suggesting that foetal as well as neonatal cells may be capable of 
inducing cytotoxic T cell responses (Moller, 1963). 
In addition to the ontogeny of the stimulator cell the ontogeny of 
the accessory cell is also of interest since recent reports involving 
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studies of the in vitro induction of antibody responses have suggested that 
cell activity, like the capacity to induce proliferative responses in MLC, 
may be related to the age of the cell donor (Hirsch et al., 1970; Hardy 
et al., 1973; Landahl, 1976). 
The following investigations were undertaken to determine when, if 
ever, foetal liver populations contain cells fulfilling either a stimu-
lator or an accessory role in the induction of cytotoxic T cells in vitro. 
6.2 Methods and materials 
6.2.1 Animals 
CBA/H and BALB/c mice were used in all experiments. Two to three 
month old females were housed with males and examined daily for vaginal 
plugs. The appearance of a plug was taken as day zero, and birth occurred 
on day 19. 
6.2.2 Preparation of cell suspensions 
Foetal liver cells were removed and suspensions made in F-15 con-
taining 10% FCS by gently pressing the organs through a fine stainless 
steel grid. Cells were pooled from 2-3 litters of the same. gestational 
age. The cells were then washed three times in medium by centrifuging 
at 400 g for 5' then declumped once more. Viability was estimated by 
trypan blue exclusion. Spleen and lymph node cell preparations were made 
as described in Chapter 2. 
6.2.3 51 cr-labelled targets 
51 cr-labelled P815-X2 mastocytoma cells (P815), L-929 cells (L cells) 
and macrophages were prepared as described in Chapters 2 and 3 (Sections 
2.2.5 and 3.2.2). 
6.2.4 Treatment of cells with anti-8 and complement 
Anti-8 ascitic fluid was prepared and used as described in Chapter 3 
(Sections 3.2.5 and 3.2.6 respectively). 
UJ 
Ck:: 
:::> 
.._ 
.....J 
:::> 
u 
~ 
:::> 
u 
0) 
0 
.....J 
6.0 
5.0 
4.0~-------------------~-
13 14 15 16 17 18 t 1 2 3 4 
AGE IN DAYS 
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6.2.5 Tissue culture procedures 
Mixed lymphocyte cultures and cytotoxicity assays were performed as 
described in Chapters 2 and 3 (Sections 2.2.4, 2.2.5 and 3.2.2). 
6.3 Results 
6.3.1 The stimulator capacity of foetal liver cells 
Estimations of the stimulator activity of foetal liver cells from 
donors of various ages were made by culturing irradiated BALB/c foetal 
or neonatal liver at a range of concentrations with either 2 x 10 6 CBA/H 
6 lymph node cells or 4 x 10 CBA/H spleen cells. Both spleen and lymph 
node responder cells were used to determine whether adequate numbers of 
accessory cells were present in the stimulator population. As shown in 
Figure 6.1 very significant levels of cytotoxic activity were generated 
with all foetal liver preparations and with neonatal liver cells from 
donors less than 4 days of age. It is notable that when 4 x 10 6 rather 
than 2 x 10 6 foetal liver cells were used for culture a significant 
reduction (~10-fold) in the response was observed with cells from donors 
of more then 16 days gestation, suggesting an increase in the toxicity 
of foetal liver preparations with age. The careful removal of liver 
parenchymal cells by declurnping procedures, particularly with cells from 
older donors was found to be critical for the generation of optimal 
responses. 
The observation that very similar levels of cytotoxic activity were 
generated with either spleen or lymph node responder populations indi-
cated that accessory cells were not limiting in foetal liver at any of 
the gestation periods tested. 
Irradiated CBA/H foetal and neonatal liver cells were also able to 
stimulate significant cytotoxic responses when cultured with BALB/c lymph 
node or spleen responder cells (Figure 6.2). However, in contrast to 
BALB/c, CBA/H neonatal liver cells were still strongly stimulatory 5 days 
TABLE 6.1 
SPECIFICITY OF CYTOTOXIC CELLS INDUCED BY ALLOGENEIC FOETAL AND NEONATAL LIVER CELLS 
Stimulator population 
A. 2 x 106 BALB/c 
foetal liver cellsa 
II 
II 
II 
II 
II 
2 x 106 BALB/c 
adult livera 
4 x 106 BALB/c 
adult spleena 
B. 2 x 106 CBA/H b 
foetal liver cells 
4 x 106 CBA/H 
adult spleenb 
Gestation period P815 cell (days) targetse 
13 5. 80 
15 5.99 
16 6.10 
18 6.23 
2 day neonatal 6.01 
4 day neonatal Bg 
Bg 
6.05 
16 Bg 
Bg 
log C.U./culture 
BALB/c macrophage L cell 
targetsd targ_ets 
6.17 Bg C 
6.06 II 
5.91 II 
6.06 II 
6.10 II 
N.T. N.T. 
N.T. N.T. 
5.98 Bg 
N. T. 5.72 
N.T. 5.63 
CBA/H macrophage 
targets 
N.T. 
II 
II 
II 
II 
It 
N.T. 
N.T. 
5.79 
5.74 
a 2 x 106 CBA/H lymph node responder cells used throughout. All stimulator cells were irradiated (1000 R). 
b 2 x 106 BALB/c lymph node responder cells used throughout. 
c Background values for all targets were <4.4 log C.U. 
d Assays on either 51 cr labeled BALB/c or CBA/H macrophages were of 14 hrs duration. 
e Assays on 51 cr labeled P815 or L cell targets were of 4 hrs duration. N.T. = not tested; Bg = Background. 
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after birth. These observations possibly reflect a difference between the 
two strains in the rate with which their livers differentiate into adult 
form since neonatal BALB/c livers always macroscopically resembled adult 
livers sooner after birth than did CBA/H livers. 
6.3.2 The nature of the effector population 
In the previous section it was demonstrated that allogeneic foetal 
liver cells from as early as day 13 of gestation have the capacity to 
induce cytotoxic responses in MLC. In this section the identity of the 
effector population and its specificity are established. 
As illustrated in Table 6.1.A and B the cytotoxic cells induced by 
foetal liver stimulator cells from donors of all ages tested were specific 
for the sensitising antigens. Thus CBA/H lymph node cells stimulated with 
d BALB/c foetal liver cells lysed P815 (H-2) and BALB/c macrophage targets 
k but not L cell (H-2) targets. Conversely BALB/c lymph node cells sensi-
tised with CBA/H foetal liver cells lysed L cell and CBA/H macrophage 
targets but not P815 targets. The fact that both macrophage and neo-
plastic cell targets were specifically lysed suggested that the sensi-
tising antigens were predominantly H-2 antigens and not oncofoetal 
antigens. It is also notable that the cytotoxic activity induced by both 
foetal liver cells and adult spleen cells was of similar magnitude. 
The activity of both BALB/c (Table 6.2) and CBA/H effector popu-
lations was completely abrogated following treatment with anti-8 ascitic 
fluid and complement, strongly suggesting that the active population was 
comprised solely of cytotoxic T cells. 
In summary, allogeneic foetal liver stimulator cells induced cyto-
toxic T cell responses of similar magnitude and specificity to those 
induced by allogeneic adult lymphoid organs. 
TABLE 6.2 
REMOVAL OF EFFECTOR CELL ACTIVITY WITH ANTI-8 ASCITIC FLUID 
AND COMPLEMENT 
Treatment of effector populationa 
Untreated 
Anti-8 ascitic fluid 
+ C' 
Normal ascitic fluid 
+ C' 
b Log C.U./culture 
5.73 
4.38 
5.57 
a Effector cells from a culture of 2 x 10 6 irradiated BALB/c 
16-day foetal liver cells and 2 x 10 6 CBA/H lymph node 
responder cells assayed on day 5. 
b Cultures were assayed on 1 x 10 5 51 cr labeled P815 targets. 
Background = 4.31 log C.U. 
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6.3.3 The accessory cell content of foetal liver preparations 
There are two possible explanations for the independence of responder 
accessory cells when foetal liver cells are used as a source of stimu-
lator cells: 
(a) Stimulation by foetal cells (like neoplastic 
cells) is relatively independent of accessory 
cells. 
(b) Foetal liver populations contain significant 
numbers of accessory cells. 
(a) Carbonyl iron treatment of foetal liver cells - To test the 
first alternative liver cells from 16 day CBA/H foetuses were treated 
with carbonyl iron prior to culturing with BALB/c lymph node cells. This 
treatment removed approximately 30% of the foetal liver cells and resulted 
in cotrq?lete abrogation of the response (Table 6.3). Furthermore, the 
response to carbonyl iron treated stimulator cells could not be restored 
by either the addition of irradiated responder spleen cells to the 
cultures or by the use of spleen rather than lymph node responder cells 
(Table 6.3). Similar results were also obtained with cells from 14, 17 
and 19 day CBA/H foetuses. 
These results contrasted with those obtained with adult lymphoid 
populations (see Chapter 5) and suggested that in foetal liver either 
two populations, one with stimulator activity and another with accessory 
cell activity or possibly one population exhibiting both properties were 
removed by treatment with carbonyl iron. The question of the degree of 
accessory cell dependence in this culture system thus remained unresolved. 
(b) Three cell experiments with foetal liver accessory cells -
To determine whether a subpopulation of cells existed in foetal liver 
with properties resembling those of the accessor1 cells found in adult 
lymphoid organs, irradiated CBA/H foetal liver cells from 14, 16, 17 and 
19 aay donors were cultured with untreated or carbonyl iron treated, 
Stimulator 
population 
3 x 10 6 liver 
cells from 
16-day CBA/H 
foetuses 
II 
II 
II 
II 
II 
TABLE 6. 3 
THE EFFECTS OF CARBONYL IRON TREATMENT 
OF FOETAL LIVER STIMULATOR CELLS 
Carbonyl 
iron 
treatment 
C 
+ 
+ 
+ 
Responder 
population 
2 x 10 6 BALB/c 
lymph node cells 
II 
4 x 10 6 BALB/c 
spleen cells 
II 
2 x 10 6 BALB/c 
lymph node cells 
+ 
4 x 10 6 BALB/c 
irradiated spleen 
cells 
II 
Cytotoxic activity 
log C.U./culture 
5.93 
4.49 
5.68 
Bg 
a Cytotoxic activity assayed on 2 x 10 4 51 cr labeled L-929 targets. 
b Bg = 4.33 log C.U. 
c Carbonyl iron treatment removed 30% of the foetal liver population. 
+=treatment; - = no treatment. 
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Figure 6.3 - The accessory cell activity of CBA/H foetal liver cells. 
+/+ line denotes cultures comprised of 4 x 10 6 irradiated BALB/c spleen 
stimulator cells and 2 x 10 6 CBA/H lymph node responder cells. 
-/+ line same as+/+ but stimulator cells were treated with carbonyl iron 
prior to irradiation. To determine the accessory cell contant of 
CBA/H foetal liver cells 4 x 10 6 irradiated cells from 14, 16, 17 and 
19 day donors were added to -/+ cultures ( 0 ) . As a control the 
same cells were added to +/+ cultures ( • ) . 
(), 4 x 10 6 irradiated, carbonyl iron treated foetal liver cells were 
added to-/+ cultures. t denotes birth. Figures to the left of the 
arrow are days of gestation. 
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irradiated BALB/c spleen cells and CBA/H lymph node responder cells. 
As deroonstrated in Figure 6.3 foetal liver cells from all donors t es ted 
were able to significantly reconstitute the response. In this expe rime nt 
enhancement of the response ranged from 22-fold with cells from 19 day 
donors to SO-fold with cells from 14 day donors. The apparent difference 
between the latter populations in their accessory cell content was not a 
consistent finding. Similar levels of reconstitution were observed with 
either 2 x 106 or 4 x 106 foetal liver cells and in no instance were the 
cells found to be inhibitory at the concentration used. Treatment of 
the foetal liver populations with carbonyl iron prior to culture completely 
abrogated their reconstituting activity (Figure 6.3). 
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D I S C U S S I O N 
A. Foetal liver stimulator cells - It was established in this chapter 
that from as early as day 13 of gestation allogeneic foetal liver cells 
were able to induce cytotoxic T cell responses of similar magnitude and 
specificity to those induced by adult lymphoid populations. The stimu-
lator activity of foetal liver cells was completely removed by carbonyl 
iron treatment but unlike adult lymphoid cells this loss in activity did 
not appear to be the result of selective depletion of non-stimulating 
accessory cells since the replacement of these did not restore the res-
ponse. All stimulator cells in foetal liver from day 13 of gestation 
onwards therefore appeared to be adherent or "sticky" cells. A number of 
cell types known to be present in foetal liver at this time fit this 
description. 
Thus, from day 13 of gestation foetal liver contains varying numbers 
of non-haemopoietic cells, pluripotent stem cells, granulocytic cells, 
+ 
mature and immature macrophages (Cline and Moore, 1972) and Ig cells 
Melchers et al., 1975; Melchers and Phillips, 1976; Rosenberg and Parish, · 
1976) . 
Using a rosetting technique and the same CBA/H strain mice used in 
this study Rosenberg and Parish (1976) described a subpopulation of cells 
in foetal liver with low levels of surface Ig which were first detectable 
on day 13 of gestation when they represented approximately 2% of the 
population. Their numbers increased steadily to about 15% by day 18 of 
gestation and thereafter declined rapidly. These cells, which did not 
appear to acquire their surface Ig passively and were therefore thought 
to be immature B cells, were completely removed by treatment with carbonyl 
iron but not by incubation on plastic surfaces. After birth the majority 
+ of Ig cells resembled mature B cells and were not removed by treatment 
with carbonyl iron. Melchers et al. (1975), and Melchers and Phillips 
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(1976) have also described a similar population of immature B cells in 
foetal liver. Unfortunately the adherence properties of these cells were 
not studied. 
The carbonyl iron adherent stimulator cells in foetal liver may 
therefore include any one or all of the following: mature or immature 
macrophages, immature B cells and perhaps other haemopoietic cells such 
as normoblasts which make up a considerable portion of the foetal liver 
population at all stages of its development (Cline and Moore, 1972). The 
finding that 30% - 40% of the foetal liver cells are removed by carbonyl 
iron from day 14 of gestation onwards certainly suggests that cells other 
than macrophages and B cells are removed by this treatment since the 
latter populations combined only make up approximately 5% of the popu-
lation on day 13-14 of gestation and approximately 20% by day 18 of 
gestation (Cline and Moore, 1972; Rosenbe_rg and Parish, 1976). The fact 
that only small numbers of B cells and macrophages are present on day 
13-14 of gestation when optimal stimulation was already in evidence does 
not preclude their being the only cells with stimulator activity since 
similar numbers of neoplastic cells induce very s _ignificant cytotoxic 
activity (see Chapter 3). 
The stimulation observed with neonatal liver cells is probably 
caused by more mature lymphoid cells or macrophage-like cells since the 
haemopoietic activity of the liver declines rapidly soon after birth 
(Metcalf and Moore, 1971; Stutman et al., 1970). It will be interesting 
to see whether neonatal stimulator cells are also removed by carbonyl iron. 
The decline in haemopoietic activity in liver after birth combine d 
with the migration of cells from the liver to the bone marrow and spleen 
probably also explains the early and rapid loss of stimulator activity 
after birth observed with BALB/c neonatal liver cells. An increase in 
the number of liver parenchymal cells, which in adult liver have been 
found to be highly toxic in culture (personal observation) , probably also 
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contributes to the decline in the response. The fact that days CBA/H 
neonatal liver cells still stimulated strong cytotoxic T cell responses 
suggests that haemopoietic activity may be sustained for longer in this 
population than in the BALB/c population. The depression of the response 
which occurred when the number of BALB/c foetal liver cells from donors 
of more than 16 days_ gestation was increased from 2 x 10 6 to 4 x 10 6 / 
culture may reflect the presence of immunosuppressive agents in foetal 
liver which must be present in critical concentrations to be effective. 
Two possible sources of suppression are granulocytic cells which are 
known to be toxic in culture (Rode and Gordon, 1974) and whose concen-
tration increases quite dramatically about the time suppression is first 
observed (Cline and Moore, 1972) and alpha1-foetoprotein a product of 
foetal cells which has been reported to inhibit MLC responses (Murgita 
and Tomasi, 1975). 
In a syngeneic MLC system involving combinations of foetal liver 
stimulator cells and adult spleen responder cells Chism et al. (1976), 
also noted an inununosuppressive effect when stimulator:responder ratios 
were increased above a certain critical level. 
The existence of immunosuppressive cells and factors plus the fact 
that many early studies were performed in the absence of 2-ME and at only 
one stimulator and responder cell concentration may explain the failure 
of others to detect stimulator cells in early foetal liver preparations. 
The possibility cannot be excluded, however, that the cells in foetal 
liver which are capable of inducing optimal cytotoxic responses may be 
incapable of inducing optimal proliferative responses. Evidence in 
support of this suggestion comes from studies by Wagner and Wyss (1973), 
who observed that neonatal spleen cells induced optimal cytotoxic T cell 
responses from birth onwards whereas optimal proliferative response s were 
not induced until the donors were well over 10 days of age. The recent 
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demonstration by Press (1975), that adult levels of Ia+ cells in spleen 
are not reached until well after 16 days of age may perhaps explain this 
difference. 
Recently it has been shown that syngeneic foetal liver cells, from 
as early as day 14 of gestation, can stimulate cytotoxic T cell responses 
specific for oncofoetal antigens (OFA). Since OFA are found on a 
variety of foetal and neoplastic cells but not on the equivalent normal 
adult cell type the demonstration in the present study that effector T 
cells raised against allogeneic foetal liver cells lysed adult macrophage 
targets as efficiently as neoplastic cell targets suggested that the 
sensitising antigens in the allogeneic system were predominantly H-2 
antigens and not OFA. 
B. Foetal liver accessory cells - The general lack of surface 
markers apart from Ig on the accessory cell population found in adult 
spleen implied that these cells were possibly represented by an inunature 
subpopulation of B cells. 
In this chapter data was presented which convincingly demonstrated 
that immature, immunoincompetent cells in the form of foetal liver cells 
were quite capable of performing an accessory cell function. Furthermore, 
these cells, like those in adult lymphoid organs were also removed by 
carbonyl iron. The fact that these cells are inununoincompetent provided 
further evidence that the co-operation observed with accessory cells in 
MLC does not require the specific recognition of either the stimulator 
or the responder population. 
The carbonyl iron adherent accessory cell population in adult spleen 
+ - + + -is predominantly Ig, 8 , FcR-, CR-, and Ia. A similar carbonyl iron 
+ + 
adherent subpopulation of cells which was Ig, 8, CR, FcR- has been 
demonstrated in foetal liver from day 13 of gestation (Rosenberg and 
Parish, 1976). Whether Ia antigens are also exhibited on this population 
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or on any other lymphoid or macrophage-like population in foetal liver is 
unresolved. Although Ia antigens have been isolated and characterised in 
14-15 day foetal liver cells the nature of the Ia bearing cell was not 
ascertained (Delovitch and McDevitt, 1975). 
+ + + While it is tempting to suggest that the Ig, 8-, CR, FcR-, Ia- cell 
in foetal liver is equivalent to the accessory cell described in adult 
spleen the possibility cannot be excluded that its presence is merely 
coincidental. In foetal tissues Ig cells may also have accessory cell 
function as well. The low number of bound SRBC and the instability of 
the Ig rosettes in foetal liver cell preparations preclu:ies their success-
ful isolation on Isopaque/Ficoll and thus makes their functional character-
isation difficult. 
The early appearance of accessory cells functional in MLC provides 
further evidence for the difference between this population and the 
accessory population that collaborates with T and B cells in the formation 
of antibody since the latter population does not appear until well after 
birth (Landahl, 1976). 
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SUMMARY 
In this chapter the stimulator and accessory cell content of foetal 
liver cells from donors of various ages was studied. From as early as 
13 days of gestation all_ogeneic foetal liver cells were shCMn to 
stimulate cytotoxic T cell responses of similar magnitude and specificity 
to those induced by allogeneic adult spleen cells. Stimulator activity 
was completely removed following treatment of the foetal liver cells with 
carbonyl iron. This loss in activity did not appear to be the result of 
the selective depletion of non-stimulati_ng accessory cells since replace-
ment of these did not restore the response. Stimulator cells, like 
accessory cells in this system, therefore appeared to belong to a sub-
population of "sticky" cells which represented approximately 30% of the 
population. One interpretation of the data was that stimulator cells 
and accessory cells are one and the same in foetal liver. The stimulator 
population was not further identified but may include mature or immature 
macrophages or immature B cells all of which are known to be carbonyl iron 
adherent and present in the populations studied. Foetal liver cells were 
also noted to become increasingly immunosuppressive after 16 days 
gestation. 
From as early as day 14 of_ gestation foetal liver cells were also 
found to be a source of carbonyl iron adherent accessory cells. The 
+ + possibility of this population being equivalent to the Ig, 8 , CR-, 
+ 
FcR-, Ia population of accessory cells in adult spleen was discussed. 
The early appearance of accessory cells during ontogeny provided further 
evidence for the difference between this population and the one collabor-
ating in antibody formation. 
CHAPTER 7 
PRODUCTS RELEASED BY CULTURED SPLEEN CELLS CAN 
SUBSTITUTE FOR ACCESSORY CELLS IN MLC 
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7.1 Introduction 
It has become increasingly evident that direct contact between cells 
is often not a prerequisite for cellular collaboration. In many instances 
factors produced by the collaborating cells are the active moieties. For 
example, T cell derived factors have been described in supernatants from 
mixed lymphccyte cultures and cultures of cells with T dependent antigens 
which are capable of replacing helper T cells in both humoral (Dutton et 
al., 1971; Schimpl and Wecker, 1972i Arnerding and Katz, 1974i Taussig et 
al., 1975), and cell mediated irn.~une responses (Altman and Cohen, 1975; 
Plate, 1976). Similarly, factors produced by cultured peritoneal cells 
have been shown to replace the adherent population required for the 
induction of antibody responses in vitro(Moller et al., 1976). 
Supernatant factors capable of replacing adherent accessory cells in 
MLC have also been reported. In an early study Bach and others (1970), 
described a factor, produced by peritoneal cells in the absence of antigen, 
which could restore the proliferative response in adherent cell depleted 
mixed lymphocyte cultures. More recently, Miller and Mishell (1975), 
observed that the accessory cells required for the induction of cytotoxic 
T cells in vitro could be replaced with a factor produced by spleen cells 
in the presence or absence of alloantigen. 
In this chapter preliminary data is presented which, like that of 
Miller and Mishell (1975), suggests that cells present in the spleen are 
capable of producing accessory cell replacing factors when cultured in the 
absence of alloantigen. 
7.2 Methods and materials 
7.2.1 Animals 
6-8 week old BALB/c and CBA/H mice were used throughout. 
7.2.2 Tissue culture techniques 
Mixed lymphocyte cultures and cytotoxicity assays were carried out 
as described in Chapters 2 and 3. 
7.2.3 Carbonyl iron treatment 
Adherent cells were removed by treatment with carbonyl iron powder 
as described in Chapter 3. 
7.2.4 The separation of cells on the basis of surface Ig. 
Spleen cells were separated into _Ig + and Ig subpopulations by the 
rosetting procedure described in Chapter 3. 
7.2.5 Preparation of supernatants 
Supernatants were prepared by culturi_ng cells in a final volume of 
2 ml in complete medium in 24 well Linbro trays for 18 hours at 37°C in 
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a humidified atmosphere of 7% 0 2 , 10% CO2, 83% N2. After incubation the 
cultures were harvested and centrifuged at 900 g for 10 1 • The super-
natants were collected and pooled. Supernatants were generally used the 
day they were harvested although they were found to be stable for at 
least three weeks if stored at -70°C. The following populations of cells 
were used to prepare supernatants: 4 x 106 irradiated, untreated or 
carbonyl iron treated BALB/c or CBA/H spleen cells or 4 x 10 6 irradiated 
+ + -Ig, Ig or recombined (Ig + Ig) BALB/c or CBA/H spleen cells. The 
same batches of Eagles Minimal Essential Medium (F-15), heat inactivated 
foetal calf serum and 2-mercaptoethanol were used for all experiments. 
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Figure 7.1 - Supernatant factors can replace accessory cells in MLC. 
·-·, BALB/c spleen supernatant + (+/+) culture. 0---0' CBA/H spleen supernatant + (+/+) culture. 
• . , BALB/c spleen supernatant + (-/+) culture. 0-0, CBA/H spleen supernatant + (-/+) culture. 
~,A I supernatants prepared from carbonyl iron treated BALB/c 
spleens or CBA/H spleens. 
+/+, denotes cultures containing 4 x 10 6 irradiated BALB/c spleen 
stjrnulator cells+ 2 x 10 6 CBA/H lymph node responder cells. 
-/+, denotes cultures containing 4 x 10 6 irradiated, carbonyl iron 
treated BALB/c spleen cells+ 2 x 10 6 CBA/H lymph node responder 
cells. 
All supernatants were obtained from overnight cultures of BALB/c 
or CBA/H irradiated spleen cells. 
7.3 Results 
7.3.1 Supernatants from spleen cell cultures can substitute for 
accessory cells 
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The stimulator and supernatant combinations used to determine whether 
factors from spleen cell cultures could replace accessory cells in MLC are 
summarised in Table 7.1. 2 x 106 CBA/H lymph node responder cells were 
used routinely in all cultures. As sha.,.rn in Figure 7.1 supernatants from 
cultures of either BALB/c or CBA/H spleen cells almost completely restored 
the response to carbonyl iron treated stimulator cells (88% and 69% 
reconstitution respectively). Furthermore, both supernatants still had 
considerable activity following four-fold dilution with fresh medium. In 
this experiment the addition of supernatants to control, accessory cell 
containing cultures had no significant effect on the response although in 
other experiments enhanced responses were noted. Lymph node cells 
cultured in the presence of supernatants alone neither proliferated nor 
differentiated into effectors indicating that the active moiety in the 
supernatant was not a a non-specific rnitogen. Supernatants from cultures 
of carbonyl iron treated spleen cells were completely devoid of activity, 
a finding which strongly implied that accessory cells were the source of 
the active factor. 
It should be stressed, however, that the efficiency with which 
supernatants reconstituted the response to carbonyl iron treated stimulator 
cells was extremely variable. Thus as sha.,.rn in Table 7.2 (line 5) although 
the addition of supernatants always resulted in a significant increase in 
the response the degree of reconstitution of the response varied from 
6-368%. 
7.3.2 + The capacity of Ig and Ig spleen cells to produce 
accessory cell replacing factor(s) 
In Chapter 5 it was shown that the Ig+ fraction of spleen cells was a 
much richer source of accessory cells than the Ig fraction. If as 
Stimulator populationc 
Untreated 
a 
+ 
+ 
Carbonyl iron 
treated 
+ 
+ 
+ 
+ 
TABLE 7.1 
PROTOCOL FOR EXPERIMENTS WITH SUPERNATANTS 
b Source of supernatant 
BALB/c spleen 
Carbonyl iron 
treated BALB/c 
spleen 
CBA/H spleen 
+ 
+ 
+ 
+ 
+ 
a +, denotes components included in the culture. 
Carbonyl iron 
treated CBA/H 
spleen 
+ 
b Supernatants were prepared by culturing irradiated cells at a final concentration of 2 x 106 /ml, overnight. 
c 4 x 10 6 irradiated BALB/c spleen cells were used as stimulators and 2 x 106 CBA/H lymph node cells as 
responders throughout. 
Carbonyl irona 
treatment of 
stimulator 
population 
d 
+ 
+ 
+ 
+ 
+ 
TABLE 7.2 
+ THE ABILITY OF Ig AND Ig SPLEEN CELLS TO PRODUCE ACCESSORY CELL REPLACING FACTOR 
Source o? 
supernatant 
+ Ig spleen cells 
Ig spleen cells 
Unfractionated 
spleen cells 
+ Ig + Ig spleen 
cells 
5.74 
3.88 
N.T. 
N.T. 
1 
5. 84 (126) 
N.T. 
6.17 
4.07 
2 
5.67 (31.6)c 
5.37 (15.8) 
4.97 (6.3) 
N.T. 
Experiment No. 
3 
6.26 
5.20 
4.95 (0) 
4.94 (0) 
6 .02 (55) 
5.50 (17.5) 
5.98 
4.00 
4 
6. 74 (547) 
6.32 (221) 
6.54 (368) 
6.68 (SOS) 
5.98 
4.00 
5 
6.63 (452) 
6.29 (200) 
6.51 (337) 
6.54 (368) 
6 
6.26 
5.20 
5.28 (0) 
5. 74 (31.8) 
5.5 (17.3) 
5.60 (22. 7) 
a 4 x 10 6 irradiated BALB/c stimulator cells and 2 x 10 6 CBA/H lymph node responder cells were used throughout. 
b -, denotes no supernatant. The supernatants used in experiments 1 - 4 were prepared from irradiated BALB/c 
spleen cells while those used in experiments 5 and 6 were prepared from irradiated CBA/H spleen cells. 
c Figures in brackets represent the percentage reconstitution of the response. 
d -, no treatment; +, treatment. 
N.T., not tested. 
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suggested in the previous section the accessory cells themselves produce 
+ accessory cell replacing factor, supernatants from cultures of Ig cells 
should be a better source of the factor than supernatants from cultures 
of Ig cells. + -Supernatants from individual cultures of Ig and Ig 
populations were therefore prepared and compared for their reconstituting 
activity. As illustrated in Table 7.2 the activity of the supernatants 
from both populations was very variable. Hence, reconstitution with 
+ 
supernatants from cultured Ig cells ranged from 0-547% while those from 
cultured Ig cells ranged from 0-221%. It was notable, howeverJ that the 
+ 
supernatants from cultured Ig cells in all experiments but one had 
significantly more activity than those from cultured Ig populations. 
The finding that supernatants from cultured Ig cells completely restored 
the response in two experiments is difficult to explain but possibly 
reflects either the production of factors by cells other than accessory 
cells, or a more proportionate distribution of accessory cells between the 
+ -Ig and Ig fractions. 
D I S C U S S I O N 
In this chapter a factor(s) was d2scribed which was capable of 
replacing accessory cells in MLC. This factor, termed accessory cell 
replacing factor (ACRF) was produced independently of stimulation by 
+ 
alloantigen by unfractionated spleen cells, Ig and to a lesser extent 
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Ig spleen cells of both stimulator and responder origin. A similar 
accessory cell replacing factor produced by T cell depleted spleen cells 
cultured in the presence or absence of allogeneic cells has also been 
described by Miller and Mishell (1975). 
Two findings, firstly that carbonyl iron treated cells did not 
+ produce ACRF and secondly that Ig cells were generally a better source 
of the factor than Ig cells strongly suggested that accessory cells 
themselves were responsible for the production of the factor. Further-
more, the fact that ACRF was produced in the absence of stimulation with 
alloantigen provided further evidence that the fulfilment of accessory 
cell function requires neither the recognition of nor the processing of 
antigen. 
The complete reconstitution of the response with supernatants from 
cultured Ig cells observed in two experiments deserves further comment. 
The activity of these supernatants may reflect either the production of 
T cell or macrophage factors capable of enhancing the response or 
alternately a more equitable distribution of accessory cells between the 
+ Ig and Ig fractions. The latter situation could arise if the mice used 
were overtly stimulated with antigen and as a result had an increased 
number of immature splenic B cells or macrophages. This is not a remote 
possibility since the animals used in these studies are bred under 
specific pathogen free conditions but just prior to use are maintained 
under conventional conditions and are therefore more susceptible to mild 
infections. 
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The extreme variability in the activity of the various supernatants 
tested may also be explained if only spleens from animals recently 
stimulated with antigen contained sufficient numbers of accessory cells 
to produce appreciable amounts of ACRF in vitro. The use of spleen cells 
from recently irrununised nuce for the preparation of supernatants may help 
to resolve this point. When accessory cells themselves rather than ACRF 
are used to restore the response in adherent cell depleted cultures the 
inunune status of the animals is probably less critical since fewer 
accessory cells would be required to reach the required local concen-
tration of ACRF than would be required to produce a similar concentration 
in a supernatant. 
The preliminary nature of the data described in this chapter pre-
cludes any positive statements on the target for ACRF or its mode of 
action. Kasakura and Lowenstein (1965) and Kasakura (1970, 1976) have 
described blastogenic factors produced by lymphocytes cultured in the 
absence of antigen which induced the proliferation of both syngeneic and 
allogeneic lymphocytes. ACRF does not seem to fit into this category, 
however, since lymph node responder cells cultured in the presence of 
supernatants for 5 days neither proliferated nor differentiated into 
effector cells. Alternative possibilities are that ACRF only induces 
proliferation in responder cells after they have bound antigen or that 
it acts at stimulator cell rather than responder cell level. These 
alternatives will be elaborated on in the following chapter. 
Clearly, there are many experiments yet to be done before the 
identity of ACRF and its mode of action can be elucidated. Some of 
these include: the physical and biochemical characterisation of the 
factor(s); pre-incubation of stimulator or responder populations with 
ACRF to determine the target cell for ACRF activity; and d e termination 
of the conditions required for maximal production of ACRF in vitro. 
It will also be interesting to see whether L cells which can function as 
both stimulator and accessory cells produce factors resembling ACRF. 
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S U M M A R Y 
In this chapter very preliminary data was presented which suggested 
that accessory cells could be replaced by a factor(s) termed accessory 
cell replacing factor (ACRF) which was produced by spleen cells of either 
responder or stimulator cell genotype cultured in the absence of antigen. 
Two further observations, firstly that supernatants from cultures of Ig+ 
spleen cells were generally a better source of ACRF than cultures of 
unfractionated spleen cells or Ig spleen cells and, secondly that carbonyl 
iron treated cells did not produce ACRF, suggested that accessory cells 
were responsible for the production of ACRF. The fact that ACRF did not 
induce the proliferation of responder lymph node cells implied that it did 
not function simply as a T cell mitogen. Whether ACRF acts at the level of 
the stimulator or the responder population was not resolved. 
CHAPTER 8 
GENERAL DISCUSSION 
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8.1 Introduction 
The aim of this work was to identify and characterise the cells which 
interact in the stimulation of cytotoxic T cell responses to alloantigens 
in vitro. Interpretations of the individual findings have been given at 
the end of each chapter. In this concluding section further implications 
of the findi_ngs are dis cussed and a model is proposed which attempts to 
explain how the components of the system, viz., stimulator cells, accessory 
cells, and precursors of cytotoxic T cells interact. 
8.1.1 Synopsis of observations 
Although few comparative studies of the stimulatory capacity of 
different cell populations exist, it can be concluded from the data in 
Tables 1.2, 3.1 and 3.2 that in mice and humans lymphocytes and some 
neoplastic cells generally stimulate stronger cytotoxic T cell responses 
than mature macrophages or non-lymphoid cells. 
Ontogenic studies and studies with adult lymphoid populations provided 
evidence that stimulator activity was a function of both mature and 
immature lymphoid cells and was not dependent on the presence of surface 
lg, Ia antigens or Fe or complement receptors. Furthermore, significant 
cytotoxic T cell responses were obtained in the absence of I region 
differences between stimulator and responder populations, providi.ng further 
evidence that helper T cells which recognise Ia antigens, are not an 
. 
absolute requirement for the induction of cytotoxic T cell responses ~n 
vitro. 
When mature non-adherent resting lymphocytes were used as a source of 
stimulator cells in primary MLC there was an additional and absolute 
requirement for an adherent accessory cell population. This cell population 
was present predominantly in spleen, bone marrow and foetal liver, and to a 
lesser extent in lymph nodes and the peritoneal cavity, but was absent from 
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the thymus. The accessory cells were required for the induction rather 
than the maintenance of the response, functioned whether syngeneic or 
allogeneic with the responder population and were completely removed by 
treatment with carbonyl iron. Moreover, the observation that accessory 
cells could be replaced with L cells and factors produced by lymphoid cells 
cultured in the absence of antigen, suggested that this population featured 
in neither the presentation nor the processing of antigen and thus differed 
from the accessory cell population required for the induction of antibody 
responses in vitro. 
+ -The splenic accessory cell was further characterised as an Ig 8 and 
+ + 
tentatively FcR-, CR-, Ia cell which was not a mature macrophage. This 
data together with indirect evidence from ontogenic studies implied that 
the functional population was comprised predominantly of immature B cells, 
. + 
although the possibility that some accessory cells were immature FcR 
macrophages was not completely eliminated. 
Although accessory cells were required for the induction of primary 
responses when resting lymphocytes were the source of stimulators this 
requirement was less critical when neoplastic stimulator cells or memory 
responder populations were used. 
The induction of a primary cytotoxic T cell response in vitro there-
fore appeared to require a minimum of three cell types: lymphoid 
+ - + + -stimulator cells, Ig 8 FcR-CR-Ia accessory cells and precursor cytotoxic 
T cells. How these individual populations interact with each other is 
unknown at present and can only be speculated upon. 
8.1.2 A model for T cell induction 
A. Considerations - An adequate model must account for at least 
some of the following facts: 
(1) Serologically defined MHC antigens alone, either in purified 
form, on subcellular membrane fragments or presented on the 
surface of non-lymphoid cells are insufficient stimuli for 
the induction of primary cytotoxic T cell responses 
(Lafferty et al., 1969, 1972, 1974a, 1975, 1976; 
Rode and Gordon, 1974; Engers et al., 1975b and 
Wagner et al., 1976a). 
(2) Membrane fragments and lN irradiated, glutaraldehyde 
fixed and heat (45°C) treated cells all induce strong 
secondary cytotoxic T cell responses but not primary 
responses (Rolli_nghoff and Wagner, 1975; Enge rs et al. , 
t "1 " 1975b; Wagner e a~., 1976a; Hayry and Andersson, 1976}. 
( 3) The primary response to non-stimulati_ng, UV irradiated 
or heat treated spleen cells can be restored by the 
addition of third party stimulator cells (Lafferty 
et al., 1974a; Schendel and Bach, 1974, 1975). 
(4) Glutaraldehyde fixed lymphoid cells are able to 
stimulate primary responses if they are activated with 
mitogens prior to fixation (Lightbody and Kong, 1976). 
(5) Stimulator cells must be metabolically active and 
possibly capable of synthesisi_ng proteins (Wagner, 1973) . 
(6) Helper T cells activated by H-2I or Mls loci coded 
ant_igens are not an absolute requirement for cytotoxic 
T cell induction (Nabholz et al., 1974; Klein et al., 
1975b; Forman and Klein, 1975 
Hodes et al., 1976). 
; Melief et al., 1975; 
(7) When resting non-adherent lymphocytes are used as a 
source of stimulators there is an absolute requirement 
for an adherent accessory population (Wagner et al., 
1972; MacDonald et al., 1973b, Chapters 4 and 5). 
Taken t _ogether these observations suggest that critical inductive 
signals not supplied by antigen alone are required for the induction of 
primary cytotoxic T cell responses. Similar conclusions have also been 
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reached by Lafferty and Cunningham (1975) who proposed a model for 
cytotoxic T cell induction, based on the original Bretscher/Cohn 2 signal 
model for B cell induction (Bretscher and Cohn, 1970), where the stimu-
lator cell population provided both the antigenic stimulus (signal 1) and 
the additional inductive stimulus (signal 2). Bach et al. (1976) have 
also proposed a 2 signal model which differs from that of Lafferty and 
Cunningham (1975), in that the second s _ignal is provided by a helper T 
cell rather than the stimulator cells. 
The data obtained with LPS activated and therefore possibly Ia+ 
fixed stimulator cells (Lightbody and Ko_ng, 1976) and more particularly 
UV treated stimulator cells (Lafferty et al. 1974a; Schendel and Bach, 
1975) and heat treated cells (Schendel and Bach, 1974) indicate that in 
some instances the second inductive signal may come from sources other 
than stimulator cells, probably helper T cells. Recent studies have 
indeed suggested that factors produced by T cells can stimulate cytotoxic 
T cell precursors (Altman and Cohen, 1975; Plate, 1976). However since 
helper T cells, especially those rec_ognisi_ng Ia antigens and Mls antigens, 
are not normally an absolute requirement for cytotoxic T cell induction 
they are probably not the prime source of signal 2 in mixed lymphocyte 
cultures. 
Whether two signals - one resulti_ng from antigen recognition and the 
other deri vi_ng from stimulator cells (or some other source} - are, in 
fact, required for T cell induction, or alternatively a single inductive 
signal suffices is as contentious an issue for T cells as it is for B 
cells (Bretscher and Cohn, 1970; Coutinho and Moller, 1974; Moller et al ., 
1976). For the sake of simplicity the inductive signal will also be 
referred to as signal 2 in the model to be described here. 
If stimulator cells,as proposed by Lafferty and Cunningham (1975), 
provide both signals for T cell induction the presence of an accessory 
cell population would appear to be superfluous. However, the abrogation 
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of the response following the removal of accessory cells and their apparent 
active participation in induction suggests a vital role for this popu-
lation. Accessory cell activity may be manifested in two possible ways: 
(1) Accessory cells - a unique subpopulation of lymphocytes -
supply inductive signals directly to responder cells. 
(2) Accessory cells activate lymphocytes in such a way that 
the lymphocytes are then able to deliver signal 2. Thus, 
accessory cells may convert resting lymphocytes to 
stimulator cells, implying that only activated lymphocytes 
are capable of delivering signal 2. 
The inherent capacity to supply inductive signals is by no means unique 
to cells resembling accessory cells. Apart from helper T cells, there is 
also evidence that blast cells and neoplastic cells can directly stimulate 
cytotoxic T cell responses. Thus, when the stimulator activity and 
accessory cell requirements of T lyrophoblasts obtained from mixed lympho-
cyte cultures and unstimulated T lymphocytes were compared, the former 
population was observed to induce stronger cytotoxic responses and to be 
less accessory cell dependent that the latter (Lafferty and Woolnough, 
1977). Similarly P815, L-929 and EL-4 cells, all of which are rapidly 
dividing neoplastic cell lines and probably perpetually in a 11blast-like" 
state, are capable of inducing significant cytotoxic T cell responses in 
the absence of accessory cells (Chapter 5 and Lafferty and Woolnough, 1977). 
Blast-like cells, unlike resting lymphocytes, therefore appear to have the 
ability to independently transmit inductive stimuli to precursor cytotoxic 
T cells. 
The fact that accessory cells exhibit few of the surface markers 
normally associated with mature B cells or macrophages and are present in 
appreciable quantities in haemopoietic organs, such as bone marrow and 
foetal liver, suggests that they too may be "activated" or "blast-like" in 
nature and, as a consequence, may be able to interact directly with responder 
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T cells. Thus, when syngeneic to the responder population accessory cells 
may function as a source of inductive stimuli for cytotoxic T cell pre-
cursors while cells in the accessory cell depleted stimulator population 
provide a source of antigen. In such a system lymphocytes would merely 
function as inert vehicles of transplantation antigen and it could be 
predicted that any source of MHC antigen would suffice for induction pro-
vided adequate numbers of accessory cells were available. However, antigen 
presented in soluble or subcellular form fails to stimulate a response and 
several lines of evidence s _uggest that lymphocytes in the stimulator popu-
lation play an active role in the inductive process. Thus, lymphocytes 
treated with metabolic inhibitors, or inactivated by fixation, UV 
irradiation or heat treatment all fail to stimulate primary responses 
although they still exhibit antigens in a form recognisable by memory cells 
(Rollinghoff and Wagner, 1975, Hayry and Andersson, 1976). The inability 
of the UV treated cells to stimulate is not the result of the simultaneous 
inactivation of accessory cells since the addition of irradiated responder 
spleen cells to cultures of UV treated stimulator cells and untreated 
responder cells (equivalent to the three cell system described in Chapter 5) 
did not restore the response Lafferty et aZ. 1974a). A further interpre-
tation of the latter observations is that accessory cells do not provide 
substantial direct stimuli to responder cells. The possibility cannot be 
excluded, however, that for some obscure reason only viable, intact cells 
can present antigen in an immunogenic way to unprimed T cells and that 
inductive stimuli from accessory cells are directed to responder cells. 
A more attractive system is one where accessory cells activate resting 
lymphocytes in the stimulator population and convert them to "stimulator 
cells". Such a system would explain both the apparent active involvement 
of stimulator cells in the inductive process and the requirement for 
accessory cells. 
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Figure 8.1 - Diagrammatic representation of the cellular interactions 
proposed to occur during the induction of cytotoxic T cell response 
~n vitro. Induction requires both the recognition of Kor D antigens 
+ 
+ 
by Ly 2-3 precursor cytotoxic T cells and the receipt of an inductive 
signal provided by activated stimulator cells or possibly accessory 
+ cells. Responses may be further amplified by factors from Ly-1 helper 
T cells stimulated by Ia or Mls antigens. 
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B. The model - Figure 8.1 summarises the cellular interactions 
thought to be required for the generation of cytotoxic T cell responses in 
mixed lymphocyte cultures. Stimulator cells bearing H-2K or H-2D gene 
products are recognised by allogeneic precursor cytotoxic T cells with 
receptors specific for these antigens. This interaction alone is insuf-
ficient for induction and must be accompanied by a further inductive signal 
provided by the stimulator cell. The delivery of this signal is dependent 
on the prior activation of the stimulator lymphocytes by accessory cells, 
possibly via a factor. 
It is proposed that only cells which are activated (immature cells, 
blasts, neoplastic cells) or are receptive to activation (lymphocytes) and 
which, as a result of such activation, can produce inductive stimuli when 
bound to precursors of cytotoxic T cells, can function as "stimulator cells". 
Stimulator capacity may thus reflect a certain physiological state and as 
such may not be omnipresent. Induction of cytotoxic T cell responses via 
"stimulator cells" is independent of other cell types but responses may 
be amplified by helper T cells and possibly accessory cells. 
Non-lymphoid cells bearing Ia ant_igens such as epithelial cells may 
circumvent the necessity of supplying inductive stimuli themselves by 
activating helper T cells which then provide an alternative source of 
inductive signals. Thus, following rec_ogni tion of antigen, cytotoxic T 
cell precursors may be induced to proliferate by stimuli from activated 
stimulator cells or helper T cells. 
It should be emphasised that while the model illustrated in Figure 8.1 
may explain the responses observed in the three-cell system described in 
Chapter S;such a mechanism may in fact only represent an amplification 
process in a conventional MLC. If accessory cells are in fact "stimulator 
cells" they may provide the primary source of stimulation in untreated 
spleen cell stimulator populations. Accessory cells of either stimulator 
or responder origin would have the additional capacity to recruit further 
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"stimulator cells" from the resting lymphocyte pool by producing 
"activation factors". Accordingly accessory cells may be both "stimulators" 
and recruitors of "stimulators". Characterisation of the supernatants 
described in Chapter 7 and the isolation of accessory cells will help to 
resolve these issues. 
8.1.3 The nature of signal-2 
The nature and the mode of action of the inductive stimulus or "signal-
2" is unknown. One possibility is that it takes the form of a signal to 
proliferate. Evidence in support of this suggestion comes from studies 
with memory populations where it has been shown that the differentiation 
of memory cells into secondary effectors is relatively independent of 
both accessory cells (Chapter 6) and proliferation (MacDonald et al., 1975; 
Wagner and R~llinghoff, 1976). 
Alternatively, inductive signals may ensue when antigens on the 
surface of "stimulator cells" align with their respective receptors on the 
surface of responder T cells. The recent report that fixed cells could 
stimulate provided they were activated prior to fixation (Lightbody and 
Kong, 1976) suggests that the recognition of antigens present on the surface 
of blast cells may indeed be sufficient stimulus for induction. 
8.1.4 Postulates on stimulator antigens and T-cell receptors 
It is worth noting that the recognition of a single antigen on a 
stimulator cell by a single receptor on the responding T cell as illustrated 
in Figure 8.1 may prove to be an oversimplification. Simultaneous recog-
nition of membrane antigens in association with or in addition to Kor D 
antigens by one or more receptors may in fact be a prerequisite for the 
induction of cytotoxic T cell responses to alloantigens. As mentioned in 
Chapter 1 a variety of systems along these lines have already been suggested 
for the induction of cytotoxic T cells with specificity for virus-infected 
or chemically modified syngeneic or allogeneic cells (Zinkernagel and 
Doherty, 1974; Shearer, 1974; Blanden et al., 1975; Zinkernagel, 1976; 
von Boehmer and Haas, 1976). 
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Recently Janeway etaZ.(1976) proposed a model for a T cell receptor 
system which involved two intimately associated receptors one with speci-
ficity for non-MHC antigens and the other with specificity for alloantigens 
and low affinity for self MHC antigens. It was suggested that the induction 
of responses by T cells with specificity for ant.igens expressed on the 
surface of self cells required the occupation of both receptors whereas the 
induction of responses by T cells recognising alloantigens required only 
the bindi.ng of the receptor specific for alloantigen. 
It is possible, however, that a uniform T cell receptor system operates 
and that the stimulation of allo-reacti ve T cells also requires the recog-
nition of more than one antigen by two independent receptors. The second 
ant.igen could take the form of minor histocompatibility antigens or may be 
represented by part of the K or D ant.igens. In the latter instance a 
"hapten-carrier" type of arrangement could be envisaged where each receptor 
recognises a different determinant on the same molecule. Since the minor H 
antigens are highly polymorphic and are known to be recognised in 
association with Kor D antigens (Bevan, 1975) they may form the bulk of the 
non-MHC antigens recognised with Kor D antigens. Thus a subset of T cells 
which all have "MHC" receptors specific for one particular alloantigen but 
"non-MHC" receptors specific for any number of minor H antigens would 
greatly expand the "apparent" response to any one alloantigen. Such a 
system would explain the apparently h.igh proportion of T cells responding 
to alloantigens equally as well as that proposed by Janeway et al. and has 
the additional advantage that it makes no awkward demands on the specificity 
or affinity of the receptors for MHC antigens. 
The reason that activated lymphocytes and neoplastic cells stimulate 
stro.nger cytotoxic T cell responses than other cells may be a reflection of 
the type and the concentration of antigen expressed on their surfaces. 
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Accordingly, only intact and activated cells may express stable complexes 
of MHC and non-MHC antigens in sufficient concentration to induce an 
appreciable primary response. In contrast, the concentration of antigenic 
complexes may be less critical for the restimulation of memory effector T 
cells and would explain why these cells are stimulated by subcellular 
antigens, fixed and UV treated resting lymphocytes and non-lymphoid cells. 
8.1.5 In vivo correlates 
The foregoing highly speculative discussion was based almost entirely 
on data obtained from in vitro experiments. It may well be asked what 
relationship the cells required for the induction of immune responses, in 
vivo, to allografts and tumours bear to those described in vitro. 
As already discussed at some length in Chapter 1 it is generally agreed 
that cytotoxic T cells play a prominent role in the rejection of allografts 
and tumours. Although some exceptions do exist there is considerable 
evidence that the removal of passenger leukocytes from donor skin (Summerlin 
et al., 197 ), kidney (Stuart et al., 1971) and thyroid (Lafferty et al., 
1975, 1976) allografts results in a severe depression of their imrnunogenicity 
and the consequent prolongation of their survival in the recipient. These 
observations imply two thi.ngs: first, that lymphoid cells are superior 
stimulators in vivo as well as in vitro and second, that transplantation 
antigens carried on tissue cells need not present the major barrier to 
allo-transplantation. 
There is also evidence that helper T cells activated by Ia antigens 
are not an absolute requirement for the rejection of allografts although an 
!_ region difference between the donor and the recipient certainly acceler-
ated the rejection process (Sandel and Bach, 1976i Wagner et al., 1976b). 
Helper T cells therefore appear to perform as an amplifier population both 
in vitro and in vivo . The role of accessory cells in vivo is unkna..m and 
may be extremely difficult to establish since they can be of either donor 
or recipient origin. 
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To conclude, there is clearly still much to be done in elucidating the 
mechanisms by which cytotoxic T cells are generated both in vitro and in 
vivo. Verification or amendment of the model proposed here awaits further 
studies on stimulator, accessory and helper T cell populations and ulti-
mately rests on the characterisation of both the antigens recognised by T 
cells and the receptors used to rec_ognise them. 
APPENDIX I 
A PROCEDURE FOR REMOVING RED CELLS 
AND DEAD CELLS FROM LYMPHOID CELL SUSPENSIONS 
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Introduction 
It is important that efficient methods are available for removing 
dead cells and red cells from lymphoid cell suspensions as such cells 
frequently interfere with immunological assays. For example, red cells 
can inhibit mixed lymphocyte cultures (MLC) and dead cells can non-
specifically bind proteins and thereby give high backgrounds in antigen-
binding studies. In accurately assessing cytotoxic antisera it is also 
important that there is initially a low percentage of dead cells in the 
cell suspensions being examined. Furthermore, if dead cells can be 
easily eliminated, sequential cytotoxicity assays with different anti-
sera become possible. 
Two methods have already been published which can be used to 
eliminate dead cells and red cells from lymphoid cell suspensions. One 
procedure separates viable cells from red cells and damaged cells by 
centrifuging the mixture on albumin density gradients (Shortman et al., 
1972c). By varying the pH of the albumin gradient different separations 
were achieved, i.e. at pH 5.1 cells killed by antibody and complement 
were not removed whereas at pH 7.2 such cells were depleted. The second 
method is based on the observation that dead cells aggregate and adhere 
to surfaces in media of low ionic strength (von Boehmer and Shortman, 
1973). This procedure is technically simpler than the albumin gradient 
method, but suffers from the disadvantage that dead cells cannot be 
eliminated from all cell suspensions and there is no depletion of red 
cells. This paper describes an additional red cell and dead cell removal 
procedure which is generally rrore versatile than the previously reported 
methods. 
Methods and materials 
Animals 
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CBA/H and BALB/c mice of either sex and from 6-10 weeks of age were 
used. 
Irranunization and irradiation of mice 
CBA/H mice were primed intraperitoneally 1-3 months before use with 
500 µg of alum-precipitated dinitrophenol-bovine serum albumin (DNP-BSA), 
mixed with 10 9 Bacillus pertussis organisms (Commonwealth Serum 
Laboratories, Melbourne) in 0.2 ml saline. Recipient CBA/H mice were given 
850 rads whole body y-irradiation from a 60 co source at 40-50 rads/min, 
24 hr before cell transfer and challenge with antigen. In transfer 
experiments, irradiated recipients received intravenously 5 µg of DNP-MON 
and 10 7 viable lymphocytes in 0.5 ml of phosphate buffered saline (PBS)/ 
10% foetal calf serum (FCS). 
Antigens and antisera 
Monomeric fl.agellin (MON) , mol. wt 40,000, was prepared from the 
flagella of Salmonella typhimurium SL 870 (Ada et al., 1964), and oxi-
dized to prevent repolymerization (Parish and Stanley, 1972). The MON 
was dinitrophenylated accordi.ng to the method of Eisen (1964), and a 
preparation of MON conjugated with approximately 1.5 DNP groups/mole used. 
A cytotoxic anti-8 ascitic fluid was prepared in AKR/J mice as 
reported elsewhere (Kirov, 1974). 
Preparation of lymphoid cells 
Two procedures were used to obtain cell suspensions from spleen, 
thymus and lymph node. The first procedure was carried out at 0-4°C and 
entailed cutting the lymphoid organs into small segments, extruding the 
segments through a stainless steel sieve into PBS/10% FCS and then 
washing the extruded cells twice in PBS/10% FCS by centrifugation at 4°C. 
This method yielded cell suspensions with viabilities ranging from 
55-70%. The second procedure resulted in cell suspensions with much 
higher viabilities (85-95%) and has been described in detail previously 
(Parish et al., 1974). Briefly, the procedure consisted of preparing 
the cell suspensions at room temperature (15-20°C) and removing large 
aggregates and fine debris by multiple centrifugations of the cells at 
low g-forces. 
132 
Cortisone-resistant thymus cells were obtained from CBA/H mice which 
had received 3 mg of cortisol intraperitoneally 24 hr before sacrifice. 
These thymus cells were prepared at 0-4°C as described above. 
Total viable and dead cells in each lymphoid cell suspension were 
counted in a haemocytometer usi_ng the Trypan blue exclusion method. In 
this procedure 0.1 ml of the cell suspension in PBS/10% FCS was mixed 
with 0.1 ml of 0.1% (w/v) Trypan blue in PBS, and the proportion of 
unstained cells counted 1-2 min later. 
When cells were prepared for tissue culture, they were collected 
and washed in Eagle's minimal essential medium (F-15) (Grand Island 
Biol_ogical Co., Grand Island, New York) buffered with sodium bicarbonate 
and supplemented with 10% FCS, 100 µg/ml streptomycin, 100 units/ml 
penicillin G and 10- 4 M mercaptoethanol. 
Enumeration of anti-DNP plaque-forming cells (PFC) 
PFC were enumerated using the technique of Cunningham and Szenberg 
(1968). To detect anti-DNP PFC, sheep erythrocytes were coated with 
dinitrophenylated rabbit anti-sheep erythrocyte Fab (Strausbauch et al., 
1970). The tissue culture response was largely IgM in nature so only 
direct PFC were assayed. In the in vivo experiments both direct and 
indirect PFC responses were estimated, indirect PFC being developed by a 
rabbit antimouse Ig antiserum. 
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In vitro culture of lymphoid cells 
The mixed lymphocyte cultures (MLC) consisted of incubating 
y-irradiated BALB/c spleen cells (4 x 10 6 /ml) with CBA/H lymph node cells 
(2 x 10 6 /ml) and measuring cytotoxic activity after 4 days of culture 
(Lafferty et al., 1974}. Cytotoxic cells specific for the H-2d antigen 
(i.e. BALB/c) were assayed against 51 cr-labelled P815 rnastocytoma (H-2d) 
target cells (Brunner et al., 1968). 
The in vitro anti-DNP response to DNP-MJN was produced by culturing 
CBA/H spleen cells (5 x 10 6 cells in 2.5 ml) in 16 mm Linbro trays 
(Linbro Chemical Co., New Haven, Connecticut, USA) as described previously 
(Kirov, 19 7 4) . 
Procedure for removal of red cells and dead cells 
To 5.0 ml of PBS/10% FCS or tissue culture medium containing from 
10 7 to 5 x 10 8 lymphocytes was added 20 µl of 25% (w/v) sodium azide 
(final concentration 0.1%) and the mixture was then brought to 20°C by 
incubation for 3 min in a 37°C water bath. This preparation was layered 
gently onto 4.0 ml of separating medium which had also been prewarmed to 
20°C and which consisted of 12 parts of 14% (w/v) Ficoll (Pharmacia, 
Uppsala, Sweden) dissolved in distilled water and 5 parts of 32.8% (w/v) 
sodium metrizoate (Isopaque; Nyegaard and Co., Oslo, Norway), the complete 
mixture containing 0.1% (w/v) sodium azide. This mixture had a density of 
1.09, was stored at 4°C, protected from light and will be referred to as 
Isopaque/Ficoll. It was easily sterilized by Millipore filtration. 
The separations were carried out either in 12 ml, U-bottomed, poly-
carbonate centrifuge tubes (16 x 100 mm; cat. No. 272; Ivan Sorvall Inc., 
Norwalk, Connecticut, USA) or in freshly siliconized glass tubes of 
similar dimensions. After the layeri.ng of the lymphoid cell suspension 
on the Isopaque/Ficoll, the tubes were placed in a centrifuge prewarmed 
to 20°C and spun at 2000 g (at the Isopaque/Ficoll interface) for 15 min. 
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The best depletions of red cells and dead cells were obtained if the 
centrifuge accelerated rapidly and attained 2000 g within 20 sec. After 
centrifugation the supernatant above the Isopaque/Ficoll interface was 
discarded and the white cell layer at the interface, together with all the 
separating medium above the red cell-dead cell pellet, collected. The 
white cell preparation was then diluted with 10 ml of cold medium (either 
PBS/10% FCS or tissue culture medium), mixed and the white cells pelleted 
by centrifugation at 300 g for 10 nu.n at 4°C. The pelleted cells were 
then washed once more with medium and counted. 
Results and discussion 
Effectiveness of procedure 
Table 1 summarises the efficiency of the Isopaque/Ficoll procedure 
in removing red cells and dead cells from different populations of mouse 
lymphoid cells. It can be seen that the procedure very effectively 
removes both red cells and dead cells from spleen, lymph node and thymus 
cell suspensions. Furthermore, high recoveries of viable cells were 
usually obtained. In subsequent experiments it was found that red and 
dead cells were also eliminated from bone marrow and foetal liver cell 
suspensions by this technique. 
The method was equally effective at depleting red cells and dead 
cells from lymphoid cell suspensions of either high or low viability. 
However, when >10 8 nucleated cells were applied to the Isopaque/Ficoll, 
the recovery of viable cells declined. In subsequent experiments no more 
than 10 8 nucleated cells were applied to each separation tube. 
Some technical aspects of the separation procedure should be noted at 
this point: 
(a) First, the nature of the rrediurn in which the cells were 
suspended did not significantly influence the separation 
efficiency. Similar results were obtained whether the 
cells were applied in PBS, PBS/10% FCS or F-15. 
TABLE 1 
REMOVAL OF RED CELLS AND DEAD CELLS FROM DIFFERENT POPULATIONS OF MOUSE LYMPHOID CELLS 
Initial Viability Recovery Depletion 
viability after of viable of red 
Cells fractionated procedure cells cells 
(%) (%) (%) (%) 
10 7 spleen cells 66.2 95.1 100 >99.8 
3 x 10 7 spleen cells 66.2 97 .4 100 >99.8 
10 8 spleen cells 66.2 99.7 100 98.2 
10 8 spleen cells 89 .oa 99.0 99.0 99.8 
2 x 10 8 spleen cells 66.2 92.8 85.3 99.0 
5 x 10 8 spleen cells 66.2 96.8 72.2 99.3 
10 8 lymph node cells 62.0 >99.8 95.7 >99.8 
10 8 . . cortisone-resistant 
thymus cells 58.0 99.5 82. 0 99.0 
a Spleen cell suspension prepared at 20°C. All other cell suspensions prepared on 
ice (see Methods and materials). Cell numbers refer to total number of 
nucleated cells applied. 
TABLE 2 
REMOVAL OF SPLEEN CELLS KILLED BY CYTOTOXIC ANTISERA 
Initial Viability after Recovery of 
Spleen cell treatment viability procedure viable cells 
(%) (%) (%) 
10 8 cells treated with normal 
ascitic fluid and complement 
Expt. 1 98.8 99.8 92.0 
Expt. 2 95.7 98.9 98.8 
10 8 cells treated with anti-8 
ascitic fluid and complement 
Expt. 1 66.6 98.7 83.2 
Exp t. 2 69.5 97.7 98.5 
Spleen cell suspensions prepared at 20°C prior to treatment with ascitic fluids. 
(b) In contrast, the presence of sodium azide was essential 
if good separations were to be achieved. It was noted 
that sodium azide was somewhat labile and so a fresh 
stock solution was prepared every 4-6 weeks. It is not 
known why sodium azide has such a marked influence on 
the efficiency of separation. 
(c) The separations were perform2d either in poly-carbonate 
centrifuge tubes or freshly siliconized glass centrifuge 
tubes as white cells did not adhere to the walls of 
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these tubes. As much as 30-40% of the applied cells were 
lost duri.ng the procedure if untreated glass tubes were 
used. 
The results presented so far demonstrate that the Isopaque/Ficoll 
procedure is very effective at removing dead cells from cell suspensions 
teased out from lymphoid organs. Cell death in these cell suspensions 
is probably due to mechanical stress. Several other experiments were 
carried out to determine whether cells killed by other methods, such as 
by the action of cytotoxic antisera and complement, or by several days 
in tissue culture, could also be removed by the Isopaque/Ficoll procedure. 
Table 2 summarizes the ability of the procedure to remove cells 
killed by anti-8 antiserum and complement. In two separate experiments 
it was found that antiserum-treated cell suspensions could be completely 
cleared of dead cells by the Isopaque/Ficoll procedure, with good recovery 
of viable cells. After dead cell removal >1% of the anti-8-treated cells 
were killed when they were re-exposed to anti-8 antiserum. In contrast, 
anti-8 killed the expected percentage of cells in the population treated 
with normal serum. Furthermore, there was a substantial enrichment of 
lg-bearing cells in the anti-8-treated population following dead cell 
removal, i.e. from 45-50% Ig+ cells in untreated spleen to 65-80% Ig+ cells 
in anti-8-treated spleen. 
TABLE 3 
REMOVAL OF DEAD CELLS FROM MIXED LYMPHOCYTE CULTURES (MLC) 
Cells fractionated 
2 x 10 7 cells from MLC 
3.8 x 10 7 cells from MLC 
Initial 
viability 
(%) 
41.8 
43.3 
Viability after 
procedure 
(%) 
96.4 
95.9 
Recovery of 
viable cells 
(%) 
96.3 
89. 7 
MLC consisted of incubating y-irradiated BALB/c spleen cells with CBA/H lymph node cells. 
The cells were harvested and fractionated after 4 days of culture. 
TABLE 4 
RECOVERY OF CYTaI'OXIC CELLS AFTER DEAD CELL REMOVAL PROCEDURE 
Cells fractionated 
2 x 10 7 cells from MLC 
3.8 x 10 7 cells from MLC 
. . . a Cytotoxic activity 
log C.U./culture 
Before 
fractionation 
{%) 
6.73 
6.73 
After 
fractionation 
(%) 
6.68 
6.60 
Recovery of 
cytotoxic 
activity 
{%) 
89. 2 
74.1 
Cytotoxic cells were generated by incubating y-irradiated BALB/c spleen cells with CBA/H lymph 
node cells. The cells were harvested and depleted of dead cells after 4 days of culture. 
The cell preparations tested for cytotoxic activity were the same as those used in the tests 
shown in Table 3. 
a Cytotoxic activity assayed on 51 cr labelled P815 cells. Background= 4.40 log C.U. 
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It was also found that the Isopaque/Ficoll procedure very efficiently 
depleted dead cells from cell suspensions which had been subjected to 
several days of tissue culture (Table 3). The viable cells were also 
recovered in high yield. 
Effect of procedure on immunological activity of cells 
The immunological activity of cell suspensions which had experienced 
the Isopaque/Ficoll procedure was tested in several ways. Initially it 
was shawn that there was no selective loss of either 8+(T) or Ig+(B) cells 
during the separation procedure (Parish et al., 1974). Applying a 
stringent test of the immunological function of T cells, the ability of 
cytotoxic T cells to survive the procedure was determined (Table 4). It 
was found that the cytotoxic cells were recovered in good yield (>80%) 
although there were indications that as more nucleated cells were applied 
to the Isopaque/Ficoll, there was a steady decline in the recovery of 
cytotoxic activity. In additional experiments it was found that the 
precursors of the cytotoxic T cells were also recovered in high yield 
(Parish et al., 1974). 
The immunological function of helper T cells and antibody-forming 
cell precursors (B cells) following the separation procedure was assessed 
both in vivo and in vitro by measuri_ng the antibody response to the 
thymus-dependent antigen DNP-MON. In three separate experiments removal 
of red cells and dead cells had little or no effect on the in vitro anti-
body response to DNP-MON (Table 5). A similar result was obtained with 
the in vivo antibody response (Table 6), in this case both direct and 
indirect PFC responses being not significantly affected by the separation 
procedure. 
TABLE 5 
EFFECT OF DEAD CELL REMOVAL PROCEDURE ON ANTIBODY RESPONSE OF MOUSE SPLEEN CELLS IN VTTRO 
Cell preparation 
Unfractionated spleen cells 
Spleen cells after red and 
dead cell removal 
Expt. 1 
565 ± 59b 
677 ± 41 
Direct anti-DNP PFC/culturea 
Expt. 2 Expt. 33 
1193 ± 117 1303 ± 87 
1048 ± 38 1120 ± 68 
a Spleen cells (5 x 10 6 viable cells in 2.5 ml) cultured with 100 ng/ml of DNP-MON. 
PFC assays made after 3 days of culture. 
b Standard error of mean of four cultures. 
TABLE 6 
EFFECT OF DEAD CELL REMOVAL PROCEDURE ON ANTIBODY RESPONSE OF MOUSE SPLEEN CELIS IN VIVO 
Cell preparation 
Unfractionated spleen cells 
Spleen cells after red and 
dead cell removal 
Anti-DNP PFC/spleena 
Direct 
2308 ± 216b 
2408 ± 384 
Indirect 
3648 ± 640 
4332 ± 1330 
a 10 7 viable DNP-BSA-primed spleen cells were injected into each mouse with 
5 µg of DNP-MON. The mice received 850 rads of y-irradiation 24 hr prior 
to cell transfer. PFC assays made 6 days after cell transfer. 
b Standard error of mean of five recipients. 
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Comparison with other procedures 
The Isopaque/Ficoll procedure for removing red cells and dead cells 
from lymphoid cell suspensions has several distinct advantages over 
previously described techniques. A major advantage is that the procedure 
is much more versatile than any previously reported method, being able to 
remove red cells and dead cells from a wide range of lymphoid cell 
preparations and simultaneously achieve high recoveries of viable cells. 
In contrast, when albumin gradients are used to remove red and dead cells, 
at pH 5.1 they cannot remove cells killed by antibody and complement 
whereas at pH 7. 2 the gradients give low recoveries of viable cells 
(Shortman et al., 1972). Furthermore, the low-ionic-strength filtration 
procedure described by von Boehmer and Shortman (1973) is unable to 
eliminate dead cells from lymphoid cell cultures and is also unable to 
deplete red cells from lymphoid cell suspensions. 
Thus, the Isopaque/Ficoll procedure represents a good general 
method for removing red cells and dead cells from cell suspensions. It 
is simple, and, although slightly more time-consuming than the low-ionic-
strength method, it is easier than the albumin-gradient procedure, care-
fully prepared albumin-density media not being required. 
Summary 
A procedure is described for simultaneously removing red cells and 
dead cells from lymphoid cell suspensions, based on the observation that 
when populations of lymphoid cells are centrifuged on a mixture of 
Isopaque/Ficoll, dead cells and red cells sediment whereas viable cells 
float. The technique very efficiently removed red cells from a wide 
range of lymphoid cell suspensions and eliminated lymphocytes killed by 
mechanical stress, by antibody and complement and by prolonged tissue 
culture. 
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The depletion of red cells was >99% and the recovery of viable 
lymphocytes usually >90%, the resulting cell suspensions being around 
95-100% viable. The inununological activity of B cells, helper T cells 
and cytotoxic T cells was virtually unimpaired by the separation 
procedure. 
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